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Abstract 
The consequence of many psychiatric and neurodegenerative disorders, such as 
Parkinson’s disease and schizophrenia, is an impairment in ‘executive functioning’; an 
umbrella term for several cognitive processes, including the focussing and shifting of 
attention and the inhibition of responding. The ability to form an ‘attentional set’ involves 
learning to discriminate qualities of a multidimensional cue, and to subsequently learn 
which quality is relevant, and therefore predictive of reward. According to recent research, 
the subthalamic nucleus (STN) and possibly the adjacent zona incerta (ZI) may mediate the 
formation of attentional set. Dysregulation of the STN as a result of Parkinson’s disease 
contributes to characteristic motor symptoms, and whilst deep-brain stimulation of this 
region may treat gross motor impairments, it may also impair cognition. The work in this 
thesis aimed to expand our understanding of the mechanisms of attentional set-formation, 
and the role of the STN in this process.  
This thesis evaluates new methods for examining set-formation in the attentional 
set-shifting task; rather than inferring this behaviour solely from the cost of shifting set, 
modifications to the task design in Chapters 3 & 4 explored several hypotheses designed to 
exploit a deficit in this behaviour. Chapter 6 revealed that inhibition of this region with 
designer receptors leads to a disruption in attentional selectivity, which compromises the 
ability to form an attentional set. This manifested as an inability to parse relevant 
information from irrelevant, and instead, animals learned the stimuli holistically. The 
findings in this thesis also suggested that reversal and attentional shifting processes do not 
operate independently, but rather in a hierarchy, and that consequently, the STN is a region 
that may be crucial in selecting appropriate responses during associative learning that leads 
to the formation of an attentional set.    
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Chapter 1 
 
General Introduction 
 
 
 
 
 
 
 
 
 
 
Executive functions are exercised readily in daily life, facilitating a 
variety of tasks, such as maintaining focus in a noisy environment 
or planning and executing a goal. Disruption of these processes is 
found in many psychiatric/neurodegenerative disorders and is also 
associated with healthy ageing. One such process is the ability to 
form an attentional set, and there is recent evidence that the STN – 
a key input structure of the basal ganglia – and possibly the ZI, 
might be implicated in this process. In this chapter, I will outline a 
brief history of behavioural tasks that led to the conception of the 
attentional set-shifting task used in this thesis, along with a 
theoretical framework which accounts for it. Information regarding 
the connections and neurochemistry of the STN/ZI will also be 
briefly explored, along with examining the current role of the STN 
in cognition. 
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It was the summer of 2014. As a first-year PhD student, I eagerly anticipated my 
first summer ‘vacation’ in picturesque Scotland, and decided to hire a car for the purpose of 
driving to the Highlands. I ventured westward and was staying the night in Ballachulish, 
near Glencoe, which has been lauded for its striking, natural beauty. However, there was an 
‘obstacle’ which loomed over me and required addressing before setting off from St 
Andrews – as a Canadian who has never driven in the UK before, I have never operated a 
right-hand drive car.  
I hesitantly departed from the east coast with this consideration in mind, and being a 
motoring enthusiast I felt confident in my ability to not become ‘one with nature’ by ending 
up in a ‘loch’. As the journey progressed, I gradually became more accustomed to driving 
on the left side of the road, whilst concurrently operating the gear stick with my left hand. I 
also kept a watchful eye out for signs for the A85, to guide me toward the Trossachs 
National park, whilst equally ignoring signs that would take me north, into the Cairngorms 
National park. Despite not having driven since leaving Canada over a year prior to this trip, 
I managed to arrive at my destination unscathed, and fortunately, so did the hired car. 
Whilst this adaptation in driving behaviour does not seem overly arduous, there existed a 
myriad of cognitive processes which facilitated the journey, each intersecting with 
harmonious complexity. In order to make this cross-Scotland expedition, I needed to:  
 
1. remember how to operate a car, including mechanical skills such as operating a 
clutch pedal  
2. attend to visual cues in my environment consistent with my goal, such as 
directional signs, and signs indicating the speed limit  
3. retain navigational directions for my destination, and continually update these 
directions with passing road signs 
4. extrapolate relevant memories from navigating Canadian roads to Scottish roads 
(i.e., landmark X is roughly 10 miles from the upcoming turn onto road Y)  
5. remember the rules for the direction of traffic in Canada (look left first, then right 
when proceeding)  
18 
 
6. manipulate and apply these rules to driving in the UK (look right, then left when 
proceeding)  
7. respond flexibly to sudden changes in my internal (e.g., sudden motion sickness) 
or external (e.g., deer in the road) environment  
8. avoid distraction from extraneous activities in my environment (e.g., a kilted 
bagpiper on the roadside) 
 
The listed steps illustrate fundamental cognitive requirements for everyday life, 
including the ability to identify goals and organise them into a plan, retain information in 
memory, access and integrate relevant memories with current environmental information, 
all whilst remaining flexible to changes in one’s environment. These processes exemplify 
what is known as ‘executive control’; an umbrella term used to describe cognitive functions 
such as working memory, planning, mental flexibility, and the initiation or inhibition of 
action (for review see Chan, Shum, Toulopoulou, & Chen, 2008). Inhibition of action can 
be further divided based on whether the cognitive demands arise from a required change in 
the internal (‘self-control’: resisting temptation or impulsive action) or external 
(‘interference control’: selectively attending to relevant information/inhibiting irrelevant 
information) environment (Diamond, 2013). As in my trip to Ballachulish, the roles of 
many executive functions intersect, or are dependent on one another, which gives rise to  
whether a ‘central executive’ or an attentional-controlling system may govern executive 
resources (Atkinson & Shiffrin, 1971; but see: Baddeley & Hitch, 1974).  
Research by Atkinson & Shiffrin (1968) posited that a ‘short-term memory store’ 
held the role of controlling the executive system, and introduced a formalised model which 
maintained that sensory information was stored in a temporary buffer until pertinent 
qualities of the information were encoded into ‘long-term memory’. The authors claimed 
that the role of the central executive included coordinating and monitoring complex 
subroutines and mediating novel information, whilst retrieving old information from 
storage (Atkinson & Shiffrin, 1971). Subsequent research by Baddeley & Hitch (1974) 
critiqued the role of Atkinson & Shiffrin’s central executive by claiming they focussed too 
much on it being a memory system, especially since Atkinson & Shiffrin’s model failed to 
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reconcile competing evidence for non-memory executive tasks, along with selective 
memory impairments in one sensory modality and not another (e.g., auditory and not 
vision; see Warrington & Shallice, 1969). Baddeley & Hitch (ibid) proposed a ‘working 
memory’ system which simultaneously provides storage and processing of information via 
the central executive and two slave systems: the visuospatial sketchpad (which manipulates 
visual images), and the phonological loop (which stores and rehearses speech-based 
information; Baddeley, 1992; 1996).  
Research attempting to identify the neurological substrate of the central executive 
has  revealed that the prefrontal cortex (PFC) is the most likely contender for this role 
(Duncan, 2001; Miller & Cohen, 2001). Evidence which spurred early experimental 
research mostly stemmed from observations of aberrant behaviour after some form of 
trauma, irrespective of direct aetiology (i.e., tumour, injury, cerebrovascular occlusion, etc.). 
Increased admission rates of brain-damaged patients – typically to the frontal area – during 
World War II (Goldstein & Scheerer, 1941), and in some case studies, as early as the end of 
World War I (Gelb & Goldstein, 1920, reviewed in Goldstein & Scheerer, 1941), present as 
some of the earliest formalised research of executive functioning impairment. Whilst this 
exploration of covert cognition by examining overt behaviour paved the road for 
researchers in the generations to come, these experiments were predominantly qualitative 
case studies, with a general diagnosis of “dementia” or “amnesia”, and in the case of the 
World War veterans, symptoms resembling “dementia praecox” (i.e., schizophrenia; ibid). 
Based on this account, there appeared to be a functionally similar consequence of frontal 
brain damage and psychiatric symptoms.  
1.1 Impairments in executive functioning  
 Patients with schizophrenia who experience cognitive symptoms, typically exhibit 
impairments in executive functioning, including difficulty sustaining attention, trouble 
focussing, and varying degrees of impairment in working memory (National Institute of 
Mental Health). Since schizophrenia affects several distinct brain regions, generally 
resulting in a decrease in brain volume (Wright et al., 2000), the brain region of origin for 
the pathology of schizophrenia is still under debate. One specific region that experiences 
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reduction of volume is the PFC (see: Takayanagi et al., 2010), resulting in its dysfunction, 
and likely contributing to the observed cognitive symptoms (Meyer-lindenberg et al., 2005). 
Furthermore, aberrant PFC morphology can also be used as a predictor for symptom onset, 
and potential development of schizophrenia amongst high-risk groups (Chakirova et al., 
2010). In addition to schizophrenia, PFC dysregulation has been implicated in a plethora of 
psychiatric illnesses and conditions resulting if a variety of executive impairments, 
including attention-deficit/hyperactivity disorder (ADHD) (Bush, Valera, & Seidman, 
2005), depression (Mann et al., 1996; but see: Stanley, Virgilio, & Gershon, 1982), 
Alzheimer’s disease (Donix, Small, & Bookheimer, 2012), frontotemporal dementia 
(Rohrer & Warren, 2011), Parkinson’s disease (Taylor, Saint-Cyr, & Lang, 1986), along 
with participating in a reward circuit facilitating drug abuse (Volkow & Fowler, 2000). In 
patients PFC tumours, the degree of insult varies by case, which creates heterogeneous 
symptomology. For example, in one case a patient scored highly in language ability, 
memory proficiency, visual perception, ethical reasoning and computational calculation, 
but was impaired in decision-making, and despite being able to solve decision-making 
problems in abstract circumstances (i.e., in a test or battery), the patient could not apply 
problem-solving solutions to ‘real-life’ situations (Eslinger & Damasio, 1985).  
Given the involvement of the PFC in the mediation of executive functioning, and 
that its dysregulation leads to impairment in said functioning, it is apparent why it has been 
ascribed the role of the ‘central executive’; however, it is pertinent to note the important 
connections the PFC shares with other regions of the brain, many of which actually present 
as the origin for the pathology of the aforementioned psychiatric illnesses. Inherently, the 
frontal cortex does not operate independently, and participates in conjunction with other 
cortices, subcortical structures, and with certain sectors of the sensory and motor apparatus 
(see: Fuster, 2015). PFC dysregulation then, in many instances, arises as a result of a 
downstream effect from a distal brain region or group, such as the basal ganglia (BG), with 
which the PFC forms a circuit. For example, Parkinson’s disease and Huntington’s disease 
– two neurodegenerative disorders – are marked by dysfunction in the striatum, which 
consequently results in dysregulation of the fronto-striatal pathway (Obeso et al., 2008; 
Ross & Margolis, 2001). Furthermore, there is evidence that ADHD patients present with 
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dysfunction of the caudate nucleus of the dorsal striatum (Bush et al., 2005), emphasising 
the importance of the fronto-striatal pathway, and more broadly the fronto-BG circuitry, in 
the maintenance of executive functioning.  
Given this intimate connectivity, it is essential to investigate how the subcortex 
contributes to the maintenance of ‘processes’ typically considered executive functions. 
These contributory processes can be isolated and studied across a range of species to better 
understand how psychological concepts (e.g., working memory, inhibition, etc.) are 
influenced by neural substrates. It is therefore pertinent to explore how quantifiable 
neuropsychological tasks in humans, non-human primates and rodents have developed to 
probe such processes in order to shift away from qualitative case studies.  
1.2 Neuropsychological tests of executive function: sorting and 
shifting 
Seminal work by Gelb & Goldstein (1920; in Goldstein & Sheerer, 1941) concluded 
that war veterans with brain injury suffered from ‘aphasia’ or ‘dementia’ based on their 
overt, and selective impairment in ‘abstract’ thought, but not ‘concrete’ manipulation. For 
example, the patients could exercise the ‘concrete’ function of a clock by telling the time, 
but had difficulty in ‘abstract’ representation, such as setting the clock to a specified hour 
(ibid; Vigotsky & Kasanin, 1934). To formally test for this, the authors designed a ‘colour 
sorting test’, which presented patients with patches of woollen fabric dyed with several 
different colours, which also ranged in intensity (e.g., dark green to a lightly saturated 
green), and instructed patients to sort them based on their colour. This seemingly simple 
task was met with great difficulty and uncertainty on what constituted a particular colour by 
the patients, perhaps stemming from impairment in decision-making ability. Modifications 
to Gelb & Goldstein’s ‘colour sorting test’ by Weigl (1927; translated and republished in 
Weigl, 1941) replaced fabric swatches with different cardboard shapes varying in colour, 
along with a change in instructions. Subjects could now sort the shapes however they 
wished (e.g., based on colour), and upon sorting would then be asked to pick a new strategy 
and sort them again (e.g., shape), and this continued until the subject could no longer 
formulate a novel strategy. Brain-damaged patients expressed difficulty in shifting to novel 
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strategies, and instead perseverated with an existing one. Despite this information, Weigl’s 
task still presented with shortcomings, especially since diverse sorting strategies were 
admissible owing to many stimulus shapes (e.g., sorting varied quadrilaterals separately) 
(ibid: experiment 5). In order to address this, and in an effort to move towards examining 
cognitive performance, rather than a simple diagnosis, the Wisconsin Card Sorting Task 
(WCST) was developed (Berg, 1948).   
The WCST, which is still widely used today, presents subjects with a deck of cards, 
illustrated with a number of coloured shapes, and the subject must learn – through trial and 
error – the correct strategy for sorting the cards either based on the number of shapes on the 
card, the colour of the shapes, or the shapes themselves. The subject is requested to proceed 
through a deck of cards and asked to sort each ‘response card’ in to one of the four 
‘stimulus card’ piles in front of them, and sorting of a ‘response card’ is followed by 
feedback indicating whether their selection was correct or incorrect (figure 1.1). Following 
attainment of learning criterion (i.e., five consecutive correct responses in Berg, 1948), the 
experimenter will ‘shift’ the sorting strategy to a novel one, which provides a measure of 
cognitive flexibility, along with a quantitative index for number of errors, which previous 
sorting tasks failed to measure (Grant & Berg, 1948). Healthy control participants exhibit a 
behavioural cost (i.e., an increase in trials and errors) when the strategy is shifted, however 
subsequent experiments revealed that this ‘cost’ was exacerbated in groups with executive 
functioning impairment, including patients with dorsolateral prefrontal cortex (dlPFC) 
damage (Milner, 1963), age-related cognitive decline (Ridderinkhof, Span, & Molen, 2002), 
schizophrenia (Nieuwenstein, Aleman, & de Haan, 2001), ADHD (Romine et al., 2004), 
along with neurodegenerative diseases such as Alzheimer’s disease (Nagahama, Okina, 
Suzuki, Nabatame, & Matsuda, 2005) and Parkinson’s disease (Paolo, Triister, Axelrod, & 
Koller, 1995; for review see: Brown & Tait, 2016).  
Concurrent to the development of the WCST, a separate group of researchers 
investigated the mechanisms of discrimination learning in experimental animals. These 
experiments measured the animals’ ability to perceive differences between stimulus 
qualities (i.e., shapes vs lines) by rewarding one stimulus and not another in various 
apparatuses, including mazes (Lashley, 1929) and a “jumping stand” (Lashley, 1930). The 
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latter, as the name implied, required rats to jump from a small, unstable elevated platform 
towards one of two cardboard cut-outs differing in visual pattern, such as shape (e.g., 
horizontal line, triangle) and ‘brightness’ (e.g., black or white), with one stimulus pairing  
 
Figure 1.1: The WCST requires subjects to sort a response card from the unsorted pack to 
one of the four stimulus cards in the sorting piles; for example, the current card can be 
sorted based on colour (pile 1), number (2), or shape (3); image from Brown & Tait (2016).   
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(e.g., black triangle) being correct, whilst the other pairing (e.g., white horizontal line) was 
incorrect.  The correct stimulus could be easily folded, allowing entry into a reward 
chamber with a larger platform, whilst the incorrect stimulus was immovable; overall, rats 
learned to discriminate between the visual patterns on the stimuli cards fairly quickly (ibid). 
Jacobson subsequently adapted Lashley’s procedure for work with monkeys, in which 
subjects were trained to retrieve food by displacing a visual stimulus card to gain access to 
a food well (Jacobson, 1936), which ultimately inspired the Wisconsin General Testing 
Apparatus (WGTA), and is still used in both monkey and human research to date (Harlow 
& Bromer, 1938). With this task, Harlow critiqued ‘rat psychologists’ for not focussing on 
how we “learn to learn”; an effect which he observed in primates and referred to as 
“learning set”, and can be regarded as a practice effect of sorts, arising from consecutive 
discrimination learning/reversal learning (Harlow, 1949).  
At the same time, Lawrence investigated the effects of ‘transferring’ stimulus 
aspects between discrimination learning trials in rats (1949). In his experiment, rats were 
trained in a ‘two-choice’ (either stimulus A or B) apparatus with a ‘waiting area’ placed in 
front to two goal compartments, which extended linearly with a reward found at each end. 
The apparatus was modified such that two “stimulus dimensions” were presented in 
compound, with one dimension predictive of reward (‘relevant’), and the other was non-
predictive (‘irrelevant’). For example, for one group of rats, the brightness of the goal 
compartment (black vs white paint) may be relevant, whilst the width of the compartment 
(or the texture of the floor) was irrelevant for obtaining reward. Following training, rats 
completed a testing phase in a ‘T-Maze’ with the same stimulus dimensions present, 
however the relevancy of the stimulus dimension was switched for half of the rats. 
Lawrence found that rats completed the testing phase with fewer errors if the relevant 
dimension stimuli were the same as the training phase (“positive transfer”), compared to 
rats that were tested on the previously irrelevant dimension stimuli (“negative transfer”; 
ibid). This observation that there is a cost of shifting to an irrelevant dimension formed the 
basis for ‘attentional set’, by illustrating that distinct qualities of cues learned during 
discrimination learning can influence subsequent learning in similar situations.  
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To reconcile Lawrence’s observations, Sutherland & Mackintosh (1971) proposed a 
‘two-stage’ theory of discrimination learning, which assumed that animals must learn to 
attend to a relevant stimulus dimension (i.e., shapes) and learn to attach the correct 
responses to stimuli (i.e., approach triangle; avoid square). The authors posited that 
stimulus input is fed into a number of ‘analysers’, which evaluate this input along particular 
dimensions. These analysers contain different possible outputs, which form an attachment 
to a given response (i.e., approach or avoid; see figure 1.2). For example, during a task in 
which the ‘shape’ dimension is relevant (triangle=correct; rectangle=incorrect), and the 
‘brightness’ is irrelevant, the rat would receive a reward for selecting a black triangle (vs a 
white square). This will strengthen the ‘shapes analyser’ since the output of triangle formed 
an ‘approach’ response attachment (whilst square formed an avoidance response 
attachment). Furthermore, during this trial the ‘brightness analyser’ would also be 
strengthened due to partial reinforcement (i.e., the output of ‘black’ would also form an 
approach response attachment); however in a subsequent trial, in which a white triangle 
may be presented, this brightness analyser would lose strength, upon selection of the 
correct stimulus. The authors’ anthropomorphised process of strengthening or ‘switching in’ 
analysers forms the basis for attentional set-formation; by focussing attentional resources 
toward a particular stimulus dimension, novel learning within this dimension is enhanced; 
this process can also be likened to Harlow’s process of ‘learning to learn’ (Harlow, 1949; 
Sutherland & Mackintosh, 1971). 
1.3 Attentional set  
The concept of ‘set’ has been ascribed various definitions across psychology (see: 
Gibson, 1941), such as ‘concepts’ or ‘attitudes’ (Vigotsky & Kasanin, 1934), a ‘mental set’ 
(Grant & Berg, 1948), leading up to the current – and still widely used – ‘attentional set’ 
(Sutherland & Mackintosh, 1971). In this context, ‘set’ refers to a predisposition for 
attentional resources to be preferentially directed towards relevant stimulus qualities 
resulting in enhancement of novel learning, whilst concurrently inhibiting irrelevant 
information (Brown & Tait, 2016). Attentional set can then be regarded as a cognitive 
shorthand or heuristic, in which knowing about contingencies and rules allows the animal 
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to anticipate for future events, limiting the range of available options, and increasing the 
speed of processing (Brown & Tait, 2010). Consequently, when faced with an unexpected  
 
Figure 1.2: Diagram of Sutherland & Mackintosh’s two-stage theory of learning; stimulus 
input is fed through ‘analysers’, which are strengthened or weakened by the response 
attachment formed with their outputs; solid lines indicate learned response attachments; 
hashed lines indicate other possible response attachments; B designates black; W, white; T, 
triangle; S, square; L, left; R, right; adapted from Sutherland & Mackintosh (1971).  
problem, this attentional set must be overridden, and thus remaining cognitively flexible is 
crucial for the ability to ‘shift’ attentional set. Measuring the strength of an attentional set 
can be inferred by examining this ‘cost’ in learning performance by comparing the number 
of trials to acquire a discrimination within the same dimension (i.e., intradimensional; ID) 
with the number of trials when learning requires a shift in attention (i.e., extradimensional; 
ED). As such, the shifting required for an ED discrimination is not inherently more difficult 
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than acquiring an ID discrimination; the increased learning requirements arise as a result of 
a predisposition to selectively attend to one stimulus dimension over another. This 
consideration is referred to as the “Einstellung effect” (see Luchins, 1942), which posits 
that novel learning is retarded by the erroneous application of a previous rule or principle. It 
thus follows that in the absence of an attentional set, there would be no cost of learning an 
ED acquisition; however, in the absence of set, there would now be an existent deficit 
during ID learning, when an attentional bias would have facilitated novel learning.  
A measure of set-shifting performance presents as a valuable index of several 
cognitive processes for clinical and experimental neuropsychology, and therefore various 
tasks have been developed in both humans and animals. These attentional set-shifting tasks 
employ a ‘total change’ design (Slamecka, 1968), which presents a series of discriminations, 
including stages in which completely novel exemplars are introduced, along with reversal 
learning stages. These total change design tasks can be contrasted to ‘rule change’ set-
shifting tasks’ (otherwise known as ‘rule-shifting tasks) (Settlage, Butler, & Odoi, 1956), 
such as the WCST, which maintain the same stimuli throughout the task. This thesis will 
exclusively focus on a rodent attentional set-shifting task of total change (Birrell & Brown, 
2000), which owes its conception to the Cambridge Neuropsychological Automated Test 
Battery (CANTAB) (Roberts, Robbins, & Everitt, 1988; Sahakian & Owen, 1992).  
The CANTAB ID/ED task – via a touchscreen interface – presents subjects with a 
series of discriminations based on visual stimuli of shapes with superimposed lines 
representing two perceptual dimensions (figure 1.3). Subjects begin by learning a simple 
discrimination (SD) with only one presented dimension, and once criterion performance is 
achieved, a second – irrelevant – dimension is added in compound to the first. Following a 
compound reversal stage, novel exemplars are introduced at the ID, which maintains the 
relevancy of dimension from the previous stages (i.e., shapes). At the ED stage, novel 
exemplars are again introduced, but here the previously relevant dimension is now rendered 
irrelevant, and the previously irrelevant dimension is now relevant. Given its interface, the 
task could be administered to humans (Owen, Roberts, Polkey, Sahakian, & Robbins, 1991), 
and non-human primates (Dias, Robbins, & Roberts, 1996b; Roberts et al., 1988) alike. 
Research in humans has expanded our understanding of impairments in behavioural  
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Figure 1.3: Sample stimuli and test procedure from the CANTAB, which is a two-choice 
visual discrimination task. Subjects initially learn that ‘shape’ (and not ‘line’) is relevant 
for reward, even after the presentation of novel stimuli at the ID. Relevancy changes to line 
at the ED and subjects must shift their attention to a previously irrelevant dimension image 
from Brown & Tait (2016).     
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flexibility amongst brain-damaged patients and those suffering from mental illness 
(Lawrence, Sahakian, & Robbins, 1998; Owen et al., 1991; 1993).  Excitotoxic lesion 
studies in monkeys have provided invaluable findings regarding the functional architecture 
of the PFC (Dias, Robbins, & Roberts, 1996a; Dias et al., 1996b; Roberts, Robbins, Everitt, 
& Muir, 1992); however the monkey task reportedly takes several weeks to complete (9-11 
weeks in Roberts et al., 1992), which complicates the dosing schedule for pharmacological 
studies, along with increased odds of neuroplasticity throughout the post-surgery test period. 
To account for this, the CANTAB ID/ED task was adapted for use in rats.  
It is well-documented that rats are not particularly visual animals, and possess poor 
visual acuity for detail (Birch & Jacobs, 1979) and being nocturnal, rats typically flee from 
brighter environments. Instead, rats rely on their highly attuned sense of smell and touch as 
primary investigative senses. Whilst previous discrimination learning tasks have employed 
visual stimuli (Lawrence, 1949; Mackintosh & Little, 1969), training and testing usually 
spanned hundreds of trials (Bussey, Muir, Everitt, & Robbins, 1997) for rats to attain 
criterion learning, providing little refinement from the CANTAB; therefore designing a 
species-appropriate task, which targets the rats’ natural tendencies was paramount for the 
rodent  ID/ED task. Work by Wood, Dudchenko, & Eichenbaum (1999) found that rats can 
be trained to dig in small bowls filled with sawdust to obtain a food reward, which suited 
their natural digging and foraging behaviour. In a follow-up experiment, the authors added 
various odours to bowls of sand, some of which were predictive of reward in an effort to 
investigate non-spatial memory in rats (Dudchenko, Wood, & Eichenbaum, 2000). Birrell 
& Brown (2000) expanded on the fundamental principle of this task, by introducing various 
digging media, and textured covers for the digging bowls as stimulus dimensions, which 
could be used alongside odour cues as another dimension.  
The bowl-digging paradigm introduced in Birrell & Brown (2000) matched the 
primate CANTAB task in that novel stimuli were introduced at the ID and ED stages, 
respectively (figure 1.4). More importantly, data from control rats matched the established 
patterns for learning – namely a cost of shifting set from the ID stage to the ED stage – 
previously evidenced in humans (Owen et al., 1991) and non-human primates (Dias et al., 
1996b). Testing in rats could also be accomplished in a single session, presenting as a 
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technical refinement to examining set-shifting performance in animals. Furthermore, 
lesions to the rat medial PFC (mPFC), which is the rodent analogue of the primate lateral 
PFC, led to comparable behavioural deficits – namely impaired set-shifting performance 
marked by increased trials at the ED stage, whilst lesions of the rat orbital PFC (OFC; 
structurally analogous in the primate) matched the impaired reversal learning performance 
seen in primates (Birrell & Brown, 2000; Brown & Bowman, 2002; Dias, Robbins, & 
Roberts, 1997; McAlonan & Brown, 2003).  
Research by Dias et al. (1996a) posited that lesioning two different regions of the 
PFC (e.g., lateral vs orbital) produced a ‘double-dissociation’; they evidence that a lesion of 
the lateral PFC does not disrupt reversal learning, and that the OFC does not likely play a 
role in attentional set. More broadly, this implied that the mechanisms for reversal learning 
were different to those involved in attentional set. It is important to note that the OFC-
lesioned monkeys in Dias et al. (1996a) took twice as many trials to acquire the ID 
compared to control and lateral-PFC lesioned animals, yet the data regarding the cost of 
set-shifting for this group was not reported. The OFC-mediated reversal learning 
impairment was subsequently replicated in rats (McAlonan & Brown, 2003), and owing to 
a revised task design in which reversal stages were placed before the ED stage (the reversal 
stages in Dias were presented after the ED), it was found that lesioned rats failed to present 
with a ‘positive cost’ of shifting set – in which the ED is greater than the ID – which led 
McAlonan & Brown to speculate whether an attentional set had even been formed.  
The failure to form an attentional set presents a novel behavioural deficit compared 
to that of a shifting impairment, and can be inferred as a likely cause of the lack of an 
ID/ED difference, stemming from the rationale that if set was not formed, then it does not 
require shifting. To aid in the inference of this behavioural deficit, the rodent attentional 
set-shifting task (ASST) can be modified by removing the reversal stages, and replacing 
them with multiple ID stages to promote set-formation (Bissonette et al., 2008). Chase et al. 
(2012) found that four consecutive ID stages (the 4-ID task) were sufficient to restore the 
cost of set-shifting in OFC-lesioned rats, suggesting that OFC-mediated deficits in reversal 
learning and set-formation were due to a single cognitive deficit, which also challenged the 
established notion of a ‘double-dissociation’.  
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Figure 1.4: Sample stimuli and typical task procedure of the rodent attentional set-shifting 
task. Rats initially learn that the odour dimension is relevant (with O1 being correct), 
which is reinforced by novel exemplars at the ID stage (O3 is now correct); the dimension 
shifts relevancy to medium at the ED stage (now M5 is correct) with the presentation of 
novel exemplars. 
32 
 
Further research suggested that the impairment in attentional set-formation may 
involve several neural substrates. It was found that rats with quinolinic acid (QA) lesions of 
the dorsomedial striatum (DMS) do not present evidence for attentional set-formation, even 
on the 4-ID task (Lindgren, Wickens, Tait, Brown, & Dunnett, 2013), suggesting that the 
DMS-mediated set-formation impairment manifests differently than the OFC-mediated 
impairment. Furthermore, lesions to the non-cholinergic neurons of the rat basal forebrain 
(Tait & Brown, 2008) may also impair set-formation, as no ID/ED difference was observed, 
along with replicating the previously observed impairment in reversal learning in monkeys 
(Roberts et al., 1992); however further research specifically investigating set-formation is 
needed.   
Recent experimental evidence from our lab has suggested that the subthalamic 
nucleus (STN) and possibly the zona incerta (ZI) may also play a role in the formation of 
attentional set (Tait, Phillips, Blackwell, & Brown, 2016). The STN and the ZI are 
anatomically adjacent regions of the BG and are located ventral to the thalamus. Of these 
two neural substrates, the STN garners considerably more research interest than the ZI. The 
STN is a key input structure in the BG, responsible for regulation of many components of 
the BG itself, along with receiving projections from the PFC (Baunez & Lardeux, 2011; 
Nambu, Tokuno, & Takada, 2002), whereas the ZI, which lies dorsal to the STN and is 
comprised of a dorsal (ZID) and ventral (ZIV) component, actually remains among some of 
the least-studied regions in the brain (Urbain & Desche, 2007). 
1.4 The Basal Ganglia  
BG functioning has largely been researched in relation to the control of movement, 
stemming from the fact that BG dysregulation has been identified in various movement 
disorders, such as Parkinson’s disease (DeLong, 1990; Obeso et al., 2008). The BG are a 
group of subcortical nuclei which form a complex network of connectivity, and also project 
to other regions in the subcortex, along with the neocortex. Classically, the BG were 
regarded as a series of ‘connective loops’, and were thought to be a closed ‘relay’ system 
which received information from the cerebral cortex, and then “funneled” this information 
through a series of closed and parallel loops through the striatum, pallidum and substantia 
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nigra (SN), in order to provide feedback to the cortex via the ventrolateral thalamus 
(Alexander, DeLong, & Strick, 1986). Over the next few years, this information was 
formalised into the first coherent model of BG functioning (figure 1.5a), which included 
two circuits of motor control – the ‘direct’ and ‘indirect’ pathways (Albin, Young, & 
Penney, 1989; DeLong, 1990; Penney & Young, 1986).  Both pathways originate from the 
striatum, with the ‘direct’ pathway resulting in an increase in thalamo-cortical activity, and 
the ‘indirect’ pathway, a decrease in thalamo-cortical activity. This created a “rate model” 
of BG functioning, in which the ‘direct’ pathway facilitated movement, and the ‘indirect’ 
pathway inhibited/stopped movement. In the ‘direct’ pathway, medium spiny neurons 
(MSNs) of the striatum express D1-type dopamine receptors, which exert tonic, inhibitory 
control over the SN-reticulata (SNr) and internal globus pallidus (GPi), which are now 
inhibited, and therefore their projection to the thalamus results in increased thalamo-cortical 
activity (Albin et al., 1989). In the ‘indirect’ pathway, MSNs expressing D2-type receptors 
from the striatum inhibit the external globus pallidus (GPe), which attenuates the GPe’s 
inhibitory effect on the STN, which in turn stimulates the SNr and GPi, resulting in 
decreased thalamo-cortical activity (ibid). The modulation of striatal dopamine is crucial 
for movement, and as expected dopaminergic depletion – the key feature of the 
Parkinsonian state – renders the STN ‘hyperactive’ and consequently enhances activation 
of the ‘indirect’ pathway (Gerfen et al., 1990; Obeso & Lanciego, 2011). In turn, silencing 
the STN via deep-brain stimulation (DBS) has become a popular therapeutic option for 
amelioration of motor symptoms of Parkinson’s disease (Benabid et al., 1994). 
1.5 Connections of the STN and ZI 
Advancement in tracing technology has provided anatomical evidence that the STN 
receives direct input from several key areas of the brain (figure 1.5b). The identification of 
a third – ‘hyperdirect’ – pathway of the BG, which projects directly from the cortex to the 
STN, elevated the role of the STN from an intermediary or ‘control’ structure between the 
GPe and GPi, to a key input structure in the BG (Nambu et al., 2000, 2002). This 
hyperdirect pathway originates in motor-related cortical areas (including the primary motor 
cortex, supplementary motor area, and the dorsal and ventral premotor cortices; see Nambu, 
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Takada, Inase, & Tokuno, 1996; 1997), yet there was additionally evidence from tracing 
studies that showed that frontal ‘cognitive’ areas, such as the mPFC and OFC, directly 
project to the STN as well (Janssen, Visser-Vandewalle, & Temel, 2010). It is suggested 
that the fronto-subthalamo pathway operates in competition with the ‘direct’ pathway 
(Leblois, Boraud, Meissner, Bergman, & Hansel, 2006), and that this pathway is fast-acting, 
compared to the slower striatal pathways (Isoda & Hikosaka, 2008; Nambu, 2004), which 
may work to suppress activation of the ‘direct’ pathway (Aron & Poldrack, 2006a). This 
connection, coupled with the finding that the STN also has a direct output projection to the 
ventral thalamus (Rico et al., 2010) – therefore bypassing the pallidum –  likely suggests 
that the STN is crucial in the rapid control and selection of responses.  
The STN may also play a modulatory role in inter-BG circuitry, and the 
identification of an STN-GPe-GPi ‘microcircuit’ also ascribed a new role to the GPe for 
controlling BG output activity, rather than merely being a ‘go-through’ station in an 
‘indirect’ pathway (Obeso, Rodriguez-oroz, Blesa, & Guridi, 2006). The reciprocal 
connection between the STN and the GPe normally exhibits weakly correlated, irregular 
activity (Urbain et al., 2000); however, following dopamine depletion in Parkinson’s 
disease, this reciprocal connection exhibits highly correlated, rhythmic bursting activity 
(Bergman, Wichmann, Karmon & De Long, 1994), which likely contributes to the 
increased downstream inhibition of the thalamocortical neurons, which may eventually 
express as akinesia and rigidity. 
In light of these new connections and updated roles for functioning, the view that 
the BG operates as an ‘on-off’ pathway for action selection is outdated; current modelling 
suggests that the BG operates via a series of parallel, largely segregated re-entry loops or 
channels (see Redgrave, Vautrelle, & Reynolds, 2011), which receive input from 
functionally segregated areas of the cerebral cortex (i.e., limbic, associative, sensory and 
motor; for review see Mcgeorge & Faull, 1989) in concert with the dense, and intimately 
interconnected inter-BG modulatory networks (i.e., the STN-GPe-GPi microcircuit), which 
contribute to the shaping of output behaviour.  
Research regarding the functioning of the ZI – literally, the ‘uncertain zone’ – is 
sparse, yet evidence exists that the ZI has distinct cytoarchitectonic subdivisions, and that 
  
 
 
Figure 1.5: a) An illustration of the classic Albin-DeLong model of the Basal Ganglia; red lines indicates excitatory projections, 
blue lines inhibitory, and green lines dopaminergic. Solid arrows indicate the ‘direct’ pathway, and hashed lines the ‘indirect’ 
pathway, in which the STN was seen as a relay centre; b) A revised model of Basal Ganglia connections based on recent findings, 
illustrating a revised, and increasingly complex, role for STN functioning (simplified from Obeso and Lanciego, 2011). 
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each subdivision gives rise to a distinct pattern of efferent projections (for review see 
Romanowski, Mitchell & Crossman, 1985; also Watanabe & Kawana, 1982). Early 
research has demonstrated that the rat ZI receives afferent inputs from the thalamus 
(Swanson, Cowan & Jones, 1974), hypothalamus (Krieger, Conrad & Pfaff, 1979), brain 
stem (Bowsher, 1975) and the cerebellum (Faull & Carman, 1978). More recent research 
has determined that projections originating in the cerebral cortex terminate in the ZI, and 
that the ZI and the STN may work together to process this cortical information, as it was 
found that cortical representations in these regions have highly overlapped borders, 
primarily from the layer V neurons of the cortex, but also from areas implicated in higher 
cognitive functioning, such as the OFC and mPFC (Kita, Osten, & Kita, 2014). Recent 
research has also evidenced that the ZI projections to cortical layer I of the neonatal rodent 
brain are crucial during development and maturation, as disrupting this pathway during the 
first postnatal week increases the likelihood of epileptiform activity in the adult brain (Chen 
& Kriegstein, 2015).  
The ZI also projects to – in some cases reciprocally – and exhibits predominantly 
inhibitory influence to several key areas of the brain, including the cortex, BG, brainstem, 
thalamus and spinal cord (for review see Mitrofanis, 2005; Power, Kolmac & Mitrofanis, 
1999). The inhibitory projection to the dorsal thalamus (Power, Kolmac, & Mitrofanis, 
1999), exerts a powerful influence on the firing properties of thalamic neurons (Bartho et 
al., 2002). These projections mostly originate in the ZIV – which lies adjacent to the dorsal 
STN – and plays a role in vibrissal sensorimotor functioning (Shaw, Liao, Chen, Huang, & 
Lin, 2013; Urbain & Desche, 2007), and furthermore, this thalamic projection also extends 
into the whisker representation regions of the primary somatosensory cortex (Nicolelis, 
Chapin, & Lin, 1995), ultimately forming a reciprocal connection with the ZI.  
1.6 Functional division of the STN and ZI  
Despite the evidence that the STN and ZI are largely involved in motor control, a 
functional division within these two regions has been presented. This division of the STN 
has been identified in both non-human primates (Joel & Weiner, 1997) – and in more a 
simplified subdivision of cytoarchitecture – in rodents (Groenewegen & Berendse, 1990). 
 37 
 
Both the primate and rodent STN receives BG input via the GPe, yet the STN also receives 
direct afferent input from the cortex, which may project differentially within the nucleus 
itself, and by species.  
 In the primate, three functional divisions of the STN have been circumscribed: a 
dorsolateral ‘motor’ part, a medial ‘limbic’ part, and a ventrolateral ‘associative’ part 
(Parent & Hazrati, 1995). The dorsolateral section projects to sensorimotor territories in the 
putamen and GPe, the medial section projects to limbic regions of the ventral GPi, whilst 
the ventrolateral associative (cognitive) regions project to the GPi/SNr and the caudate 
nucleus (Joel & Weiner, 1997; Parent & Hazrati, 1995). Advancement in anterograde 
tracing technology has revealed a considerable convergence of projections from 
functionally diverse cortical areas into the primate STN, creating potentially important 
interfaces between terminal fields, which appear to overlap rather than be anatomically 
distinct (Haynes & Haber, 2013). For example, limbic projections from the cortex to the 
medial STN also extend into the adjacent lateral hypothalamus (LH), and that the 
processing of limbic information is performed by both regions, suggesting that the lateral 
LH might be considered the limbic cone of the STN (ibid; Berthoud & Munzberg, 2011).  
 In the rat, the simplified cytoarchitecture compared to the primate brain has given 
rise to two constituent subregions; the medial and lateral regions, with little evidence for a 
dorsal/ventral subdivision (Berendse & Groenewegen, 1991a; Groenewegen & Berendse, 
1990; Heimer, Zahm, & Alheid, 1995). The lateral section comprises two-thirds of the 
nucleus, receiving projections from the motor and pre-motor cortices, whilst the medial 
third of the STN receives input from the anterior cingulate, prelimbic, agranular insular 
cortices, and orbitofrontal cortices, along with the ventral pallidum (Berendse & 
Groenewegen, 1991a; for review see Janssen, Visser-Vandewalle, & Temel, 2010). 
Electrophysiological studies compliment these anatomical tracing results by suggesting 
there might be a functional division of the STN as well, and similar to the primate STN, the 
subdivisions of the rodent STN are not entirely segregated from each other (Janssen et al., 
2010). STN dendrites can extend nearly the entire length of the nucleus (Heimer et al., 
1995), and the limbic projections from the cortex also extend beyond the medial STN, into 
the adjacent lateral LH (Berendse & Groenewegen, 1991). Experiments investigating the 
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STN’s contribution to cognitive functioning, including the experiments in the current thesis, 
would benefit by targeting the frontal connections of the medial STN.   
Research evidencing a functional division of the ZI is sparse, yet anatomical tracing 
studies have shown that the ZI receives input from the cortex, BG, brainstem, and spinal 
cord, leading to partially overlapping regions which contribute differential effects on 
behaviour, including controlling visceral activity, influencing arousal, orienting visual 
attention, and maintaining posture and locomotion (Lin, Nicolelis, Schneider, & Chapin, 
1990; Mitrofanis, 2005). For example, lesioning or stimulating the rostral ZI (and no other 
region) will decrease food/water intake, changing ingestive activity (Tonelli & Chiaraviglio, 
1995); however the same procedure when applied to the caudal ZI induces changes in 
posture and locomotion (Edwards & Isaacs, 1991).  
Most of the rostral ZI and the ZID receive limbic projections from the cingulate, 
and the majority of the ZIV and caudal ZI receive projections from the somatosensory 
cortex (ibid). In addition to a rostral-caudal and dorsal-ventral regional division of 
functioning, the medial third of the ZI contain projections from the dorsomedial frontal and 
primary motor cortices; projections which also extend into the adjacent LH (ibid; Lin et al., 
1990). In addition to the identified subdivisions, it is worth noting that this ‘subthalamic 
region’, including the STN, ZI, and LHA, with converging and overlapping cortical 
projections from the mPFC and OFC, likely works in concert to some degree to shape 
output behaviour (Kita et al., 2014).   
1.7 Neurochemistry of the STN and ZI 
1.7.1 Glutamate  
Considerable research has shown that the dominant postsynaptic receptor in the 
STN is the glutamate receptor (for review see Clarke & Bolam, 1998). Pioneering 
electrophysiology research by Robledo & Féger (1990) demonstrated that the STN exerts 
an excitatory effect on its efferent structures, and that furthermore, chemical blocking of 
STN neuronal activity with muscimol [a γ-aminobutyric acid receptor-type A (GABAA) 
agonist] produced reductions in neuronal activity in the GP, EP and SNr. Robledo & Féger 
(1990) also noted that the STN uses glutamate for neurotransmission to the SNr, which 
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presented new evidence for  glutamatergic transmission in subthalamic projections. 
Subsequent neurophysiological tracing research spearheaded by Atsushi Nambu spanning 
nearly a decade (1996; 1997; 2000; 2002) built on the seminal findings posited by 
Hartmann-von Monakow et al. (1978), which originally identified that the STN receives 
direct excitatory cortical projections from wide-spanning areas of the frontal cortex, 
including the supplementary motor area (Nambu et al., 1996) and premotor area (Nambu et 
al., 1997), along with glutamatergic projections from the thalamus and brainstem (Joel & 
Wiener, 1997; Mathai & Smith, 2011). The ‘hyperdirect’ pathway is the chief excitatory 
(glutamatergic) input for the STN, and work by Nambu et al. (2000) found that stimulation 
of the primary motor and somatosensory cortices via implanted electrodes in monkeys 
resulted in a pattern of early, short-latency excitation, followed by a late excitation in the 
STN, GPe and GPi, in which the early excitation of the STN preceded that of the early 
excitation for the GPe/GPi. Similar to Robledo & Féger (1990), STN-muscimol treatment 
in Nambu et al. (2000) abolished both the early and late excitation events in the measured 
GP neurons following cortical stimulation. Building on Robledo & Féger (1990), Nambu 
(2000) found that injections of N-methyl-D-aspartate (NMDA) receptor antagonists, and 
not α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate receptor 
antagonists into the STN attenuated the early and late excitations found in the GP, which 
suggests that the ‘hyperdirect’ pathway (cortico-subthalamic) is largely mediated by 
NMDA receptors. These fast-acting ionotropic receptors (compared to slower-acting 
metabotropic receptors) convey motor-related cortical information to the GP via the STN, 
with shorter conduction time than the effects conveyed through the striatum (Nambu et al., 
2000).  
Of the NMDA receptor, the NR1-type receptor is the most prevalent, and despite 
NMDA being the most prominent ionotropic glutamate receptor type in the STN, and 
despite the findings in Nambu et al. (2000), there also exists evidence that AMPA may play 
a role in modulating STN activity during a state of nigrostriatal dopamine denervation (i.e., 
in Parkinson’s disease), in which systemic administration of AMPA antagonists [in 
conjunction with Levedopa (L-DOPA) – a dopamine agonist and treatment for Parkinson’s 
disease] have been shown to reverse STN hyperactivity (Vila et al., 1999). This may arise 
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from the fact that AMPA mediates faster neurotransmission than NMDA (for review see: 
Ozawa, Kamiya & Tsuzuki, 1998), along with cascades of compensatory neurotransmission 
within the BG during a dopamine-denervated state (see section 1.7.2; for review see: 
Galvan, Kuwajima & Smith, 2006). Furthermore, Mouroux & Féger (1993) demonstrated 
that the expected pattern of STN excitation following electrophysiological stimulation of 
the parafascicular nucleus of the thalamus was silenced following both NMDA- and 
AMPA-antagonism, suggesting that both of these ionotropic receptors contributed to STN 
excitation.  
In addition to the ionotropic glutamate receptors of the STN, there exists a 
population of metabotropic glutamate receptors (mGluRs); these are mostly asymmetrical 
and colocalised on a single synapse with the ionotropic receptors (Porter, Greene, Higgins, 
& Greenamyre, 1994). Whilst the ionotropic receptors contribute to fast-acting, excitatory 
behaviour, the slower-acting mGluRs regulate sustained depolarisation (Ozawa, Kamiya & 
Tsuzuki, 1998); the colocalised organisation of these two receptor types leads to complex 
glutamate signalling in the STN (Clarke & Bolam, 1998). There are three distinct families 
of mGluR (Group I, II, & III) each differing based on their mechanism of action and 
cellular response outcome; for example, activation of Group I mGluRs – consisting of 
mGluR1 and mGluR5 – leads to a net excitatory response by inducing a mobilisation of 
intracellular Ca
2+
, along with increasing NMDA (Kuwajima, Hall, Aiba, & Smith, 2004). 
Conversely, Group II mGluRs, which include mGluR2 and mGluR3, are negatively coupled 
to adenylyl cyclase, and yield an inhibitory effect on signal transduction (Conn & Pin, 
1997; Kuwajima et al., 2004).  
In vitro electrophysiology studies have determined that Group I (both mGluR1 and 
mGluR5) receptor types are found in the STN of the rodent (Awad, Hubert, Smith, Levey, 
& Conn, 2000) and non-human primate (Clarke & Bolam, 1998; Kuwajima et al., 2004; 
Wang, Ong, Lee, & Huganir, 2000), and that these receptors are mostly localised on 
postsynaptic dendrites of the STN, and may contribute to an important role in net excitatory 
drive to several key areas of the BG, including the GPe and GPi, along with the thalamus 
(Galvan Kuwajima & Smith, 2006; Obeso & Lanciego, 2011). Group II (both mGluR2 and 
mGluR3) receptor types are also found in the STN, and are presynaptically localised on 
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STN terminals; the activation of these receptors inhibits excitatory transmission at STN 
synapses (Bradley et al., 2000). However, both mGluR2 and mGluR3 can also be found 
postsynaptically, and it is postulated that this distribution may aid in regulating output 
activity of the STN (Clarke & Bolam, 1998; Tamaru, Nomura, Mizuno, & Shigemoto, 
2001; Wang et al., 2000).  
The usually regular, tonic activity of glutamatergic neurons in the STN (Bevan & 
Wilson, 1999; Nakanishi, Kita, & Kitai, 1987) is rendered irregular in the Parkinsonian 
brain, with bursts of high-frequency spikes; this dysregulation appears to be essential for 
clinical manifestation of the disease (Porter et al., 1994; Tai et al., 2003; Vila et al., 1999). 
Furthermore, 6-hydroxydopamine (6-OHDA) lesions of the SNc – leading to striatal 
dopamine depletion – serves as a Parkinsonian disease model, partly by increasing 
glutamatergic output activity from the STN (for review see Henderson & Dunnett, 1998). 
During this state of glutamate hyperactivity (i.e., Parkinson’s disease), application of an 
mGluR5 antagonist (2-methyl-6-(phenylethynyl)-pyridine; MPEP), has been shown to 
regulate activity, resulting in an attenuation of severe motor and sensorimotor asymmetries 
(Phillips, Lam, Ackerson, & Maidment, 2006). 
Glutamatergic cells are sparsely found throughout the entire rat ZI, with a slightly 
higher concentration in the medial ZID, making up 40% of the total number of cells in this 
region, whereas glutamate-immunoreactive cells make up 15% of the cells in the other 
sectors of the ZI (Kolmac & Mitrofanis, 1999). In a follow-up study, Heise & Mitrofanis 
(2004) found evidence for glutamatergic projections from the ZI to other parts of the BG, 
predominantly in both parts of the substantia nigra along with the pedunculopontine 
tegmental nucleus (only in the pars dissipata), with fewer projections to the caudate-
putamen, GP, STN and EP. Interestingly, Heise & Mitrofanis (2004) found that very few 
cells were GABA-positive, which is believed to be the predominant neurotransmitter-type 
in the ZI (see Nicolelis, Chapin & Lin, 1995; section 1.7.3); however, in a review by 
Mitrofanis (2005), the author emphasises and details experiments that argue that the ZI is 
an area with extensive connections to a variety of brain regions, comprised of a 
heterogeneous collection of cells differing in size and shape. For example, the tracer 
injection site in Heise & Mitrofanis (2004) was in the medial portion of the ZI, so it is 
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possible that the cells labelled downstream in the SN and EP do not fully represent the 
breadth of connections of the ZI, whereas Nicolelis, Chapin & Lin, 1995 used retrograde 
tracers from the primary somatosensory cortex to map out subdivisions within the ZI. It is 
clear that glutamate signalling in the ZI influences output behaviour, as infusions of both 
AMPA or kainic acid agonists (but not NMDA) directly to the medial or rostral ZI induce a 
marked stimulation of locomotor activity, along with a postural change, and that 
furthermore, administration of the respective antagonists resulted in an inhibition of 
locomotor activity (Supko, Uretsky & Wallace, 1991). These excitatory projections place 
the ZI in a position to induce a modulatory effect on BG and cortical activity, and merit 
further investigation in an effort to disseminate the subpopulations of neurotransmitters 
within this area.   
1.7.2 Dopamine 
It has been documented through retrograde tracing and immunohistochemistry 
studies that the rat STN receives dopaminergic projections from the SNc and the ventral 
tegmental area (VTA) (Brown & Wolfson, 1978; Brown et al., 1979; Campbell et al., 1985; 
Hassani, Francois, Yelnik, & Feger, 1997), including sparse arborisations via the striatum 
(Gauthier, Parent, & Levesque, 1999). This dopaminergic projection has also been 
identified in the cat (Meibach & Katzman, 1979; Rinvik et al., 1979), and the primate 
(Rinvik et al., 1979; Galvan et al., 2014) STN; however there is less robust evidence for 
this in the human brain, with weak, albeit specific binding for D1-type dopamine receptors 
(Augood, Hollingsworth, Standaert, Emson, & Penney, 2000). Indeed several studies have 
documented that the D1, D2, D3, and D5 receptor messenger RNAs and binding sites were 
present in the rodent STN (Flores et al., 1999; Svenningsson &Le Moine, 2002; Baufreton 
et al., 2003), highlighting a potentially diverse profile of dopamine modulation within the 
nucleus.  
Functionally, earlier in vivo research suggested that dopamine largely had an 
inhibitory effect on STN neurons via D1 and D2 dopamine receptors (Campbell et al., 1985; 
Hassani & Féger, 1999), whilst another group of researchers found that D1 agonism had a 
predominantly excitatory effect on STN neurons (Kreiss, Anderson, & Walters, 1996). 
More recent in vitro research has elucidated that activation of D1-like receptors (specifically 
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D5) increases burst firing in subthalamic neurons, therefore shaping neuronal activity 
(Baufreton et al., 2003). There is also evidence that activation of D2-like receptors are 
implicated in excitatory synaptic transmission, with a different mechanism of action 
compared with D1-like receptors (Zhu, Shen & Johnson, 2002; Floran, Floran, Erlij & 
Aceves, 2004; Galvan et al., 2014). These D2-like receptors influence firing either 
presynaptically or postsynaptically: binding with D2 and D3 receptors reduces resting K
+
 
conductance, and thus promotes firing (presynaptic; Zhu, Shen & Johnson, 2002; Baufreton 
& Bevan, 2008), whereas selective D4 agonism decreases GABA release to the STN (see 
section 1.7.3), thus reducing inhibition of the nucleus (postsynaptic: Shen & Johnson, 2003; 
Floran, Floran, Erlij & Aceves, 2004).  Furthermore, the fact that an inward current induced 
by dopamine superfusion (in vitro) was observed, despite the application of tetrodotoxin (a 
sodium channel blocker) and ionotropic glutamate receptor antagonists [both AMPA/KA 
antagonists: (±)-sulpiride and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and NMDA: 
2-amino-5-phosphonopentanoic acid (AP5)], suggests that dopamine exerts a direct action 
on postsynaptic STN neurons (Shen & Johnson, 2003).  
The aforementioned studies illustrate that dopamine exerts a direct excitatory effect 
on STN neurons, and that furthermore it likely works in concert with glutamate to shape the 
excitatory drive of the STN. This synergy is made particularly salient during a state of 
dopamine denervation of the nigrostriatal pathway, which is typically seen during 
Parkinson’s disease, resulting in glutamate hyperactivity (Bergman, Wichmann, Karmon & 
De Long, 1994). Furthermore, increasing dopamine neurotransmission through L-DOPA 
treatment has a positive effect on regulating the aberrant firing activity of the glutamatergic 
STN neurons (Hassani & Féger, 1999), and as stated in section 1.7.1, L-DOPA, in 
conjunction with an AMPA antagonist reverses the hyperactivity of the STN (Vila et al., 
1999). More recent research by El Arfani and colleagues (2014) found that rats with 6-
OHDA-lesions of the nigrostriatal pathway that received both L-DOPA and  MK801 – an 
NMDA receptor antagonist – experienced enhanced dopamine release, compared to 
lesioned rats receiving L-DOPA alone. Several studies have also shown that decreasing 
STN activity via HFS induces a significant increase in extracellular dopamine in the rat 
striatum (Bruet et al., 2001), particularly by increasing D1 receptor levels, whilst decreasing 
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D2 and D3 receptor levels in the nucleus accumbens (Carcenac et al., 2015). This may 
partially explain the therapeutic efficacy of STN-HFS to treat motor symptoms of 
Parkinson’s disease (see section 1.7.5).  
Functionally, in vivo studies have found that dopaminergic inputs to the STN may 
be crucial in regulating movement, as the application of apomorphine (dopamine agonist) 
induced an increase in abnormal, nondirected orofacial movements; this behaviour may 
largely be driven by D1-like receptors, since D1-like and not D2-like receptor antagonists 
blocked the expression of this behaviour (Parry et al., 1994). In the absence of a dopamine 
agonist, chemical antagonism of the D1-like receptors in the STN results in catalepsy in rats 
(Hauber, 1998). These results support the assertion that dopamine plays a prominent role in 
the regulation of motor functions, and excitatory drive in the STN.  
Within the ZI, a sparse population of dopaminergic neurons have been exclusively 
identified in the rostral sector, and are found in the medial region (both dorsal and ventral) 
in both the cat and the rat; these cells comprise roughly 15% of the total number of cells 
within this region (Wagner, Eaton, Moore & Lookingland, 1995; Cheung, Ballew, Moore, 
& Lookingland, 1998; Kolmac & Mitrofanis, 1999; Mitrofanis, 2005). These sparse 
dopaminergic cells have been shown to project to a variety of brain areas, including 
ipsilateral projections to the adjacent lateral hypothalamus – which contains a large, 
densely populated group of dopaminergic cells – neighbouring regions such as lateral 
preoptic area and the limbic structures at the diencephalic-telencephalic juncture, along 
with more distal regions such as the central nucleus of the amygdala, horizontal diagonal 
band of Broca, and the paraventricular nucleus (Wagner et al., 1995; Cheung, Ballew, 
Moore, & Lookingland, 1998; Kolmac & Mitrofanis, 1999).  
Research regarding the role of these neurons in behaviour is still limited, with 
earlier work evidencing that direct injection of a D1-receptor agonist to the ZI had a 
stimulatory control on the release of lutenising hormone and occurrence of ovulation, and 
selective D1-receptor antagonism inhibited ovulation; conversely chemical manipulation of 
the D2-receptor had no effect on sexual cycles (James, Mackenzie, Tuohy-Jones & Wilson, 
1987) Subsequent work by Tonelli & Chiaraviglio (1995) demonstrated that administration 
of a dopamine or a specific D2-receptor agonist into the ZI reduced food and water intake, 
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whilst a D1-receptor agonist had no effect, suggesting that D2 receptors may modulate 
ingestive behaviour.  
1.7.3 GABA 
The principal inhibitory neurotransmitter, GABA, exerts its effects via two ligand-
gated channels (GABAA and GABAC) and one regulated via G-protein (GABAB) (Jones et 
al., 1998). An important inhibitory input to the STN originates from the GPe, which uses 
both GABAA and GABAB to regulate STN output activity, and has been found in both 
monkeys (Galvan, Charara, Levey, & Smith, 2004) and rats (Bell, Churchill, & Kalivas, 
1995). GABAergic boutons from the GPe form symmetric synapses on the STN, which 
differs from the asymmetric glutamatergic afferents (Smith, Bevan, Shink, & Bolam, 1998). 
This inhibitory projection from the GPe is critical in shaping STN output activity via the 
indirect pathway, as it has also been shown that administration of the GABA antagonist 
bicuculline significantly increases STN activity (Robledo & Féger, 1990). As outlined in 
the preceding sections, STN activity is largely shaped by glutamate binding, but may also 
be influenced by dopamine binding; work by Floran et al. (2004) found that selective D4 
receptor agonism inhibited GABA release from the GPe to the STN, which would in turn 
increase STN activity. In addition to the D4 receptor, Baufreton & Bevan (2008) detailed 
that dopamine binding at presynaptic D2-like receptors attenuates GABAergic transmission 
(via the GABAA receptor). Parkinson’s disease is marked by a reduction in GABA and 
excess glutamate signalling, which contributes to STN hyperactivity, likely resulting from 
nigrostriatal dopamine denervation (El Arfani et al., 2014).  
There is mixed evidence for the existence of GABAergic cells within the STN, and 
their functional contribution to STN activity. Early work posited that the STN neurons use 
GABA as an inhibitory transmitter (Nauta & Cuenod, 1982; Rouzaire-Dubois, Hammond, 
Yelnik & Féger, 1984); a consideration whic h was largely replaced by the predominant 
excitatory role the STN currently holds, with its robust glutamatergic cell population (for 
review see Parent & Hazrati, 1995). A separate line of research has maintained that there 
still exists a GABAergic cell population within the STN, albeit sparse. This population has 
been identified largely by targeting and labelling – through immunohistochemistry 
techniques – glutamic acid decarboxylase (GAD): the GABA-synthesising enzyme, which 
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is a reliable, specific marker for GABA neurons (Kaufman, Houser & Tobin, 1991; 
Gonzales, Kaufman, Tobin & Chesselet, 1991), along with the use of in situ hybridisation 
histochemistry for GABA transporter 1 (Yasumi et al., 1997). These techniques have been 
applied to the rat (Oertel & Mugnaini, 1984; Yasumi et al., 1997), monkey (Benson, 
Isackson, Hendry & Jones, 1991) and human (Nisbet et al., 1996) STN, which revealed few 
positively labelled cells within the nucleus suggesting that the existence of GABAergic 
cells in the STN may be minimal. Despite the advancement of these studies, the neuronal 
nature of these GABAergic cells has not been determined, nor is there a description of the 
morphological features. In a more recent study, Lévesque & Parent (2005) performed GAD 
immunohistochemistry on post mortem human brain tissue and revealed that these 
GABAergic cells comprise 7.5% of the total neuronal population of the STN, and are more 
abundant in the caudal-ventral-medial section of the nucleus, which is largely implicated in 
limbic and associative functioning.        
GABAergic cells are the most populous neurotransmitter founding in the ZI, and are 
most densely located in the ZIV, but can be found throughout the entire nucleus (Nicolelis 
et al., 1995; Mitrofanis, 2005; Park, Hoffman, & Keller, 2014). Furthermore, the 
projections originating in the ZI to the cortex (incertocortical projection) and the dorsal 
thalamus (incertothalamic projection) are also GABAergic, and in the case of the thalamus, 
the ZI provides a significant inhibitory influence via the GABAA and GABAB receptor on 
the firing properties of the reticular thalamic nucleus – a region implicated in many higher-
order functions (Bartho et al., 2002; Nicolelis et al., 1995; Park, Hoffman & Keller, 2014). 
In addition to the incertocortical and incertothalamic projections, the ZI also exerts 
GABAergic projections to the superior colliculus (Kim, Gregory & Hall, 1992), which 
contributes to orienting behaviour, along with inhibitory projections to the brainstem 
(Nicolelis, Chapin & Lin, 1992). Behaviourally, muscimol (GABA agonist) injected into 
the rat ZI produced head tilting ipsilateral to the injection site, whilst administration of 
bicuculline (GABA antagonist) produced head tilting to the contralateral side (Murer & 
Pazo, 1993). These findings, particularly those documenting the GABAergic projections of 
the ZI, suggest that the ZI is a major somatosensory relay in the ventral thalamus, carrying 
inhibitory signals to neocortical and subcortical regions. Consistent with the distinct 
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cytoarchitectonic subdivisions of the ZI, the predominant distribution of GABAergic cells 
in the ZIV overlap with the glutamatergic cells in the ZID, and it has been speculated 
whether this inhibitory ventral region and excitatory dorsal region may divide ZI function 
(Mitrofanis, 2005).  
1.7.4 Serotonin 
Early tracing studies found a distribution of serotonin (5-hydroxytryptomine; 5-
HT)-immunoreactive nerve fibres in the monkey and rat STN, mostly in the ventral and 
medial regions of the nucleus, and were more likely found in the caudal sections in the rat 
(Mori, Takino, Yamada, & Sano, 1985). Recent research has identified that these 
projections originate in the dorsal raphe nuclei (DRN) and that there are several types of 5-
HT receptor in the STN, including evidence of 5-HT1A, 5-HT1B, 5-HT2C and 5-HT4 
receptors, although only a sparse number of axon terminals were observed in the STN (for 
review see Reznitsky, Plenge, & Hay-schmidt, 2016; see also Stanford, Kantaria, Chahal, 
Loucif, & Wilson, 2005).  
The effects of 5-HT in the STN can result in two distinct effects on the same 
neuron: excitation is mediated by the 5-HT2C and 5-HT4 receptors, whilst inhibition is 
mediated by the 5-HT1A/B receptor (Stanford, Kantaria, Chahal, Loucif, & Wilson, 2005). 
Furthermore, application of exogenous 5-HT or a non-specific 5-HT2 agonist increases 
STN neuron firing rate, without changing STN firing pattern, and that these excitations 
were reduced by 5-HT2C and 5-HT4 receptor antagonists (Stanford, Kantaria, Chahal, 
Loucif, & Wilson, 2005; Xiang, Wang, & Kitai, 2005).  Application of 5-HT elicits a 
biphasic response on STN neurons – an initial excitation event, followed by inhibition – 
which were maintained even after application of picrotoxin (a GABAA antagonist) and 
CNQX (AMPA/KA antagonist); however application of a 5-HT1A antagonist blocked this 
inhibitory event, which suggested that although 5-HT receptors are sparse in the STN, 5-
HT-mediated excitation and inhibition events are separate entities that arise from direct 
postsynaptic receptor mediated  effects  (Stanford, Kantaria, Chahal, Loucif, & Wilson, 
2005). It has also been shown that activation of the 5-HT1B receptor inhibits 
neurotransmission in the STN, and that at lower concentrations of 5-HT (10µM) reduces 
glutamate-mediated excitatory postsynaptic currents by 35%, yet a higher concentration 
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(100µM) of 5-HT was required to inhibit the GABA-mediated inhibitory postsynaptic 
currents to a comparable extent (Shen & Johnson, 2008). These findings suggest that 5-HT, 
similar to dopamine, may exercise a regulatory role in controlling STN output activity.  
In the rat ZI, serotonin-immunoreactive cells are sparsely found throughout all 
regions, with no particular area of concentration, making up around 2% of the total cell 
population in the dorsal, ventral and caudal sectors and around 5% of the total cell 
population in the rostral sector (Kolmac & Mitrofanis, 1999). In the ZI, 5-HT plays a role 
in neuroendocrine function (see Kordon et al., 1980), and it is thought that the serotonergic 
projections from the medial ZI may modulate prolactin and gonadotrophin secretion 
(Bosler, Joh, & Beaudet, 1984). Further, and more recent, research found additional 
evidence that 5-HT in the ZI is implicated in neuroendocrine function: application of 5-HT 
directly to the ZI inhibits the secretion of lutenising hormone, which in the ZI is mediated 
by 5-HT7 receptor activation (Siddiqui, Abu-amara, Aldairy, Hagan, & Wilson, 2004).  
1.7.5 Neurochemical pathways and HFS 
Seminal work by Benazzouz and colleagues (1993) found that unilateral STN-HFS, 
applied in monkeys that were rendered hemiparkinsonian with 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP; dopamine depleting toxin) lesions, alleviated the observed 
muscular rigidity in the contralateral forelimb (for review see Gubellini, Salin, Kerkerian-
Le Goff & Baunez, 2009; but also Baunez & Gubellini, 2010). This work ultimately 
inspired Benabid et al. (1994) to apply HFS to Parkinson’s patients, and since then 
silencing the STN via HFS has become a popular therapeutic option for efficiently 
alleviating the cardinal symptoms of Parkinson’s disease, including akinesia, rigidity and 
tremors (Benabid et al., 1994; Limousin et al., 1995). There is also more recent evidence 
suggesting that STN-HFS may also be useful in reducing symptoms of severe forms of 
obsessive-compulsive disorder (OCD), lending positive therapeutic outcome by targeting 
the medial STN (Mallet et al., 2008; but see Pelloux & Baunez, 2013). For treatment of 
OCD symptoms, therapeutic efficacy is benefitted by targeted stimulation of the rostral and 
medial STN, which is known to receive cortical information from the OFC (see Karachi et 
al., 2005), and provides further support that impulsive/compulsive behaviour may be 
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mediated by a network of key brain areas such as the OFC, striatum and the STN (see 
section 1.8; but also Eagle & Baunez, 2010; Baunez & Lardeux, 2011).  
 As outlined above, the most compelling evidence for the efficacy of this 
neurosurgical treatment in Parkinson’s disease is the ability for HFS to silence hyperactive 
glutamate signalling in the STN, which manifests as irregular bursts of high-frequency 
spikes (Porter et al., 1994; Henderson & Dunnett, 1998; Tai et al., 2003; Vila et al., 1999). 
It is thought that dopamine depletion alters the activity of the MSNs in the nigro-striatal 
projection, which in turn, enhances the activation of the ‘indirect pathway’ (and therefore 
the glutamatergic STN), ultimately overactivating inhibitory output neurons in the GPi and 
SNr (Gerfen et al., 1990; Crossman, 1990; Obeso & Lanciego, 2011).  
The direct mechanism of action for STN-HFS is still not well understood (see 
Carcenac et al., 2015); however there is strong evidence that STN-HFS increases striatal 
dopamine release and metabolism, which consequently attenuates glutamate hyperactivity 
(Bruet et al., 2001; Messiner et al., 2003; Bergmann et al., 2004; Lacombe et al., 2007; 
Carcenac et al., 2015). Specifically, STN-HFS causes a significant increase in extracellular 
D1 dopamine receptor levels in the rat striatum, which may contribute to the therapeutic 
effects on motor symptoms (Carcenac et al., 2015). Furthermore, STN-HFS is an effective 
adjunct to L-DOPA treatment, reducing the required L-DOPA medication by up to 50% 
amongst Parkinson’s patients on chronic STN-HFS (Benabid et al., 1998; Moro et al., 
1999). This noted reduction in medication in rodent models of Parkinson’s disease is likely 
due to the fact that STN-HFS coupled with L-DOPA administration results in greater 
extracellular dopamine release than when rats received either treatment alone (Lacombe et 
al., 2007). Given that activation of D1-like receptors (specifically D5) increases burst firing 
in subthalamic neurons, therefore shaping neuronal activity (see Baufreton et al., 2003), it 
is speculated that STN-HFS stabilises dopamine levels in the striatum, resulting is a 
normalisation of STN function (Lacombe et al., 2007).  
 Despite its clinical efficacy, STN-HFS may result in cognitive and psychiatric 
impairments, and Parkinson’s patients who have been treated by STN-HFS have reported 
increased apathy, depression, mania, impulse control disorders, and executive functioning 
(Saint-Cyr et al., 2000; Houeto et al., 2002; Romito et al., 2002; Funkiewiez et al., 2004; 
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Drapier et al., 2006; Ulla et al.,  2006; Frank, 2006; Tan, Hartung, Sharp, & Temel, 2011). 
It is worth noting that STN-HFS only partially mimics STN inactivation as compared to 
STN lesioning in rats (see Baunez et al., 2007; but also Gubellini et al., 2009), and that the 
noted deficits in cognitive performance (see section 1.8) are not as pervasive. Furthermore, 
STN-HFS is reportedly less effective at treating the cognitive impairments associated with 
unilateral nigro-striatal dopamine denervation, such as increased trial omissions in a choice 
reaction time task (for task information see section 1.8), which likely stems from the 
impairment in initiating contralateral motion acts (see Carli, Evenden & Robbins, 1983), 
and it therefore generally concluded that the therapeutic effects of STN-HFS are well-suited 
to treating motor symptoms, but are less effective at treating impaired cognitive functions 
(see Darbaky, Forni, Amalric & Baunez, 2003). To account for this, recent work by 
Carcenac et al., (2015) found a significant decrease in D2 and D3 receptor levels in the rat 
nucleus accumbens following STN-HFS – regardless of L-DOPA treatment – and it is 
speculated that this may partially account for neuropsychiatric and cognitive side effects of 
STN-HFS. Furthermore, Dalley et al. (2007) demonstrated with positron emission 
tomography that highly impulsive rats also exhibit a reduction in D2 and D3 receptor 
availability in the nucleus accumbens. 
In addition to introducing cognitive side-effects, STN-HFS may alter mood and 
emotional processing, including contributing to depressive symptoms (Funkiewiez et al., 
2004; Takeshita et al., 2005; Appleby, Duggan, Regenberg, & Rabins, 2007; Tan, Hartung, 
Sharp, & Temel, 2011). It is worth noting that Parkinson’s patients already have increased 
incidence of developing depression (30-40% of patients; for review see Cummings, 1992), 
which is partially due to pathological loss of axons and cell bodies of 5-HT neurons in the 
DRN (Tan et al., 2011). It has been observed that STN-HFS significantly inhibits normal 5-
HT neurotransmission in the DRN (inhibiting 40-50% of the firing rate), and whilst the 
actual pathway originating from the STN to the DRN that is driving this effect has yet to be 
formally identified, it likely operates via the SNr, mPFC or ventral pallidum (Temel et al., 
2007; Tan et al., 2011). Behaviourally, STN-HFS has been shown to acutely induce 
depressive symptoms which reversed immediately after cessation of the stimulation 
(Tommasi et al., 2008). These findings suggest that STN-HFS, whilst largely treating 
 51 
 
motor symptoms of Parkinson’s disease by regulating STN hyperactivity, may introduce a 
plethora of side effects, along with increasing the likelihood for mood disorders.  
In addition to STN-HFS surgery, the caudal ZI (cZI) has also become a target for 
HFS surgery to treat pervasive motor symptoms of Parkinson’s disease (Plaha, Ben-Shlomo, 
Patel, & Gill, 2006; Guehl et al., 2008; Blomstedt et al., 2012; Watson, Lind, & Thomas, 
2014), along with essential tremor (Plaha, Khan, & Gill, 2008; Plaha et al., 2011). The cZI 
is located posterior and dorsal to the STN and Plaha and colleagues (2006) have reported 
that cZI-HFS therapy may result in better clinical improvement than STN-HFS therapy for 
improving contralateral Parkinsonism, yielding greater improvement in tremor activity, 
bradykinesia, and rigidity. It appears that cZI-HFS is particularly effective at severe forms 
of Parkinson’s disease, resulting in a dramatic improvement in rigidity, akinesia or 
bradykinesia, and tremors in clinical trials of bilateral cZI-HFS (Plaha et al., 2006; Guehl et 
al., 2008; Plaha, Khan, & Gill, 2008; Plaha et al., 2011); it appears that unilateral cZI-HFS 
is effective at treating severe Parkinsonian tremor, but reportedly less effective at treating 
rigidity and bradykinesia compared to bilateral cZI-HFS (see Blomstedt et al., 2012). 
Similar to STN-HFS, cZI-HFS therapy decreases the required L-DOPA dosage in patients 
by up to 50%, suggesting that this area may also play a role in the mediation of Parkinson’s 
symptoms (Plaha et al., 2006; Guehl et al., 2008).  
These findings, and the very fact that the ZI is an effective target for HFS are quite 
remarkable, particularly since the predominant neurotransmitter throughout the ZI is 
GABA (see section 1.7.3), and that furthermore, rodent STN-HFS studies which report 
electrode placement/lesions in the ZI observe a different – and generally less efficient – 
behavioural profile (for review see Gubellini et al., 2009). The exact reason why cZI 
therapy is effective is still unclear, with some researchers offering interpretations such as 
the proximity of the cZI to the ventral posterior lateral thalamic nuclei and pallidothalamic 
fibre tracts, in which the latter has been suggested as a target for HFS (see Gallay, 
Jeanmonod, Liu, & Morel, 2008; Watson, Lind, & Thomas, 2014). Plaha, Khan, & Gill, 
(2008) argue that inactivating the GABAergic projections from the ZI to the output nuclei 
of the BG, including the thalamus serves to normalise aberrant tremor oscillations – during 
the Parkinsonian state, enhanced activation of the ‘indirect pathway’ (and STN) 
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overactivates inhibitory output neurons in the GPi and SNr, which overly inhibits the 
thalamo-cortical output pathway (Gerfen et al., 1990; Crossman, 1990; Obeso & Lanciego, 
2011). This consideration has been subject to scrutiny however, largely due to the fact that 
GABAergic immunoreactive cells only comprise 10% of the total cell population in the 
caudal region of the ZI (Kolmac & Mitrofanis, 1999), and it is speculated by other 
researchers that this relative paucity of GABAergic cells compared to other regions of the 
ZI may contribute to its clinical efficacy (Watson, Lind, & Thomas, 2014). As stated 
previously, the ZI has distinct cytoarchitectonic subdivisions, and that each subdivision 
gives rise to a distinct pattern of efferent projections (see Romanowski, Mitchell & 
Crossman, 1985). Consequently, a distinct population of calbindin neurons (specifically 
D28k) have been identified in the cZI, which comprise 25% of the total cells in the caudal 
region, compared to 5% of the total cells found in rostral, dorsal, dorsolateral and ventral 
regions (Kolmac & Mitrofanis, 1999), and it is speculated that the inactivation of these 
calcium-binding proteins aids in the therapeutic effects of cZI-HFS (Watson, Lind, & 
Thomas, 2014). Additionally, the caudal pole of the ZI has a distinct patch of 
acetylcholinesterase activity – the enzyme which breaks down acetylcholine – and it is also 
thought that HFS-inactivation may mimic an acetylcholinesterase inhibitor (Watson, Lind, 
& Thomas, 2014), which has been used to predominantly treat cognitive symptoms of 
Parkinson’s disease, but has been also shown to increase the rate of tremor amongst 
patients (for review see Pagano et al., 2015). In summary, the direct mechanism of action 
for cZI-HFS is not well established, and more research regarding the contributory 
neurochemical pathways implicated in this therapy, and ultimately regarding the ZI in 
general, is essential.  
1.8 The STN and cognition  
To date, the majority of research regarding the function of the STN has been largely 
devoted to investigating the STN’s involvement in motor functioning. A simplified 
interrogation of PubMed’s database illustrated this disparity, in which a search of cognitive 
research of the STN (subthalamic nucleus [Title] AND cognition [Title/abstract]) yielded 
41 results, whilst motor research (subthalamic nucleus [Title] AND motor [Title/abstract]) 
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generated an overwhelming 794 results. An identical search regarding the ZI found 34 
articles regarding motor performance, and none pertaining to cognition, further illustrating 
that this region is under-researched.  
Consequently, experimental research with non-human animals regarding the role of 
the STN originates from a motor research perspective, by examining the effects of lesioning 
the STN in combination with striatal dopamine (DA) depletion (Baunez et al. 1995; Baunez 
& Robbins, 1999; Phillips & Brown, 1999; El Massioui et al., 2007) or after systemic 
application of  dopamine D1/D2 antagonists (Baunez & Robbins, 1997), to better 
understand the cognitive deficits that arise in Parkinson’s disease, and similarly those 
which arise from HFS therapy. This preclinical research – predominantly in rats – has 
suggested that chemical lesioning the STN may result in a variety of cognitive impairments, 
including deficits in memory, decision-making/impulse control, and visuo-spatial attention 
(for reviews see: Gubellini et al., 2009; Baunez & Gubellini, 2010; Baunez & Lardeux, 
2011). The majority of the lesion-based experiments in rats that have investigated the role 
of the STN in cognition have typically employed an operant chamber, with either a nose-
poke aperture for determining response selection, or a more conventional lever-pressing/-
releasing assignment, which will be described in further detail below.  
1.8.1 Visuo-spatial attention  
This research has predominantly utilised cognitive tasks which require high 
attentional demand, such as the 5-choice serial reaction time task (5CSRTT), and other 
tasks of visuo-spatial attention (see Carli, Robbins, Evenden, & Everitt, 1983). These tasks 
typically train rats to respond to brief flashes of light presented randomly in one of five 
spatial locations by requiring the rat to poke their nose into the hole that emitted the light. 
The 5CSRTT provides measures of discriminative accuracy, reaction time, perseveration 
(nose-poking in additional choice holes, or panel-pushes to initiate the trial), and premature 
responding (responses made prior to the presentation of the cue light), all of which are 
useful in measuring impulsivity behaviour, and indeed, there is evidence that the STN may 
play a role in several forms of impulsive behaviour, including adopting riskier strategies 
(see section 1.8.2; for review see Jahanshahi, Obeso, Baunez, Alegre, & Krack, 2015; but 
also see Evenden, 1999 for review on impulsivity). These tasks and others, which measure 
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impulsivity/compulsivity (e.g., the Go-No Go task & Stop-signal reaction time task) 
suggest that lesioning the STN results in impulsive response selection, and that the STN 
likely enables us to “hold our horses” by providing deliberative potential in decision 
making, perhaps owing to its ability to supress thalamocortical output activity (Aron & 
Poldrack, 2006; Frank, Samanta, Moustafa, & Sherman, 2007; see section 1.8.2). This 
effect has been replicated in both monkeys and in rats (for review see Jahanshahi, Obeso, 
Baunez, Alegre, & Krack, 2015).  
Early work by Baunez et al. (1995) hypothesised that lesioning the dopaminergic 
neurons of the dorsal striatum would induce motor impairments consistent with Parkinson’s 
symptoms, and further, that subsequently lesioning the STN would provide the same 
therapeutic effects as it does in humans and monkeys. It was revealed that 6-OHDA lesions 
resulted in motor initiation deficits, consistent with Parkinson’s symptoms, on a task in 
which rats were trained to release a lever after the onset of a visual stimulus within a time 
limit to obtain reward. These 6-OHDA-lesioned rats exhibited a delayed lever-releasing 
response. When STN lesion surgery was administered two weeks following 6-OHDA 
surgery, the observed motor initiation impairment was attenuated, yet rats with these 
combined lesions exhibited premature responding (lever release before visual stimulus 
onset). Rats that had only received bilateral ibotenic acid lesions of the STN exhibited 
decreased accuracy, and similar to the combined lesion group, increased premature 
responding (ibid); furthermore, STN-lesioned rats demonstrated ‘speeding’ behaviour, in 
which their latency to respond significantly decreased. The authors concluded that STN 
lesions alleviate the motor deficits in a Parkinson’s model rat, but that they might also 
induce a cognitive impairment, particularly in attention and response control. 
In a follow-up study using a 5CSRTT, Baunez & Robbins (1997) partially 
replicated the lever-releasing findings in Baunez et al. (1995), finding that lesioning the 
STN impairs discriminative accuracy, along with inducing both premature and 
perseverative responses; interestingly, the lesioned rats in Baunez & Robbins (1997) 
exhibited increases in latency to make a response (either correct or incorrect), suggesting a 
slowing of responding. The authors found that increasing the stimulus duration, and 
decreasing the inter-trial interval (the time between the panel push that signals starts the 
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trial and the presentation of the visual stimulus) significantly improves accuracy, whilst 
also reducing the number of premature responses for lesioned animals. Despite this 
improvement, performance for lesioned rats was still significantly poorer than control rats, 
and that manipulating stimulus duration and inter-trial interval did not influence 
perseverative responding, which was remained significantly impaired amongst lesioned 
animals.  
To reconcile these findings the authors suggested that lesioning the STN does not 
only impair motor performance, and that lesioned rats may have suffered from impairments 
in orienting attention and impulse control: perseverative panel pushing at the start of the 
trial may have interfered with the rats’ ability to orient itself correctly to the stimulus cue in 
preparation for signalling, therefore increasing omissions and latency, along with 
decreasing accuracy. This interpretation also aligns with observation that increasing the 
stimulus duration would improve performance by permitting more time for the rat to make 
a correct response. The fact that lesioned rats exhibited increased premature responses 
implies that for some of the trials rats were oriented correctly, and the observed increased in 
these anticipatory errors might be indicative of an increase in impulsive action. This 
consideration is further supported by the result that decreasing the inter-trial interval from 
five seconds to two seconds essentially eliminates premature responding, and it is possible 
that the STN may normally act to inhibit behavioural excitation found following increased 
drive or motivation (see section 1.8.2). It is worth noting that despite the impulsive action 
seen in Baunez & Robbins (1997), lesioned rats did not evidence the ‘speeding’ behaviour 
(decreased latency data) previously observed in Baunez et al. (1995). Conversely, lesioned 
rats were slower than controls to respond in Baunez & Robbins (1997); this effect however 
was not restricted to trials in which lesioned rats incurred perseverative responses, which 
led the authors to postulate whether STN-lesioning induces deficits in decision making as 
well (see section 1.8.2).  
Baunez & Robbins (1997) were also interested in investigating whether deficits 
induced by STN lesions could be minimised by dopamine receptor blockade, and therefore 
systemically administered α-flupenthixol, a dopamine D1/D2 receptor antagonist. The 
authors found a reduction in premature responses and perseverative panel-pushes for STN-
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lesioned rats, but no reduction was observed in perseverative nose-poking responses; α-
flupenthixol did not influence accuracy or latency. This finding suggested that some of the 
observed deficits were independent of striatal dopamine transmission, particularly the 
perseverative nose-poke response. Furthermore, the authors speculate that perhaps the 
improvement in premature responses and the partial reduction of perseverative panel-
pushing responses may be due to a dopaminergic-mediated involvement in incentive 
motivation (see Phillips, Pfauss, & Blaha, 1991).     
Follow-up research by Baunez & Robbins (1999) attempted to replicate and expand 
on the findings presented in Baunez & Robbins (1997); instead of using α-flupenthixol, 
Baunez & Robbins (1999) performed 6-OHDA lesions of the rat striatum following 
ibotenic acid lesions of the STN. Test data from the 5CSRTT revealed that STN lesioning 
alone, as expected, produced several behavioural deficits, including decreased 
discriminative accuracy suggesting an impairment in attention, along with increasing the 
number of omissions, premature responses, and both nose-poke and panel-pushing 
perseverative responses. Consistent with Baunez & Robbins (1997), latency data for STN-
lesioned rats illustrated a ‘slowing’ or an increase in latency per trial. Administration of 6-
OHDA lesions of the striatum to STN-lesioned animals exerted an ameliorative effect on 
the number of premature responses committed only, whilst the other impairments seen 
following STN lesions remained. These results highlight that the majority of the deficits 
induced by STN lesions may be independent of a dysfunctional nigrostriatal dopamine 
projection, whereas the deficit in premature responding, might be amenable to dopamine 
transmission. Furthermore, 6-OHDA lesions by themselves had no significant effect on 
premature responses, however when 6-OHDA lesions were made following STN lesions 
there was an ameliorative effect; this observation still suggests that 6-OHDA lesions did 
have a behavioural effect, which was potentiated by STN lesions.  
Subsequent work by Phillips & Brown (1999) attempted to further investigate the 
work presented in Baunez et al. (1995) and Baunez & Robbins (1997;1999), but by using 
less debilitating unilateral lesions of the STN and of striatal dopamine, which provided the 
authors the opportunity to dissociate generalised effects (e.g., hyperkinesia) from response-
specific initiation effects, by comparing ipsilateral vs contralateral motor performance 
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biases. They found – as expected – that rats with striatal dopamine depletion exhibited 
slower reaction times consistent with a motor initiation impairment, but to the ipsilateral 
side. The authors also replicated the findings of Baunez et al. (1995) and Baunez & 
Robbins (1997;1999) that STN-lesioned rats (and combined lesion rats) exhibit increased 
premature responding. However, the combined lesion group favoured a contralateral 
response bias, which demonstrated that the STN lesion does not merely cancel the akinesia 
following striatal dopamine depletion by addition of a hyperkinetic impairment, but instead 
lesioning the STN presents a novel impairment in functioning, which disrupts the balance 
of the motor system, and by extension of the task, cognition.  
This impairment in cognition, particularly attentional behaviour, may result from 
downstream dysregulation of key neural substrates implicated in cognition – such as the 
OFC and mPFC – which directly project to both the STN and the ZI (Kita et al., 2014). 
Disconnection lesions of the mPFC-STN (i.e., lesioning the STN and mPFC unilaterally, 
but in opposite hemispheres) considerably impaired rats’ discriminative accuracy and also 
increased perseverative responding and response latencies in the 5CSRTT; moreover this 
functional deficit was remarkably similar to the impairment seen after bilateral STN lesions 
(Chudasama, Baunez, & Robbins, 2003). This connection to the STN suggests that fronto-
subthalamic connection may be important in inhibition of responding, and given that there 
is existent overlap of receptor terminations in the STN and ZI from cortical areas (see Kita 
et al., 2014), we could expect the ZI to, in part, play a cognitive role as well.  
The majority of cognitive researchers have attributed their findings to be a 
representative measure of the functioning of the STN, however little experimental evidence 
is available or has been presented regarding the role of the ZI in cognition. The paucity of 
cognitive research for the ZI may be partially due the fact that the ZI is an under-researched 
region of the brain, but also that published research regarding the physical demarcation and 
admissibility of what constitutes the STN has been inconsistent. Being a small region of 
interest, studies which use lesions to disrupt the STN sometimes incur tissue damage to the 
neighbouring ZI region. To address this, some authors have retained these subjects as their 
inclusion does not influence the behaviour of interest, nor statistical outcome (Phillips & 
Brown, 2000; Phillips & Brown, 1999). Similarly, electrophysiology or HFS studies, which 
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record from or stimulate the STN cause unavoidable electrode track damage to the ZI, 
invariably with behavioural consequences (Baunez, Christakou, Chudasama, & Forni, 
2007; Darbaky, Forni, Amalric, & Baunez, 2003; Desbonnet et al., 2004), yet the 
conclusions drawn from these findings attribute any change in functioning to a 
manipulation of the STN. In contrast, other studies have either avoided the ZI altogether 
with discrete lesions (Baunez & Robbins, 1997; Baunez et al., 2001), whereas others have 
discarded rats that present with cell loss in the ZI, but comment that the data obtained from 
those animals had little impact on behaviour, suggesting that the ZI may have a minimal 
role in this type of cognitive behaviour (Baunez et al., 1995; Baunez & Robbins, 1999).  
Given the evidence that cortical projections to the STN and ZI overlap in these 
regions (Kita et al., 2014), it is possible that both the STN and ZI work together to regulate 
activity, thus contributing to the similar behavioural evidence in some studies. Furthermore, 
this blending of boundaries applies to other regions that share intimate connections with 
this area, for example, the cortical projections to both the STN and ZI overlap into the 
lateral LH as well, suggesting that the entire region may work together to modulate 
behaviour, and functioning which may very well extend beyond response inhibition 
(Berthoud & Munzberg, 2011; Lin et al., 1990).     
1.8.2 Decision making and risky behaviours  
As highlighted above, lesioning the STN leads to evidence of impulsive response 
selection behaviour, which supports the assertion that STN enables us to “hold our horses” 
by providing deliberative potential in decision making, perhaps by raising the response 
threshold to allow time for information gathering (Frank, 2006; Jahanshahi et al., 2014). 
Impulsivity can manifest many forms, such as responding without deliberation (impulsive 
action), aversion to delayed gratification, the inability to withhold a prepotent response 
(motor inhibition), along with engaging in more risky decision making (for reviews 
Evenden, 1999; Dalley, Everitt, & Robbins, 2011; but also Eagle & Baunez, 2010). In the 
case of decision making, and particularly decisions made under high-conflict conditions 
(i.e., choosing the best response under two positively associated responses), inhibition of 
responding is crucial; it is posited that the STN may play a large role in the ‘stopping’ and 
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‘integration’ of information prior to response selection, which consequently prevents 
impulsive or premature responding (Frank, 2006; Jahanshahi et al., 2014).  
In humans, this behaviour is typically modeled in a gambling task, such as the Iowa 
Gambling Task (IGT; see Bechara, 2003), which presents real-world contingencies of 
reward and punishment (i.e., winning and losing money), and creates a ‘decision conflict’ 
between an immediate large reward, yet at the cost of a delayed, and inevitable, punishment. 
Subjects are typically presented with four decks of cards with high-paying (decks A & B) 
or low-paying (decks C & D) options; the punishment is also higher in the high-paying 
decks and lower in the low-paying decks, and the task is designed such that the high-paying 
decks cost more in the long run, and are therefore disadvantageous (Bechara, 2003). 
Individuals who select riskier options in these tasks tend to accept short-term gains in lieu 
of longer-term objectives, and therefore this task has become a useful diagnostic tool in 
detecting drug addiction, compulsive binge-eating, and pathological gambling (Bechara, 
2003; Dalley, Everitt, & Robbins, 2011).  
There is also growing evidence that patients with Parkinson’s disease are at 
increased risk for developing pathological gambling, along with other impulse control 
disorders such as hypersexuality, overeating and punding (14% of clinical population), and 
that furthermore, the likelihood of developing these disorders may be predicted by 
dopamine agonist therapy (Jahanshahi, 2013). This predisposition in Parkinson’s patients 
undergoing dopamine agonist therapy may in part be due to a reduction in activation in 
brain areas implicated in impulse control and response inhibition (OFC, rostral cingulate 
area, amygdala, & GPe), which results in riskier choices, and may be mediated by outcome 
devaluation, or reward prediction errors; essentially an interference in the ability to learn 
from losses (van Eimeren et al., 2009; 2010).  It has also been found that Parkinson’s 
patients who are undergoing STN-HFS respond more impulsively, and are consequently 
impaired in tasks which require conflict resolution, or response selection under conflict 
(Frank, Samanta, Moustafa, & Sherman, 2007; Zaghloul et al., 2012;  Zénon et al., 2016). 
It is postulated that the OFC, DMS and STN form a network of regions that may be critical 
in impulsive/compulsive behaviour, and that dysregulating this network results in increased 
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impulsive action, premature responding and perseveration, and thus contribute to this 
impairment in decision making (Eagle & Baunez, 2010; Baunez & Lardeux, 2011).  
There is evidence that inactivation of the STN with HFS in Parkinson’s patients 
selectively interferes with the ability slow down, or ‘apply the brakes’, when faced with a 
decision conflict (Frank et al., 2007). Furthermore, when faced with decision conflict, 
patients undergoing HFS demonstrate increased spiking activity in the STN, and that as 
decision conflict increases, so too does the level of the spiking activity (Zaghloul et al., 
2012). More recent research by Zénon et al. (2016) has revealed that patients who are 
undergoing HFS therapy – both on and off L-DOPA – exhibit low-frequency neuronal 
activity in the STN, and instead of signalling conflict, this activity may indicate the 
encoding of cost-benefit comparisons. Zénon et al. (2016) tested patients on an effort-based 
decision task, providing monetary incentive for effortful activity (e.g., squeezing a handgrip 
in varying intensity); behaviourally, the probability of engaging in an effortful task 
increases with reward and decreases with required effort level. L-DOPA+HFS treatment 
increased the rate of acceptance for efforts associated with lower rewards, and that when 
off L-DOPA treatment, this effect was weakened. The authors also found synchronised 
activity in populations of STN neurons that may reflect the subjective value of reward and 
the subjective cost of effort, which is postulated by Zénon et al. to be the net subjective 
value of a trial during decision making. These findings indicate that the STN plays a critical 
role in the mediation of action selection during decision making, and that furthermore this 
may be mediated by the STN encoding the information required to make cost-benefit 
comparisons, rather than signalling conflict, which may also implicate the STN in 
motivational behaviour.  
In order to investigate how the STN integrates reward information and to what 
extent such integration correlates with behaviour, Espinosa-Parrilla, Baunez, & Apicella 
(2015) conducted electrophysiology recordings of the monkey STN during a two-choice 
target-reaching task, in which selection of a visual cue (target) from a touch-screen led to 
the delivery of a higher or lower value reward (e.g., juice vs water). Two variants of the 
task were employed: the standard task, and the choice task. The standard task presented 
monkeys with an instruction cue (e.g., either a green or yellow circle, on either the left or 
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right side of the screen), which provided advanced information regarding the nature of the 
upcoming reward (e.g., green = juice, yellow = water), followed by a 1 seconds waiting 
period before presented with one trigger stimulus (e.g., red circle) in the same spatial 
location as the instruction cue, and the animals were permitted to make a selection to 
receive the designated reward. The information gathered from this standard task helped 
investigate how the type of reward expected may influence neuronal activity during 
preparation, initiation and execution of the reaching movement. The choice condition task 
was formally similar to the standard condition, except it provided two instruction cues (one 
denoting juice, and the other water), and thereby it permitted the animal to choose its 
reward when presented with the trigger stimulus. Neuronal recordings were assessed over 
three time periods: the cue-trigger delay period, the movement period and the reward period. 
The authors found that when no choice was allowed (i.e., during the standard task), the 
activity of STN neurons was rarely modulated by adjustments of behaviour, although there 
was evidence that animals responded faster in juice trials, compared to water trials, 
therefore indicating a discriminative ability for reward-predictive cues. Conversely, when 
given a choice in selecting actions that lead to reward (i.e., during the choice task), STN 
activity was sensitive to the reward type, resulting in an increase STN neuronal activity at 
the outcome phase (when receiving reward), when the less-preferred reward was chosen 
(Espinosa-Parrilla, Baunez, & Apicella, 2015). These findings also indicate that the STN 
may encode whether or not a preferred reward has been received when alternative choices 
are available, which sheds new light on how the STN may mediate decision making 
processes.  
In studies with rats, our ability to infer complex decision making processes are more 
limited than in humans (e.g., clinical populations), and therefore we must rely on inference 
from overt behaviours in modified gambling tasks or delay discounting tasks in operant 
chambers (Winstanley, Baunez, Theobald, & Robbins, 2005; Uslaner & Robinson, 2006; 
Aleksandrova et al., 2013). The delay discounting task used by Winstanley et al. (2005) 
assessed impulsive choice behaviour, which defines impulsivity as the selection of a small 
immediate reward over a larger delayed reward, and can be contrasted with impulsive 
action behaviour (i.e., motoric disinhibition). Winstanley et al. (2005) tested rats in an 
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operant box which required rats to sustain a nose-poke in a central hole in order to 
commence a trial; subsequently, two levers were presented, in which one lever provided an 
immediate food reward of one pellet (delay: 0 seconds), whilst the other lever would 
produce a reward of four pellets with increasing delays between lever-press and reward 
delivery as testing proceeded (delay: 0, 10, 20, 30, 40 and 60 seconds). The authors found 
that preoperatively, rats demonstrated the typical delay-dependant choice behaviour: 
initially preferring a larger reward when delivery is immediate, but eventually shifting to a 
smaller reward as delay is increased. Postoperatively, STN-lesioned rats chose the larger 
reward more frequently than sham-operated controls, which suggests that STN-lesioned 
rats were less impulsive in this delay-discounting task. Furthermore the evidence that STN 
lesions results in increased impulsive action (Baunez & Robbins, 1997; Baunez et al., 
2001) without increasing impulsive choice may suggest that these behaviours may be 
subject to independent regulatory mechanisms that operate in concert or an 
‘impulsive/compulsive network’ (for reviews see Eagle & Baunez, 2010; Baunez & 
Lardeux, 2011). In a follow-up study by Uslaner & Robinson (2006), the authors replicated 
the findings of Winstanley et al. (2005), and found in a delay-discounting task, STN-
lesioned rats selected the lever which led to delayed gratification more frequently than 
control rats, but only in the longest delay condition, which supports that lesioning the STN 
may in fact decrease impulsive choice behaviour. It is also possible that the incentive of the 
larger reward is more difficult to inhibit, particularly following lesioning, and owing to the 
task sensitivity of the delay-discounting task we are able to obtain different findings than an 
impulsive action task (i.e., the 5CSRTT). These findings also align with the studies in 
human Parkinson’s patient and monkeys presented above, in which the STN may play a 
critical role in outcome evaluation.  
In a recent study by Adams et al. (2017), the authors investigated the effects of 
STN-HFS in rats completing the Rat Gambling Task (rGT) – the rodent analogue of the 
IGT. Similar to the IGT and delay-discounting tasks, the rGT creates a decision conflict in 
rats by forcing them to decide the most efficient strategy to maximise food reward by 
training them to poke their nose in one of four holes which differ in reward volume (1, 2, 3, 
or 4 pellets given per trial) and with corresponding punishments in the form of a ‘time-out’ 
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(5, 10, 30, or 40 seconds), with larger rewards leading to a higher likelihood of punishment. 
In typical fashion, the most advantageous option maximised reward, yet limited 
punishment; essentially, smaller per-trial gains but lower time-out penalties. Adams et al. 
(2017) found that STN-HFS did not influence performance for those rats identified as 
‘optimal decision makers’ in the baseline assessment, but that HFS significantly improved 
choice responding for ‘risk-preferring’ rats (‘high risk, high reward’; roughly 25% of rats 
from baseline). It is worth noting that the behavioural effects of HFS for this population 
were progressive, in that improvement in decision making was not apparent until the fourth 
treatment session. This effect has been seen in the past (see Baunez et al., 2007), which has 
led Adams et al. (2017) to postulate that perhaps HFS itself may not reliably induce 
changes in decision making, and that perhaps repeated stimulation is required to trigger 
neuroplasticity, which in turn, results in cognitive change. Ultimately, more work is needed, 
as it has also been demonstrated that HFS of the STN does not truly mimic the inactivation 
obtained from lesioning (Baunez et al., 2007; Baunez & Lardeux, 2011), but global 
evidence from both HFS and lesioning, and across humans, monkeys and rats suggests that 
STN may play a pivotal role in the processes contributing to decision making. 
1.8.3 Learning and memory  
There are only a few studies which document the involvement of the STN in 
learning and memory, and it appears that STN lesions do not directly impair the learning 
process, yet may impair working memory, depending on the task paradigm (Baunez et al., 
2001; El Massioui et al., 2007). Research by Baunez and colleagues (2001) compared 
performance between a simple (SRT) and choice (CRT) reaction time task with the 
intention to investigate the role of the STN in the response preparatory process. The SRT, 
which was adapted from a task designed by Brown & Robbins (1991) for examining the 
effects of striatal dopamine depletion, required the rats to sustain a nose poke in the central 
hole of a 5-hole array, which prompted a change in brightness in the neighbouring 2 holes 
(e.g., an increase or decrease in brightness). Half of the rats were trained to ‘go right if 
bright, and go left if dim’ (and vice versa for the other half), but the rats could only make a 
response after the onset of a tone stimulus, thus requiring them to sustain their nose-poke. 
In the SRT condition, the chamber brightness which specified the location of the reward 
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was returned to an ‘intermediate’ brightness 0.3 seconds before the tone cue, whereas in the 
CRT condition, the change in brightness which specified the location of the reward was 
presented simultaneously with the tone cue; essentially, the SRT condition provided 
information in advance to aid in response preparation. Pre-operative baseline data 
suggested that reaction times (RTs) were significantly longer in the CRT condition than in 
the SRT condition, and that furthermore, a longer ‘foreperiod’ (the time before the 
presentation of the tone stimulus) decreased RTs; these findings suggested that rats 
benefitted from advanced information, and that rats demonstrated a ‘motor readiness’ effect.     
Comparing performance between the SRT and CRT conditions allows one to infer 
about the response preparatory process, and following lesions to the STN, the rats in 
Baunez et al. (2001) no longer demonstrated a difference between SRT and CRT conditions, 
indicating that lesioned animals no longer demonstrated the benefit of information 
presented in advance. The accuracy for lesioned animals in the SRT condition also 
significantly decreased, along with a significant increase in premature responding in both 
SRT and CRT conditions. Interestingly, lesions did not impair the ‘motor readiness’ of the 
rats, as increasing the foreperiod length still yielded an inverse relationship with RT post-
operatively, which contrasts the effects seen after dopamine-depleting lesions of the 
striatum (Brown & Robbins, 1991). This preserved ‘motor readiness’ suggested that 
lesioned rats were more likely impaired at response selection rather than ‘motor initiation’, 
especially since there was no difference between groups when it came to movement time 
(the time between withdrawal of the nose from the central hole to the nose-poke in the 
response hole); essentially these rats were impaired at the ‘which’ phase of response 
selection, and not the ‘when’ phase.  
The pattern of responding in premature response trials for STN-lesioned animals in 
Baunez et al. (2001) also changed to a win-stay strategy, resulting in rats perseverating to 
the same side as the previously rewarded response. The nature of this response preparation 
deficit led the authors to postulate that lesioning the STN may impair the operation of a 
‘response buffer’ – a ‘motor’ working memory.  This buffer would hold a selected response 
in readiness until its execution is required, and would need to be ‘cleared’ following 
execution to permit subsequent responding. It was theorised that following STN lesions, the 
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inability to clear the buffer following one response would cause conflict with the 
subsequent response.  It is worth noting that theoretically this conflict should only arise if 
the subsequent response differs from the previous one, and thus the reduced accuracy and 
increased reaction time should only apply to alternated responses, and whilst the data are 
not contradictory, the authors did not provide an analysis of this consideration, which 
would have bolstered the claim for the impairment of a ‘response buffer’ following STN 
lesions.  
In a subsequent study by El Massioui, Chéruel, Faure, & Conde (2007), the authors 
investigated whether they could dissociate learning and memory effects by lesioning the 
STN in rats either before or after completing a lever-pressing task. In one experiment, El 
Massioui and colleagues lesioned the STN and then required rats to learn a light-tone 
discrimination task (i.e., if light is emitted, then press the right lever), which upon criterion 
was reversed (i.e., if tone is emitted, then press the right lever); in a second experiment, 
animals were trained to complete the same light-tone discrimination as the first experiment, 
and upon criterion the STN was lesioned. Following surgery in the second experiment, all 
animals were subject to a ‘re-learning’ phase, which was identical to the original 
discrimination and rate of acquisition of this discrimination provided a measure of ‘long-
term memory’; subsequent to the ‘re-learning’ phase, half of the animals were subjected to 
a reversal, whilst the other half completed a ‘working memory’ task, which introduced 
various delays (5, 10 or 20 seconds) between the offset of the cue stimulus and the 
presentation of the levers. The authors found that STN lesions did not influence acquisition 
of discrimination learning, further supporting that inactivating this area has a minimal 
effect on learning a discrimination. When surgery was completed before the behavioural 
task, El Massioui et al. found that STN lesions facilitated reversal learning performance 
owing to a more rapid inhibition of the previously correct stimulus; essentially reduced 
perseveration, which is contrary to previous findings (Baunez et al., 1997; 1999; 2001). It 
is worth noting however that previous work employed a very short stimulus duration period 
(0.5 seconds), and that when Baunez et al. (1997) extended this stimulus duration period 
they also noted fewer omissions and premature responses.   
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When rats were lesioned following the acquisition of discrimination learning 
(second experiment), lesioning the STN did not impair the re-learning phase, and thus long-
term memory, or target control of the task parameters, remained intact. However, during 
the longest delay condition (20 seconds) for the working memory task, the percentage of 
STN-lesioned rats that reached criterion significantly decreased (only 57% of STN-lesioned 
rats managed to), owing to an increase in errors, and thereby suggesting that lesioned rats 
may have an impairment in working memory. Furthermore, reversal learning performance 
was comparable between lesioned and control groups for the second experiment, with no 
evidence for a facilitative effect for either group. The authors postulated that the facilitative 
effect on reversal learning from the first experiment may have resulted from a rapid 
forgetting of previous response tendencies. The authors argued that the reversal was not 
facilitated in the second experiment since the original discrimination stage occurred 
preoperatively – three weeks before the reversal – and therefore weakening the interaction 
effect between initial and reversal learning owing to temporal delay. This consideration 
should be interpreted with some caution, largely because the retraining trials which directly 
preceded the reversal phase adhered to the same conditions as the initial learning, and 
therefore a facilitative effect on the reversal should have been apparent in the second 
experiment as well.  
An alternative interpretation posited by the authors suggested that the facilitation of 
the reversal learning phase could have resulted from an increase in selective attention to the 
relevant stimuli, which would have facilitated the acquisition of the reversal. This 
enhancement in attentional selectivity during two-choice discrimination learning typically 
arises from overtraining (see Chapter 7; but also Sutherland & Mackintosh, 1971), and 
according to Sutherland and Mackintosh’s two-stage theory, may be indicative of 
attentional set-formation. There is no evidence for overtraining in any of the rats in El 
Massioui et al. (2007) (i.e., comparable performance during discrimination learning and 
during retraining phases, respectively), and furthermore, recently published data in a task 
better-suited to make an inference about this type of behaviour (e.g., the ASST) suggests 
that lesioning the STN/ZI-area may in fact impair the formation of attentional set (Tait, 
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Phillips, Blackwell, & Brown, 2016); a consideration that will be explored in the 
subsequent section.  
1.8.4 Attentional set 
In recent reviews by Baunez & Lardeux (2011) and by Jahanshahi and colleagues 
(2015), only tasks which predominantly measure inhibition and impulse control behaviour 
(i.e., visuo-spatial attention tasks and their variations) have been employed thus far to 
evaluate the role of the STN in cognition. Given that the STN itself is directly connected to 
frontal areas of the brain – along with key output projections within the BG – we would 
expect it to play a more complex role in executive functioning. Whilst the tasks thus far 
present a cognitive role for the STN, visuo-spatial reaction time tasks are not sensitive to 
measuring a breadth of executive demands, such as those evaluated and required during 
tasks such as the ASST. It has also been shown in human and rodent literature that tasks 
which exert strict time pressure, or demand rapid response and response inhibition, may 
exacerbate STN-mediated deficits (Baunez & Robbins, 1997; El Massioui et al., 2007; Pote 
et al., 2016). Baunez & Robbins (1997) found that increasing the stimulus duration, and 
decreasing the inter-trial interval significantly improves accuracy, especially for lesioned 
animals, whilst also reducing the number of premature responses incurred. Similarly, El 
Massioui et al. (2007) found that extending the stimulus duration period to 10 seconds, and 
arguably removing temporal requirements and excess load on the motor system, may 
eliminate perseverative behaviour. Pote et al. (2016) investigated this speed-accuracy trade-
off in Parkinson’s patients undergoing STN-HFS therapy and found that STN inactivation 
was associated with significantly faster reaction times, but with increased error under 
increasing speed conditions. It is postulated that the STN may raise response thresholds to 
permit accumulation of information before response selection, and whilst reaction-time 
tasks, or similar tasks requiring a time-based response are useful in measuring a particular 
profile of the STN in cognitive functioning, it may not be well-suited to assess the potential 
executive role of this area.   
Past data from our lab, which has been recently published (Tait et al., 2016), 
extended the work presented by Phillips & Brown (1999), but with bilateral lesions of the 
STN and dorsomedial striatum (DMS) in the ASST. The authors found that bilateral lesions 
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of the STN/ZI-area resulted in impaired discrimination learning at the outset of the task, 
including at the SD, CD, first reversal and ID stages, and furthermore, no difference 
between the ID and ED stages (figure 1.6). It was speculated that this impairment at early 
stages may have stemmed from impairment in inhibition, manifesting as ‘impulsive digging’ 
– an impulsive action behaviour. However, since performance improved as testing 
progressed, and since the ED was acquired in visibly fewer trials for STN/ZI-lesioned 
animals than controls, the authors speculated whether an attentional set had been formed, or 
if these lesioned rats were capable of forming set. Despite no ID/ED difference, it was not 
possible to reliably determine whether these rats were impaired at forming set, since the 
elevated ID performance for STN/ZI-lesioned rats could have stemmed from either an 
impairment in set-formation, or a latent impairment in inhibition found at the earlier stages 
of testing. 
The ibotenic acid lesions of the STN found in Tait et al. (2016) were nearly 
complete and encompassed both the medial and lateral sections of the nucleus, with only 
the most posterior sections being spared. Previous research has shown that the size of the 
lesion or the amplitude and frequency of the HFS directly correlates with the magnitude of 
the motoric inhibitory deficits, and thus perhaps the selective impairment in earlier stages 
of testing found in Tait et al. (2016) could have partially resulted from large lesions 
encompassing the lateral STN or ZI. This may have resulted in motor disinhibition, which 
was gradually brought under control as testing progressed (Desbonnet et al., 2004; Wiener, 
Magaro, & Matell, 2008); however there is no current evidence for the impact of this 
functional division on tasks measuring cognition, nor is there evidence lesioning the ZI 
may impair this type of (or any) cognitive behaviour. Since cognition and executive control 
is of interest, the medial STN was targeted in this thesis. 
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Figure 1.6: Figure from Tait et al., 2016 illustrating the mean TTC (+SEM) for control rats 
compared to DMS lesioned (top graph), STN lesioned (middle graph) and combined 
STN+DMS lesioned (bottom graph) rats in each discrimination learning stage; *p<0.05 
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1.9 Thesis overview  
The primary objective of the experiments conducted for this thesis was to further 
investigate the nature of the cognitive deficits detailed after lesions to the STN. This 
included manipulating the functioning of the STN, followed by testing behaviour on the 
rodent ASST to determine whether disrupting the STN induces an impairment in attentional 
set-formation. This was also in an effort to better understand how learning associations 
between stimuli contribute to the formation of set.  
Chapter 3 will firstly attempt to replicate the findings observed in Tait et al. (2016) 
on the standard 7-stage task, with lesions targeting the medial STN, and the hypothesis that 
acquisition learning at the earlier stages of the task will not be impaired as a result, along 
with evaluating the ID-ED comparison to determine the cost of shifting set (if any). A 
follow-up experiment will use a modified ID/ED task, which has been designed to evaluate 
several hypotheses which would aid in the inference of set-formation, to further probe this 
deficit.   
The experiments in Chapter 4 introduce another modified task design, which instead 
of evaluating the cost of shifting set (i.e., ID vs ED), explores the process of set-formation 
by investigating where attention is being directed to, and the level of distractibility 
exercised by the irrelevant dimension stimuli. This design is also more succinct than the 
task variant used in Chapter 3, which was implemented to reduce the time required for 
testing. This reduction permitted the use of a reduced-stress, palatable ‘jelly’ tablet as a 
method to deliver orally-bioavailable, cognitive-enhancing drugs (modafinil and 
ORG49209). The first part of Chapter 4 will demonstrate the efficacy of this ‘jelly’ 
administration method by examining the bioavailability of modafinil in the brain, along 
with its effect on behaviour. The second part of the chapter will then test whether rats – 
either lesioned or control – will benefit from these drugs in the revised task.  
In Chapter 5, a refined method of manipulating function of the STN is introduced, 
which uses a modified viral vector to allow for transient inhibition of a target cell 
population via application of a synthetic ligand. Being a relatively novel approach, this 
chapter will be primarily a pilot assessment, determining the best serotype and promoter to 
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restrict viral transduction to the STN, whilst furthermore measuring changes in c-Fos 
immunoreactivity levels during an inhibitory state.  
Chapter 6 will employ the findings from Chapter 5, and test virally-transduced rats 
on the same modified ASST from Chapter 3. This task will aid in determining the 
behavioural consequences of inhibiting the STN on the ASST, along with investigating 
how rats that are impaired at set-formation might be completing the task.  
 This is further explored in Chapter 7, where the same group of rats from Chapter 6 
are either trained to criterion or receive overtraining at the CD stage, which has been shown 
to lead to faster reversal acquisition, theoretically owing to a formation of attentional set. 
The first half of this chapter will attempt to demonstrate this learning effect in the bowl-
digging paradigm in unoperated rats, whilst the second part of the chapter will explore the 
effects of overtraining on virally-transduced rats. This chapter could also shed light on the 
relationship between associative processes (i.e., reversal learning) and how they are 
implicated in the formation of attentional set.   
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Chapter 2 
 
General Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
The current chapter describes materials and methods commonly 
used throughout this thesis. This includes information on animal 
husbandry, general surgical and histological protocol, and the 
procedure for training and testing on the standard 7-stage 
attentional set-shifting task, along with procedures for statistical 
analysis. Variations to these general methods will be described in 
the respective methods section for that chapter.  
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2.1 Animals 
All animals used in the following experiments were Lister hooded rats either 
obtained from a breeding establishment registered with the UK Home Office or bred in-
house (University of St Andrews; from Charles River stock). The female rats in Chapter 
four (experiment I)/Chapter seven (experiment I), and the male rats used in Chapter five 
were bred in-house, whilst the remaining experiments and experimental chapters 
utilised male rats from Charles River, UK. All animals were experimentally naïve prior 
to training for behavioural testing, unless otherwise stated in the respective 
experimental chapter. Animal welfare and all procedures were in compliance with the 
Animals Scientific Procedures Act (1986), and conducted under project and personal 
licenses approved by the UK Home Office and the University of St Andrews Animal 
Welfare and Ethics committee. 
Animal husbandry conditions were nearly identical for all experiments, though 
minor differences may be reported in each experimental chapter. To provide ‘social 
enrichment’, rats were group housed when possible, in groups of up to four in large 
home cages (approximately 50 cm x 30 cm x 25 cm). Following surgery rats were 
single-housed until their weight stabilised and were then reintegrated into group or pair-
housing. In some cases, rats remained single-housed for the duration of the experiment, 
typically if the rat had difficulty socially reintegrating to group housing or was a 
potential danger to itself (owing to self-injury from spontaneous seizure activity). These 
smaller home cages (approximately 40 cm x 23 x cm x 19 cm) were also used to pair-
house rats in three of the experiments (chapters five, six & seven). In their respective 
home cages, rats were given “environmental enrichment” in the form of wooden chew 
bars, shredded cardboard, triangular cardboard “houses” and a plastic tube suspended 
from the cage lid. Lighting in the colony room was maintained on an artificial twelve 
hour light/dark cycle (lights on at 07:00), with all behavioural testing conducted during 
the “lights-on” phase. The colony room and all procedure rooms were kept at 21°C ± 2°, 
with a relative humidity of 55% ± 10%.  
At least one week prior to the start of any experiment, rats were placed on a 
controlled food diet of 15-20 g of standard laboratory chow (Special Diet Services, 
Essex, UK) per rat per day; however water was always available ad libitum. Food 
control was employed primarily to encourage motivation for food rewards during 
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behavioural task work, and to prevent rats from becoming overweight during the 
experiment. Rats were weighed weekly to ensure that their weight did not decrease 
suddenly, whilst maintaining a healthy weight gain. Start and end weights for all rats 
used for the current thesis are summarised below in table 2.1. At the end of the 
experiment, female rats in experiment I of Chapter 4/7 were terminated using a lethal 
dose of anaesthetic in accordance with Schedule I of the Animals (Scientific Procedures) 
Act (1986), whilst rats in all other experimental chapters were transcardially perfused 
with paraformaldehyde (fixative) under terminal anaesthesia. The procedure for the 
transcardial perfusion will be described in section 2.5.  
Number of 
animals 
Experimental Chapters 
Start weight 
range 
End weight range  
20 Chapter 3 358-445g 348-573g 
      22 (♀) 
Chapter 4 - Experiment I      
Chapter 7 - Experiment I 
180-250g 233-328g 
20 Chapter 4 - Experiment II 231-286g 405-576g 
4 Chapter 5 - Experiment I  369-414g 377-415g 
12 Chapter 5 - Experiment II  325-361g 363-425g 
22 
Chapter 6                              
Chapter 7 - Experiment II 
363-428g 484-575g 
Table 2.1: Start/end weights and sample size of all rats, for all experiments in this thesis. 
2.2 Apparatus  
Both training and testing were conducted in the set-shifting apparatus (69.5 cm x 
40.5 cm x 18.5 cm). It was constructed from a modified plastic home cage, and divided 
into a large “waiting area” comprising two-thirds of the box, and the remainder was a 
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“testing area”, which was further sub-divided into two bowl-digging chambers (figure 
2.1). Two acrylic panels were used to occlude entry to the digging chambers – a large 
panel and a small panel – which could block entry to the entire testing area or to one 
chamber selectively. The digging bowls were ceramic pet food bowls, which had an 
internal diameter of 7 cm and a depth of 4 cm. Bowls were filled with digging substrate 
and odours were subsequently mixed in, until the internal volume was within 0.5 cm of 
the top of the bowl.  
 
Figure 2.1: Rat attentional set-shifting apparatus with size dimensions, digging bowls 
filled with odour and haptic stimuli, small and large acrylic panels, along with a water 
bowl in the “waiting area” 
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2.3 Surgery 
2.3.1 Neurotoxin  
Chemical lesions to the subthalamic nucleus were accomplished by use of (S)-2-
amino-2-(3-hydroxyisoxazol-5-yl) acetic acid or ibotenic acid, a powerful excitotoxin 
naturally occurring in the amanita muscaria mushroom. Ibotenic acid is a 
conformationally restricted analogue of glutamic acid, and it is evidenced that its 
application to a target cell population causes protracted pre- and post-synaptic 
depolarization, which ultimately causes necrosis and cell death (Schwarcz et. al., 1979). 
Compared to other conventional lesioning methods (i.e., aspiration or kainic acid), IBO 
is more selective, which minimises extraneous damage to adjacent areas and fibres of 
passage (Köhler, Schwarcz, & Fuxe, 1979; Jarrard, 1989).  
2.3.2 Injection materials    
Custom pulled glass micropipettes were used to administer ibotenic acid during 
all surgical procedures. This was chosen over metal syringes/micro-syringe pumps, 
which may introduce extraneous toxin damage to adjacent areas, such as the zona 
incerta and entopeduncular nucleus (EP; Baunez et. al., 1995; Baunez & Robbins, 1997; 
Phillips & Brown, 1999) during STN lesion surgery.  Additionally, metal syringes cause 
track damage to the ventroposteromedial thalamus, making it difficult to interpret 
behavioural results (Phillips & Brown, 1999). Thus, the use of a glass micropipette 
reduces mechanical tissue damage, in addition to a refined toxin administration to the 
STN, promoting a more localised administration.  
Micropipettes were fabricated from borosilicate capillary tubes (0.49mm bore 
diameter, 1.16-1.19mm outer diameter, 90mm long). Capillary tubes were placed in a 
vertical pipette puller (Model 720; David Kopf Instruments, Tujunga, CA, USA), which 
heated the tubes at the centre, whilst pulling the two ends apart. The injection end of the 
micropipette was then snipped to 30µm under microscope guidance. The micropipettes 
were marked at 1mm intervals, which denoted an internal volume of 200nl.  
2.3.3 Surgical procedure 
Induction of anaesthesia was accomplished with 5% isoflurane (Harvard 
Apparatus, Cambridge, MA, USA) and oxygen (1.5L/min) mixture, in an induction 
chamber, and maintained between 1-2% throughout surgery via a nosecone fitted on the 
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incisor bar of the stereotaxic frame. Once anaesthetised, rats were given 0.05ml 5% 
carprofen (SC: subcutaneous; Carprieve, Norbrook Laboratories Ltd., Newry, N. Ireland, 
UK) to aid in post-operative pain management, and 0.15ml of diazepam (IP: 
intraperitoneal; Sigma Chemical Company, St Louis, MO, USA) to maintain sedation 
after recovery from the anaesthesia. Hair was shaved from the scalp to expose the 
surgical area, and a pre-operative weight reading was taken.  
Rats were then secured into a stereotaxic frame (David Kopf Instruments, 
Tujunga, CA, USA) with atraumatic ear bars, and the skull position was leveled by 
setting the incisor tooth bar at -3.3mm. A midline incision was made along the scalp, 
and the skin and fascia tissues were retracted, exposing the skull surface, which was 
cleaned with sterile saline (sodium chloride 0.9%; Baxter International Inc., Deerfield, 
IL., USA) prior to drilling. Small burr holes were made at the appropriate stereotaxic 
coordinates, ventral to the injection site, using a precision dental drill (NSK-Nakanishi 
International; Kanuma, Tochigi, Japan). Prior to insertion of the micropipette, the dura 
was lightly scored with a syringe sharp in order for the pipette to enter the cortex 
without breaking the tip.   
Lesions to the STN were made by injection of 200nl of 0.06M ibotenic acid, 
bilaterally, at the stereotaxic coordinates AP: -3.8mm, ML: ±2.3mm, DV: -7.8mm 
(Paxinos & Watson, 1998). ML and DV measurements were taken from dura, as the 
glass micropipette may break by taking measurements from the skull surface. Infusions 
were given as a bolus injection and the pipettes were left in situ for a further three 
minutes. Surgery for control rats was identical, except that instead of a toxin, infusions 
of 200nl of 0.1M phosphate-buffer (0.2M PB: disodium hydrogen orthophosphate and 
sodium dihydrogen orthophosphate in distilled water) were given. Upon completion, the 
wounds were cleaned and closed with surgical staples, and the rat was placed in a large 
recovery cage with a heating pad underneath. 
It has been observed that the interaction of ibotenic acid with the STN cell 
population results in a prolonged and impulsive chewing behaviour whilst recovering 
from anaesthesia, which may result in self-injury (Baunez & Robbins, 1997). To 
prevent this, a twine gag was secured in the rat’s mouth to provide something to chew 
on and to limit the risk of self-injury to paws, and the rats were constantly monitored 
until chewing ceased. Rats were then single-housed for at least one day following 
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surgery, and returned to group housing following recovery. To account for post-
operative pain, rats were given “wet-mash” food, consisting of ground standard 
laboratory chow mixed with water. Rats that did incur self-injury from “chewing” were 
given 0.15 mg/kg of meloxicam (Metacam, Boehringer Ingelheil Vetmedica Inc.) mixed 
into their wet-mash daily to reduce pain, until healed.  
2.4 The rodent attentional set-shifting task 
2.4.1 Training 
The night before training, bowls (one per rat) with six Honey Loops (Kellogg 
Company, UK) each were filled with sawdust and left in the rats’ home cage to reduce 
neophobia to the food reward during training. On the day of training, rats were placed in 
the waiting area of the set-shifting apparatus and two bowls filled with sawdust with a 
half Honey Loop on the surface were placed in the testing chambers. Upon successful 
retrieval, the trial was reset and the rat had to retrieve the reward a further five times, 
yet each time the Honey Loop was baited deeper in the digging bowl (until at the 
bottom). The rat had to dig for the food reward and a dig was recorded when there was a 
substantial displacement of digging substrate. The rodent attentional set-shifting task 
targets the rats’ innate investigative and foraging tendency, thus making it a well-suited 
measure of goal-directed behaviour.   
Training also required the completion of two simple, two-choice discrimination 
stages, one for medium (two similar smelling digging substrates with no added odour) 
and one for odour (homecage sawdust with two different added odours). The list of 
stimuli used for training will appear in the following section in table 2.2. The first four 
trials of each stage were considered “exploratory trials” and allowed the rat to “self-
correct” by retrieving food from the correct bowl following an incorrect dig. An 
incorrect dig after these exploratory trials, resulted in the small panel being lowered to 
prevent entry to the correct digging chamber. Upon responding, response latency data 
was recorded along with whether it encountered only one or both bowls before initiating 
a digging response. For all discrimination learning stages, rats were given a total of ten 
minutes to respond before the trial was reset and a “non-dig” response was recorded. As 
response choice is of interest, “non-digs” were not included in the final computation and 
statistical analysis. The discrimination learning criterion was set at six consecutive 
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correct responses (chance p=0.0156). Testing typically commenced within two days 
following training. Whilst there were several variants of the set-shifting task employed 
in this thesis, the “standard 7-stage task”, as first described in Birrell & Brown (2000) 
will be described here. Any task variations employed will be detailed in their respective 
experimental chapter.  
2.4.2. Testing on the ‘standard 7-stage task’ 
A typical testing session on the 7-stage task took between one to three hours to 
complete, depending on the rats’ satiety level, familiarity with the task, and interest in 
completing the task. The task itself presented a series of seven discrimination stages, 
including a combination of novel learning and reversal discriminations. The test started 
with a simple discrimination (SD) stage, which was similar to training and presented a 
pair of either odour (in home cage sawdust) or medium stimuli. The compound 
discrimination (CD) stage introduced a pair of irrelevant stimuli to the original SD 
pairing, which served as the irrelevant dimension, and a potential distractor to 
discrimination learning. The rats then completed a CD-Reversal (Rev1) stage, which 
retained the same stimuli from the CD, but rats now had to learn that the previously 
correct stimulus was now incorrect, since the correct and incorrect exemplars from the 
CD were reversed. The intradimensional acquisition (ID) stage introduced novel 
compound odour and medium stimuli, yet the relevant dimension did not change (i.e., if 
odour stimuli predicted reward in the CD, then the novel odour stimuli in the ID would 
still predict reward). This was followed by an intradimensional reversal (Rev2) stage, 
in which akin to Rev1, rewarded the previously incorrect stimulus within the same 
perceptual dimension. The extradimensional shift acquisition (ED) stage once again 
introduced novel odour and medium stimuli, along with a change in the relevancy of 
dimension (i.e., if odour predicted reward in the ID, then medium would now predict 
reward in the ED). A difference in trials to criterion between the ED and ID stage is 
referred to as the “shift cost”, and is an index of the cost of shifting from one dimension 
to the other during novel learning. The final stage was an extradimensional reversal 
(Rev3) stage, which rewarded the previously incorrect stimulus from the preceding ED 
stage. 
Since there were a large number of possible combinations for odours and 
digging media, stimuli were arranged into pairs, which were then counterbalanced. 
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Counterbalancing attempted to control for order of presentation of stimulus pairings, 
shift type (e.g., medium to odour or vice versa), and the initial correct stimulus within a 
pairing. The complete list of exemplars for the standard 7-stage task, along with the 
stimuli used for training are summarised in table 2.2. Additional stimuli used for 
variations to the 7-stage task will be detailed in their respective experimental chapters, 
along with modifications to the task design. 
 
Table 2.2: List of exemplar pairs used in the standard 7-stage task and training. 
2.5 Histology 
At the end of behavioural testing, rats were terminally anaesthetised with a lethal 
dose of 0.8ml pentobarbital sodium (ip; JML pentobarbital, Andover, Hampshire, UK), 
and transcardially perfused with PBS (0.1M PB and sodium chloride in distilled water), 
followed by 4% paraformaldehyde in 0.1M PB. Brains were removed and refrigerated 
overnight at 4°C in 20% sucrose solution. The next day, brains were washed three times 
in distilled water then dried, and placed in wells for fixation in egg yolk. The wells were 
pre-treated with a spray lubricant (WD-40, San Diego, CA, USA) to aid in removal after 
the brains set. The brains were covered with egg yolk, then the gaps between the wells 
were filled with 40% formaldehyde and the yolk was left to set for at least five days. 
Brains were then sliced into 50µm sections with a freezing microtome (Jung Histoslide, 
2000, Reichert-Jung, Cambridge Instruments, GmbH), subdividing tissue collection into 
eight collected sets, such that one section was collected every 400µm per set. Sections 
were stored in an anti-freeze solution (sucrose dissolved in 50% 0.2M PB and 40% 
ethylene glycol in distilled water) at -20°C, until staining for immunohistochemistry. 
All sections were double-stained for neuronal nuclei (NeuN) and enhanced with cresyl 
violet to visualise remaining cell bodies, and to map the extent of the lesion.  
Media Odours
Pair I M1: Coarse tea M2: Fine tea O1: Cinnamon O2: Ginger
Pair II M3: Sand M4: Grit O3: Sage O4: Paprika
Pair III M5: Coarse shavings M6: Fine shavings O5: Turmeric O6: Cloves
Training M9: Polystyrene pieces M10:Shredded paper O9: Mint O10: Oregano
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Staining for NeuN involved first ‘washing’ all sections in 9-hole net wells, 
which entailed immersion in 0.1M PBS, five times for three minutes each. Sections 
were then placed on a stirrer for 1 hour in blocking solution (20% normal goat serum, 
0.1% triton in 0.1M PBS) and then washed again. Sections were then incubated in 
mouse anti-NeuN (1:4000; Chemicon International, Temecula, CA, USA) in antibody 
diluting solution (ADS: 0.1M PBS, 1% normal goat serum, 0.1% triton) and left on a 
stirrer overnight. The next day, sections were washed and incubated in vector IgG 
solution (anti-mouse IgG; 5µl/ml; Vector Laboratories Ltd., Peterborough, UK) on a 
stirrer for one hour. Sections were then washed again, and incubated in reagents A & B 
(10µl/ml each) of Vectastain ABC complex (Vector Laboratories Ltd., Peterborough, 
UK) for another hour. Sections were washed again and treated with Sigma Fast 3.3-
Diaminobenzidine tablets (DAB: Sigma Chemical Company, St Louis, MO, USA) for 
approximately 10-15 minutes, until tissue and neuronal nuclei were stained with a dark-
brown colour, with minimal background staining. Sections were then washed again and 
mounted on gelatine-subbed glass slides.  
Slides were placed in a slide holder and stored overnight in a formaldehyde gas 
bath to fix the tissue samples to the gelatine-subbed slides. Sections were immersed in a 
bath of xylene, which was used as a clearing agent to de-fat tissue. Sections were then 
re-hydrated with ethanol, followed by 50% ethanol solution (in tap water), and finally 
tap water. Slides were submerged in cresyl violet solution (cresyl fast violet acetate, 
dissolved in distilled water and glacial acetic acid, pH adjusted to 3.5 with sodium 
acetate) for 2 minutes, and then left in a bath of running water for 5 minutes to clean the 
sections of excess dye. Sections were dehydrated with a 50% ethanol solution, followed 
by ethanol, and finally xylene, before slides were cover slipped with DPX mountant 
(BDH Laboratory Supplies, Poole, UK). Lesions to the STN were determined with light 
microscopy at 10x and 40x magnifications, looking for cell damage either in the form of 
calcification or lack of neuronal staining. Magnitude of the lesioned area was mapped 
onto standardised schematics of the rat brain with a stereotaxic atlas (Paxinos & Watson, 
1998).  
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2.6 Statistical analysis  
All statistical analyses were computed in IBM SPSS v23 (IBM Corporation, CA, 
USA) and graphs designed in SigmaPlot v12 (Systat Software Inc., Chicago, USA). 
Data for trials to criterion, errors to criterion, latency to dig and response order (dig in 
first or second bowl) were collected. Trials to criterion and errors to criterion typically 
produces the same pattern in analysis, but trials to criterion yields a larger effect size, 
and thus increased statistical power (Tait & Brown, 2007; Field, 2009). Data for trials to 
criterion were analysed with repeated-measures analysis of variance (ANOVA), with 
specific factors and number of levels detailed in respective experimental chapters. 
Huynh-Feldt corrections were used when the within-subjects data violated the 
assumptions of sphericity. Where applicable, Bonferroni-corrected pairwise 
comparisons were calculated, which is slightly more conservative that Sidak’s 
correction and does result in slight loss of power; however is more robust and better 
reduces the chances for a type I error (Field, 2009). Significant interactions from the 
omnibus ANOVA (restricting levels and factors of interest) were re-analysed as 
restricted analyses with further repeated-measures ANOVA. For the restricted analyses, 
the error term and degrees of freedom from the omnibus ANOVA were used, and the F-
value and thus the p-value (criterion p<0.05) recomputed (Winer, 1971).    
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Chapter 3 
 
Exploring set-formation with the 11-stage 
task 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background: 
Recently published work demonstrated that lesions to the STN/ZI-
area may impair the formation of attentional set on the 7-stage task, 
yet further work is needed. This chapter attempts to replicate this 
set-formation deficit in the 7-stage task, along with evaluate the 
effects of several manipulations sensitive to the inference of set-
formation in the recently designed 11-stage task. 
Methods: 
20 rats (12 lesion; 8 control) were tested twice on the 7-stage task, 
and once on the 11-stage task.  
Results: 
Despite histology revealing predominantly unilateral lesion 
damage, lesioned rats did not demonstrate a cost for shifting set.  
However control rats also failed to demonstrate a convincing ID-
ED difference.  
Conclusions: 
It is likely that the amount of intact tissue supported function, 
leading to the inability to detect a robust behavioural deficit 
between groups on both the 7-stage and the 11-stage tasks.  
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3.1 Introduction 
In a recently published paper, it was suggested that ibotenic acid lesions to the 
STN/ZI area may disrupt the formation of attentional set: the expected difference between 
acquisition at the ED compared to the ID stage of the standard 7-stage test was not seen 
(Tait, Phillips, Blackwell, & Brown, 2016). Tait et al. (2016) also observed an increase in 
TTC at the early stages (i.e., SD, CD, Rev1 and ID) of the task raising a possibility that 
there might be a learning impairment masking evidence of an attentional set or perhaps 
impairing set formation. In subsequent (unpublished) experiments, we have not replicated 
this increase in TTC at the early stages, although there still appeared to be no ID-ED 
difference in STN-lesioned rats (Dhawan, Xia, Tait & Brown, unpublished observations). 
Furthermore, testing STN-lesioned rats on multiple ID stages (the 4ID task; adapted from 
Clarke et al., 2005 and Bissonette et al., 2008) did not result in an ID-ED difference, but 
there were no impairments at any other stage of testing (Xia, Dhawan, Tait & Brown, 
unpublished observations; Xia, 2014, University of St Andrews PhD Thesis).  
There are multiple reasons why an attentional set might not form and a lesion of the 
STN/ZI-area is not the only manipulation that has been associated with set-formation 
impairments. For example, rats with OFC lesions, with large impairments in the reversal 
learning stages of the attentional set-shifting task, also fail to exhibit a cost of shifting an 
attentional set in the standard 7-stage task (Chase, Tait, & Brown, 2012; McAlonan & 
Brown, 2003). However, when the same OFC-lesioned rats were tested in the 4ID task, 
omitting reversal stages, they not only formed an attentional set, but had an increased shift 
cost compared to control rats (Chase et al., 2012). Chase et al. (2012) interpreted the 
increased shift-cost in the 4ID task as another manifestation of the deficit causing a reduced 
shift-cost in the 7-stage task: namely, slowed set-formation. Although set was slow to form 
in the 7-stage task, once it had formed after 4IDs, when a shift was required at the ED stage, 
a new set also formed more slowly. Rats with quinolinic acid lesions of the DMS may also 
have an impairment in the formation of set: they had no cost of shifting set in either the 7-
stage task or in the 4ID task (Lindgren, Wickens, Tait, Brown, & Dunnett, 2013; but see 
also Tait et al., 2016 who reported ibotenic acid lesions of the DMS resulted in reversal 
learning impairments but normal set formation). These mixed results suggest different 
 85 
 
neural and psychological mechanisms may result in behavioural evidence of impaired set-
formation. The aim of this chapter it to explore these possible mechanisms. 
A previous attempt to investigate the nature of the set-formation impairment in 
STN-lesioned rats was, unfortunately, unsuccessful due to a failure of histological 
confirmation of the lesion damage (Xia, 2014, unpublished PhD Thesis). Nevertheless, 
there were behavioural effects seen in the group receiving ibotenic acid infusions that were 
not seen in the control group, consistent with a failure to form set in accordance with the 
hypothesis. In that study, Xia developed an 11-stage task which introduced manipulations 
to test a number of hypotheses, as outlined below: 
1. Would additional experience result in formation of set? Although 4 ID stages did not 
appear to be sufficient for set formation, it is possible that yet further experience might. 
Therefore, additional stages were included prior to the critical ED stage: in the 7-stage 
task, there are four stages (2 acquisition (CD and ID) and 2 reversals) and in the 4ID 
task, there are four acquisition stages prior to the ED. In the 11-stage task, there are 7 
stages (5 acquisition and 2 reversals) prior to the ED.  
2. Is there a memory impairment? If a rat is unable to remember previously rewarded 
stimuli, it would not be expected to focus attention differentially at the ED stage and 
there would be no ID/ED difference. There would also be no reversal cost if intervening 
discriminations caused a rat to forget prior stimuli. Therefore, reversal learning was 
tested twice, with either one or three novel acquisition stages inserted between the ID 
and its reversal. If memory for reward-relevant exemplars were disrupted by new 
stimuli, the reversals would be treated as if they were new learning. More (3 vs 1) 
intervening stages might also result in an even greater impairment 
3. Is the rat able to differentially attend to the rewarded (and hence not attend to the 
unrewarded) dimension? A ‘probe’ stage, in which the exemplars in the relevant (and 
therefore, attended) dimension were maintained, but the exemplars in the irrelevant 
(and therefore unattended) dimension were changed. If the rat is attending selectively, 
the change should not disrupt performance, either because they simply do not notice the 
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change in the irrelevant dimension or because they ignore it, having learned that the 
information is irrelevant (Tait & Brown, 2007).  
4. Are the lesioned rats learning the stimuli as configurations, rather than attending to 
stimulus dimensions? If the rats are solving the task by treating each of the four bowls 
as distinct stimuli, each being either baited or not baited, rather than perceiving that 
reward is predicted by the common exemplar in a perceptual dimension, then 
acquisition at the ID and ED stages would be equally difficult. However, a bi-
conditional stage, where reward is signalled by both stimulus dimensions (i.e., if odour 
A, then medium B), should be more readily solved by animals who are learning the 
stimulus configurations compared to those who have had experience in attending to 
only one of the stimulus dimensions at a time.  
The present chapter aims to (i) replicate previous observations that lesions of the 
STN/ZI impair the formation of attentional set and (ii) extend the observation to 
demonstrate the nature of set-formation impairments and identify an underlying mechanism. 
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3.2 Methods 
3.2.1 Animals  
Twenty male, Lister hooded rats (Charles River, UK) were used in this experiment, 
with twelve rats in the lesion group, and eight rats in the control group. Rats had a mean 
weight of 405g (range: 358-445g) at the start of the experiment. At completion of the 
experiment rats had a mean weight of 515g (range: 348-573g). All rats were experimentally 
naïve prior to testing and husbandry conditions and housing details are described in the 
General Methods in Chapter 2.  
3.2.2 Apparatus 
The attentional set-shifting apparatus is described in the Chapter 2 (General 
Methods), section 2.2.  
3.2.3 Surgery  
Ibotenic acid lesion surgery procedures are described in Chapter 2 (General 
Methods; see section 2.3.3).   
3.2.4 Behavioural training  
See section 2.4.1 of the General Methods, Chapter 2.   
3.2.5 Behavioural testing  
Testing, which was carried out with the help of an undergraduate volunteer, was 
conducted over 14 weeks, starting 2 weeks after surgery. Study I consisted of two test 
sessions on the 7-stage task, conducted over a period of 9 weeks, with not less than 4 weeks 
between each test. Study II tested rats on the 11-stage task, completed over a period of 5 
weeks. 
3.2.5.1 Study I: The 7-stage task 
Rats were tested twice on the 7-stage task, with order of exemplar pairing 
presentation and shift direction counterbalanced between tests. For a detailed explanation of 
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the stages and list of stimuli, see section 2.4.2 of the General Methods, Chapter 2. The 
procedure is summarised in Table 3.1.   
 
Table 3.1: An example of a test session including typical exemplar order, shift type, and 
stimuli used in the 7-stage task. Testing was counterbalanced for initial correct exemplars 
and for shift direction (odour-medium or medium-odour) between tests. 
3.2.5.2. Study II: The 11-stage task 
Because the 11-stage task has a large number of novel discrimination stages, a total 
of eight novel stimulus pairings were required, as shown in table 3.2.  Although the media-
odour pairings were constant, the order of their use and the correct exemplar within the 
pairing was counterbalanced within and between groups. 
Discimination 
Relevant 
dimension
Discriminanda Mixed with
Simple 
Discrimination (SD)
Medium 
Coarse tea , not 
fine tea 
Nothing 
Compound 
Discrimination (CD) 
Medium 
Coarse tea , not 
fine tea 
Cinnamon or 
ginger 
Compound Reversal 
(Rev1)
Medium 
Fine tea , not 
coarse tea 
Cinnamon or 
ginger 
Intradimensional 
Acquisition (ID)
Medium Sand , not grit Sage or paprika
Intradimensional 
Reversal (Rev2)
Medium Grit , not sand Sage or paprika
Extradimensional 
Shift Acquisition 
(ED) 
Odour 
Turmeric , not 
cloves
Coarse shavings 
or fine shavings 
Extradimensional 
Reversal (Rev3) 
Odour 
Cloves , not 
turmeric
Coarse shavings 
or fine shavings 
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Table 3.2: List of exemplar pairs in the modified 11-stage task and bi-conditional stage, 
which added five novel stimulus pairs to the 7-stage task stimuli    
The task started with a compound discrimination (CD) stage, which was then 
succeeded by two intradimensional acquisition stages (ID1 and ID2, respectively). The ID2 
stage was followed by a delayed (one intervening stage) ID1 reversal (ID1R), which was 
then succeeded by two further intradimensional acquisition stages (ID3 and ID4, 
respectively). The ID4 stage was followed by a delayed (three intervening stages) ID2 
reversal (ID2R), which was then succeeded by the final intradimensional acquisition stage 
(ID5). During the probe stage (ID5p), the reward-relevant exemplars from ID5 remained 
rewarded, and the stimuli from the irrelevant dimension were replaced with novel stimuli. 
Novel stimuli were reserved for the probe stage, and did not appear at any other stage of 
testing. The rats were then given an extradimensional (ED) shift acquisition stage, followed 
by a simple discrimination (SD) using the reward-relevant stimuli from the preceding ED 
stage. The purpose of the final SD stage was to validate that change in performance at this 
point in the task was not due to satiety or fatigue. To avoid satiety, rats were tested the 
following day on the bi-conditional discrimination. In this test, both stimulus dimensions 
were relevant in cuing the baited bowl. Attending to only one of the two dimensions would 
make learning impossible: that is to say, because the rule was bi-conditional (of the form “if 
sand, then sage, but if grit, then paprika”), failing to process the non-discriminable 
dimension (e.g., whether both bowls contained either sand or grit) would prevent 
Media Odours
Pair I M1: Coarse tea M2: Fine tea O1: Cinnamon O2: Ginger
Pair II M3: Sand M4: Grit O3: Sage O4: Paprika
Pair III M5: Coarse shavings M6: Fine shavings O5: Turmeric O6: Cloves
Pair IV M7: Cotton pads M8: Cigarette filters O7: Dill O8: Coriander
Pair V M11: Coarse cork M12: Fine cork O11: Fenugreek O12: Tarragon
Pair VI M13: Long wire coat M14: Short wire coat M13: Cumin M14: Marjoram
Pair VII M15: Beads M16: Gravel O15: Thyme O16: Carroway seeds
Probe M17: String M18: String knots O17: Fennel seeds O18: Chives
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determination of which odour was baited. The solution is more straightforward if the 
subject is able to overcome the tendency to process the stimuli as multi-dimensional and 
rather treats each bowl as an individual configuration that may/may not be baited: for 
example, sand+sage and grit+paprika are baited, while sand+paprika and grit+sage are not. 
Rats from the lesion and control groups were matched and paired for counter-balancing, 
which controlled for order of presentation of stimulus pairings, shift type (e.g., medium to 
odour or vice versa), and the initial correct stimulus within a pairing. 
The bi-conditional task rewarded two stimulus configurations (e.g., O1/M1 and 
O2/M2) whilst the other two stimulus configurations were incorrect (e.g., O2/M1 and 
O1/M2). During any given bi-conditional discrimination trial, the bowls differed on only 
one dimension [e.g., O1/M1 could be paired with either O2/M1 (same medium) or O1/M2 
(same odour)]. For a summary of the procedure of the 11-stage task, including the bi-
conditional stage, see table 3.3.  
3.2.6 Repeat testing  
Completion of multiple testing sessions followed a within-subjects protocol, such 
that all rats completed two tests on the 7-stage task, followed by one test on the 11-stage 
task. It has been demonstrated that pre-exposure of stimuli is not required for multiple test 
sessions on the 7-stage task, and that the learning effect (patterns of difference for the shift-
cost and evidence of normal reversal learning) are sustained between tests, even after short 
(e.g., 24-hour) inter-test intervals (Chase et al., 2012; Tait, Marston, Shahid, & Brown, 
2009; Wallace, Marston, McQuade, & Gartside, 2014); however, this is not to suggest that 
performance should be considered identical between test sessions. For this reason, the 
repeat-test was counterbalanced between and within groups for shift-type, and furthermore 
all stimuli were associated with reward at some point during each test, either at an 
acquisition stage or when the acquisition was reversed. As such, it was not deemed 
necessary to re-expose rats to stimuli between each of the 7-stage tests or prior to testing on 
the 11-stage task.  
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3.2.7 Data analysis    
Study I was a 2x2x7 mixed factorial design, and TTC data were analysed by 
repeated-measures ANOVA. There was a within-subjects factor of test (two levels: test 1 
and test 2), a within-subjects factor of stage (seven levels) and a between-subjects factor of 
group (two levels: control or lesion). A restricted analysis with Bonferroni-corrected 
pairwise comparison was used to analyse the shift-cost between the ID and ED stages. 
Study II utilised a 2x11 mixed factorial design, with a within-subjects factor of stage 
(eleven levels) and a between-subjects factor of group (two levels: control or lesion). 
Restricted analyses investigating factors of interest were conducted to examine the effects 
of key manipulations, with F-values corrected using error terms from the omnibus ANOVA 
(Winer, 1971). Trials to criterion data for the bi-conditional discrimination stage were 
analysed by one-way ANOVA.  
3.2.8 Histology  
NeuN/Cresyl violet immunohistochemistry procedures are described in Chapter 2 
(General Methods; see section 2.5). 
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Table 3.3: An example of the exemplar order, progression of stages, and shift type in a 
typical test session on the 11-stage task and the bi-condition stage. 
Discimination 
Relevant 
dimension
Discriminanda Mixed with
Compound 
Discrimination (CD) 
Medium 
Coarse tea , not 
fine tea 
Cinnamon or 
ginger 
Intradimensional 
Acquisition I (ID1)
Medium Sand , not grit Sage or paprika
Intradimensional 
Acquisition II (ID2)
Medium 
Coarse shavings , 
not fine shavings 
Turmeric or 
cloves
Intradimensional 
Reversal I (ID1R)
Medium Grit , not sand Sage or paprika
Intradimensional 
Acquisition III (ID3)
Medium 
Cotton pads , not 
cigarette filters
Dill or coriander
Intradimensional 
Acquisition IV (ID4)
Medium 
Coarse cork , not 
fine cork
Fenugreek or 
tarragon
Intradimensional 
Reversal II (ID2R)
Medium 
Fine shavings , 
not coarse 
shavings 
Turmeric or 
cloves
Intradimensional 
Acquisition V (ID5)
Medium 
Long wire coat , 
not short wire 
coat
Cumin or 
marjoram
Probe Medium 
Long wire coat , 
not short wire 
coat
Fennel seeds or 
chives
Extradimensional Shift 
(ED) 
Odour 
Thyme , not 
carroway seeds
Beads or gravel
Simple discrimination 
(SD)
Odour 
Thyme , not 
carroway seeds
Nothing
Correct 
combination
Incorrect 
combination
Bi-conditional (Bi-
Con)
N/A
Coarse tea with 
cinnamon & 
Fine tea with 
ginger
Coarse tea with 
ginger & Fine tea 
with cinnamon
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3.3 Results  
3.3.1 Histology  
One rat from the lesioned group failed to recover post-operatively. One control rat 
was euthanized between Study I and II, due to the onset of spontaneous seizures. The 
behaviour for the control rats was not atypical in Study I and therefore his data are included. 
Consequently, the final group sizes were: lesion: n=11; control: Study I, n=8; Study II, n=7. 
Lesion extent and cell loss was determined by NeuN/Cresyl Violet double staining. 
Of the eleven rats in the lesion group, only five rats had discernible lesions of the STN, four 
of which were only unilateral. Cell-loss in the STN was restricted to the medial portion and 
extended dorsally into the ventral zona incerta (ZIV) in 3 cases, and included the dorsal 
zona incerta (ZID) in one case. Figure 3.1 presents schematics of lesion extent, along with 
photomicrographs of cell-loss found in the bilaterally-lesioned rat, ‘typical’ cell-loss found 
amongst unilaterally lesioned rats, and photomicrographs of a control brain. 
The remaining six rats from the original ‘lesion’ group retained a visibly intact STN, 
despite all eleven rats in this group exhibiting the hallmark ‘chewing’ behaviour (see 
Section 2.3.3) during recovery from surgery, along with evidence of calcium deposits in the 
MGP. Given that these rats did not present with signs of cell-loss in the STN or ZI, these 
rats were removed prior to statistical analysis reducing the final group size for lesioned rats 
to five (4 with unilateral lesions; 1 with bilateral lesions).    
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Figure 3.1: Schematics and microphotographs of brain sections (NeuN/Cresyl Violet). Top 
to bottom: schematics illustrate the minimum (dark grey) and maximum (light grey) extent 
of the lesion; photomicrographs of the ‘typical’ unilateral lesion and the bilaterally-
lesioned rat (hashed outline indicates lesion extent); photomicrographs of a control brain. 
Sth: subthalamic nucleus; ZIV: ventral zona incerta; ZID: dorsal zona incerta; SubI: 
subincertal nucleus; LH: lateral hypothalamic area; PSth: posterior subthalamic area 
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3.3.2 Study I: Examining set-formation with the 7-stage task 
3.3.2.1 Overall findings 
Overall task performance improved between the two testing sessions (confirmed by 
a main effect of Test: F(1,10)= 6.16, p<0.05; nρ
2
= 0.32), and that unexpectedly, the overall 
performance for all rats on the ID, Rev2, and ED stages improved between test sessions, an 
effect which may be exacerbated by small, and unequal group sample sizes (Test by Stage 
interaction: F(5.35,53.46)= 2.53, p<0.05.; nρ
2
= 0.20; Huynh-Feldt correction; uncorrected df= 
6,60; Bonferroni-corrected pairwise comparison; see figure 3.2). It was also found that 
performance did not differ between various stages of the task (main effect of Stage: 
F(5.18,51.83)= 1.01, n.s.; nρ
2
= 0.09; Huynh-Feldt correction), and that therefore, the expected 
ID/ED difference was not statistically reliable (Bonferroni-corrected comparison). 
Furthermore, there were no differences between the control and lesion groups (either 
bilateral or unilateral), either overall or by Stage or by Test (main effect of Group: F(2,10)= 
2.04, n.s.; nρ2= 0.29; Stage by Group interaction: F(10.37,51.83)= 1.55, n.s.; nρ
2
= 0.24 
uncorrected df= 12,60; Test by Group F(2,10)= <1, n.s.; nρ
2
<0.14).  
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Figure 3.2: Mean TTC performance (+SEM) for all rats separated by test session; TTC 
performance globally improved between test sessions, particularly at the ID, Rev2, & ED 
stages.  
3.3.2.2 Investigating shift cost: ID vs ED stages 
Notwithstanding the lack of a significant difference overall between stages, 
including the ID and the ED stages, or an interaction with lesion groups, nevertheless 7/8 
(88%) of the control rats, compared to only 3/5 (60%) of the lesioned rats, had a positive 
shift cost (see figure 3.3) This observation suggests that there is some evidence for an 
attentional set in control rats at least. For the lesioned rats, there is not enough evidence to 
draw a conclusion either way, owing largely to a very small group size: although there was 
no significant difference between ED and ID, that fact that the difference was also not 
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significant for the control group makes it unsafe to conclude that the lesion had resulted in a 
deficit in the formation of set.      
 
Figure 3.3: Boxplot illustrating the mean shift costs (averaged across the two testing 
sessions), with hashed lines indicating the mean of the shift cost by group (lesioned rats 
had a mean cost of zero); superimposed vertical point plot depicting the distribution of the 
data for each rat, with the red triangle illustrating the shift-cost for the bilaterally-lesioned 
rat. Shift cost was calculated by computing the difference between the ID and ED stages 
(ED–ID). Only one control rat failed to exhibit a positive difference between stages. 
3.3.3 Study II: Investigating set-formation with the 11-stage task 
3.3.3.1 Overall findings 
As expected, TTC differed as a function of stage (Stage: F(10,90)= 4.66, p<0.01; 
nρ2= 0.34), but this did not differ as a function of lesion group (Stage by Group: F(20,90)= 
1.27, n.s.; nρ2= 0.22; figure 3.4). Based on this finding, it was parsimonious to conclude 
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that there was no detectable difference in performance between any of the groups, for any 
of the manipulations of the 11-stage task, including across multiple ID stages, and at the 
probe stage. Despite the visually increased TTC at the CD for lesioned rats, this comparison 
was also non-significant, marked with high variance. Furthermore, 2 of the 3 lesioned rats 
(including the 1 bilateral rat) that presented with elevated TTC at the CD (>17 TTC) also 
demonstrated a positive shift cost (i.e., evidence of an attentional set) suggesting that it was 
not the case that a sub-set of rats were impaired.  
There was a significant difference between the groups on the bi-conditional 
discrimination when the data for lesioned rats was separated into bilateral and unilateral 
damage (Group: F(2,11)= 5.36, p<0.05). This effect was largely driven by the data for the 
lone bilateral-lesioned rat, whose TTC performance was significantly higher than both 
unilateral lesioned rats and controls. Unfortunately, no conclusions can be drawn from the 
performance of a single rat, and that when the data for this one rat is combined with the 
remaining (unilaterally) lesioned animals, the effect of group is lost (Group: F(1,110= <1, 
n.s.). Irrespective of group, 3/12 (25%) of rats required more TTC in the bi-conditional 
discrimination compared to any other stage, including the ED, suggesting that for some rats, 
this was a particularly difficult discrimination to learn. The fact that they did all, eventually, 
learn the discrimination (the maximum number of TTC required amongst rats was 24) 
suggested that notwithstanding experience of solving the task by selectively attending to the 
odour or the medium at different points in the task, they were able to overcome this 
selective attention.  
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 Figure 3.4: Mean TTC performance (+SEM) for lesioned rats and sham-operated control 
rats on the 11-stage task plus the bi-conditional discrimination; red dots depict the 
performance for the sole bilaterally lesioned rat.  
3.3.3.2 Investigating shift cost: ID5 vs ED  
Similar to the ID-ED comparison in Study I, despite the lack of a significant 
difference overall between the ID5 and the ED stage, or an interaction with lesion group, 
5/7 (71%) of the control rats had a positive shift cost (the remaining 2 rats acquired the two 
stages in an equal number of trials) whereas only 3/5 (60%) of the lesioned rats did (see 
figure 3.5). The conclusion regarding set-shifting in the current study was similar to the one 
drawn for Study I, namely that the findings present mixed evidence for an attentional set in 
control rats, and that there is not enough evidence to conclude the formation of set, nor 
enough evidence to refute its formation, in the rats in the lesion group, largely owing to 
sample size, and type of lesion.  
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Figure 3.5: Boxplot illustrating shift cost, with hashed lines indicating the mean shift cost 
for rats by group; superimposed vertical point plot depicting the distribution of the data for 
each rat, with the red triangle illustrating the shift-cost for the bilaterally-lesioned rat; five 
of the seven control rats evidenced a positive difference in this comparison, whilst the 
distribution of the data for the lesioned rats illustrates marked variance. 
  
 101 
 
3.4 Discussion  
The first study in this experimental chapter attempted to replicate previous 
observations that STN/ZI-lesions impair the formation of attentional set. After two sessions 
of testing on the 7-stage task, lesioned rats did not demonstrate a cost of shifting attentional 
set. Unfortunately, sham-operated control rats also failed to demonstrate a convincing ID-
ED difference and there was no statistical support for group differences in set formation. 
The most parsimonious conclusion for the first study of this experiment would be that 
control rats did not present sufficiently robust evidence of set formation and that whilst 
STN lesions may have disrupted set formation, there is no convincing evidence of absence, 
owing to a small sample size.  
Despite the mixed evidence from the first study, it has been shown that control rats 
that have failed to demonstrate an ID-ED difference in the 7-stage task benefit from 
multiple ID stages in a subsequent task – facilitating a significant cost of set-shifting 
(Lindgren et al., 2013). Therefore, the second study of this experimental chapter presented 
multiple ID stages, whilst investigating the mechanisms of set-formation using the 11-stage 
task with the same cohort of rats. The result of the ID5-ED comparison in Study II was 
similar to the ID-ED comparison from Study I: the study failed to demonstrate robust and 
statistically-supported evidence of a cost of set-shifting in controls and compromised 
performance in lesioned rats. Overall, performance for lesioned rats did not differ from 
control rats, which included performance on the multiple ID stages, reversal stages, the 
probe, and the bi-conditional discrimination. The lack of clear behavioural effects is most 
likely due to a lack of consistent lesion damage, in both size/extent and symmetry, which 
ultimately led to a loss of statistical power owing to a reduced group size (n=5).  
3.4.1 Limitations and considerations  
The histology for the ‘lesioned’ group indicated marked asymmetry. Lesions were 
only discernible at all in five rats, of which only one had clear bilateral damage; the 
remaining four rats had only unilateral discernible lesions. Another large concern pertained 
to the consistency in achieving damage to cells in the STN; over half of the rats that 
received ibotenic acid infusions (n=6) expressed ‘indeterminate’ lesion damage. These rats 
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were not ‘intact’, in that they had calcium deposits in the MGP (which we have previously 
reported to accompany subthalamic cell loss; Phillips and Brown, 1999; Xia, Dhawan, Tait 
& Brown, unpublished), along with postoperative chewing. Nevertheless, there was no 
evidence of cell loss in the STN or ZI of these rats. It is highly likely that the failure to 
detect a robust behavioural deficit in the lesion group is predominantly due to a small 
sample size, but also due to the nature of the lesion damage being largely unilateral, and 
therefore permitting sufficient intact tissue to support function.  
3.4.1.1 Unilateral vs bilateral inactivation  
Considerable research from obtained from studies with Parkinson’s patients has 
detailed a significant difference between unilateral and bilateral approaches to HFS for 
treatment of motor symptoms. For example, bilateral HFS provides greater improvements 
in motor functioning than unilateral stimulation (Bastian, Kelly, Revilla, Perlmutter, & 
Mink, 2003; Goelz et al., 2016; Kumar et al., 1999), but induces cognitive decline not 
found in unilateral stimulation (Amara et al., 2012), including  deterioration in non-verbal 
recall performance (Williams et al., 2011) along with impaired verbal fluency and trouble 
inhibiting dominant verbal responses on the Stroop test (York et al., 2008). Furthermore, 
bilateral HFS – and not unilateral HFS – in Parkinson’s patients, impairs cognition on the 
“n-back task” (see Owen et al., 2005), which tests working memory, encoding and updating 
(Alberts et al., 2008). Cognitive performance for unilaterally-stimulated PD patients did not 
differ from patients without stimulation (Alberts et al., 2008), highlighting the importance 
of bilateral STN inactivation in generating cognitive impairment. This consideration may 
have contributed to the result found in this chapter; given that of the majority of the 
lesioned rats presented with unilateral damage (4 of the 5 rats), it is possible that sufficient 
damage was not incurred in order to evidence a cognitive deficit.  
In their study, Alberts et al. (2008) postulated that the increased activation in the 
dorsolateral prefrontal cortex (dlPFC) observed during performance of working memory 
tasks, such as the n-back task (see Jansma, Ramsey, Coppola, & Kahn, 2000; Owen, 
McMillan, Laird, & Bullmore, 2005) might be disrupted during STN-HFS, owing to the 
established fronto-subthalamo projections (see: Nambu, Tokuno, & Takada, 2002).  It is 
possible that disruption of information processing and response selection in parts of the 
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STN which contribute to cognitive impairments perhaps by incorrectly shaping output 
activity (Alberts et al., 2008). This consideration is also consistent with research in rats, in 
which the observed cognitive deficits produced by bilateral lesions to the STN could 
largely stem from the disruption of the STN–medial prefrontal cortex (mPFC) circuit 
(Chudasama, Baunez, & Robbins, 2003). Disconnection lesions of the mPFC-STN (i.e., 
lesioning the STN and mPFC unilaterally, but in opposite hemispheres) considerably 
impaired rats’ discriminative accuracy and also increased perseverative responding and 
response latencies in the 5CSRTT; moreover this functional deficit was remarkably similar 
to the impairment seen after bilateral STN lesions (Chudasama et al., 2003). Conversely, 
unilateral STN lesions induced only a mild deficit, slightly increasing both premature and 
perseverative responses compared to sham-operated animals, without affecting 
discriminative accuracy and response latency. Chudasama et al. (2003) thus concluded that 
the cognitive deficits – particularly those of attention and executive function – exhibited by 
bilateral STN lesioning depend upon the cortico-subthalamic projection, and additionally 
their research implicitly illustrates the importance of achieving bilateral STN lesions when 
examining the role of the STN in cognition. The fact that accuracy and latency were 
unaffected following unilateral lesions also weakens that position that unilateral lesions 
may induce an attentional impairment, which further suggests that perhaps bilateral lesions 
are mandatory to obtain cognitive deficits.  
Cognitive research, in which lesions to the rat STN are made, predominantly 
employ bilateral lesions to produce behavioural deficits (See Baunez & Lardeux, 2011; 
Jahanshahi et al., 2014). Unilateral lesioning has been used in animal studies to dissociate 
generalised motor effects of striatal dopamine depletion (e.g., hyperkinesia) from response-
specific initiation effects, by comparing ipsilateral vs contralateral motor performance 
biases (Phillips & Brown, 1999; see section 1.8.1), whilst consequently serving as a means 
to evaluate the quantitative differences between unilateral and bilateral lesioning. Rats with 
unilateral lesions of the STN in Phillips & Brown (1999) did not exhibit impairments in 
accuracy, omissions, or perseverative responding in nose-poke visuo-spatial discrimination 
tasks, as typically expected of rats with bilateral lesions to the STN in similar tasks (Baunez 
et al., 1995; Baunez & Robbins, 1997; 1999), however they do exhibit increased premature 
 104 
 
(anticipatory) responses. The present evidence regarding the effects of bilateral lesions on 
latency performance in visuo-spatial reaction time tasks is mixed, with evidence that 
lesioning both ‘speeds up’ (Baunez et al., 1995), and ‘slows down’ (Baunez & Robbins, 
1997; 1999) reaction-time performance; in Phillips & Brown (1999), the unilaterally-
lesioned animals took longer to respond, however this effect was to the ipsilateral side only. 
Phillips & Brown (1999) replicated their findings in a subsequent study (Phillips & Brown, 
2000), and found that unilateral STN lesions do not change reaction times, nor impair 
accuracy or error rate in a nose-poke reaction time task, but that unilateral lesions increase 
the likelihood of premature responses, compared with control surgery. The above evidence 
– from both clinical populations, and experimental animals – suggests that there is a 
qualitative and quantitative difference between unilateral stimulation/lesioning of the STN 
and bilateral. In humans, bilateral HFS for Parkinson’s patients may lead to more reliable 
improvements in motor dysfunction, but concurrently introduces more severe impairments 
in cognition. It is worth noting that the therapeutic response to bilateral or unilateral HFS 
may partially be determined by the asymmetry of the disease (i.e., which hemisphere of the 
brain is more affected by Parkinson’s disease); in cases where the severity of Parkinsonian 
degeneration is unilateral, STN-HFS of the contralateral hemisphere may improve 
therapeutic outcome (Hershey et al., 2008). In rats, unilateral lesions yield a weaker effect 
on cognition compared with bilateral lesions; bilateral lesions to the STN introduces a 
variety of cognitive deficits not expressed following unilateral lesions. Therefore, for the 
present experimental chapter with only one bilaterally lesioned rat, it is most likely that the 
majority unilaterally-lesioned animals retained sufficient cognitive function to complete the 
task with minimal impairment.  
3.4.2 Conclusions  
In summary, predominantly unilateral STN/ZI lesions were insufficient to produce 
pronounced behavioural deficits on the 7-stage task and the modified 11-stage ID/ED task. 
There was a suggestion that the unilateral lesions may have induced mild cognitive 
impairment, but in the absence of robust evidence of set formation in control rats, further 
research is needed, with a larger sample of bilaterally lesioned rats, before conclusions can 
be drawn on the explicit contribution of the STN to attentional set-formation.  
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Chapter 4 
 
Using a palatable jelly tablet to deliver cognitive-
enhancing drugs in an ‘early/late probe’ task 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background: 
This chapter presented an alternative behavioural approach; a more 
succinct alternative to the 11-stage task to infer the formation of 
attentional set, which provided the opportunity to measure the 
effects of putative cognitive-enhancing drugs.  
Methods: 
The first experiment examines the efficacy of a reduced-stress jelly 
tablet to deliver modafinil, in which brain concentrations and 
effects on locomotor activity are measured. The second experiment 
tested STN-lesioned rats on an ‘early-late’ probe task, with or 
without cognitive-enhancing drugs. The task inferred set by 
comparing two probe stages; one before set is likely formed, and 
one after multiple ID stages.  
Results: 
Brain concentrations of modafinil were comparable to oral gavage 
and modafinil, as expected, sustained locomotor activity, but only 
for later time-periods. Histology results for experiment II were 
consistent with Chapter 3; incomplete lesion damage minimised 
differences between groups, also drugs did not have an effect. 
Conclusions: 
Owing to an ongoing inability to visualise lesion damage, which 
may have attenuated the effects of the drugs, we cannot measure 
the role of the STN in set-formation from the current experiment. A 
refinement in how the STN is manipulated is pertinent. 
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4.1 Experiment I 
4.1.1 Introduction  
In Chapter 3, there was no clear evidence for an impairment in attentional set-
formation, following STN/ZI lesions. This could have been due to the fact that the lesions 
were difficult to verify and, where there was clear evidence of cell-loss, the area was small 
and mostly unilateral. In addition, behavioural evidence for an attentional set (i.e., a robust 
and statistically reliable ID-ED difference) in the control group was also weak. The purpose 
of the current experimental chapter was a further attempt to explore the possibility, 
suggested by previous observations, that lesions of the STN/ZI impair the formation of 
attentional set. To mitigate some of the issues encountered in Chapter 3, a slightly different 
approach is taken here. First, we wanted to test an alternative behavioural approach, to 
explore the possibility that we could detect evidence of an attentional set in a simplified and 
shorter version of the ASST. Second, it was reasoned that if behaviour is compromised in 
either lesioned or control rats, drugs which have previously been shown to act as 
‘cognitive-enhancers’ might restore performance in one or other group (possibly 
differentially). It was hoped that, even if the lesions failed, we would still gain information 
about the usefulness of the modification of the behavioural task and/or the potentially 
beneficial effects of drugs on either normal, sub-optimal or impaired performance. 
The 11-stage task used in Chapter 3 introduced a ‘probe-stage’ after the time at 
which an attentional set might be expected to have formed, but making an irrelevant change 
to the exemplars in the supposedly-unattended dimension to challenge the focus of attention 
of animals.  In control animals, we have previously shown (and replicated in Chapter 3) 
that animals are not distracted by this change. We reasoned that this would only be the case 
if the probe-stage is presented late (after set-formation) and not early in the session, prior to 
set-formation. Prior to the formation of set, it is reasoned that rats solve the discriminations 
by learning about the associations of multiple cues with reward (i.e., odour and medium 
and left digging chamber). According to Mackintosh’s learning theory (see General 
Introduction; Sutherland & Mackintosh, 1971), the cue which is the best predictor of 
reward will acquire salience, leading to a formation of set. Therefore, we reasoned that rats 
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that have yet to form set, or rats that – for whatever reason – have failed to form set, would 
attend to the change in the irrelevant dimension during a probe stage. The probe stage could 
therefore be used as a measure of ‘pre-set’ and ‘post-set’ learning performance. This 
manipulation could therefore serve as an alternative to the ID/ED contrast typically used, 
which is actually a measure of set-shifting ability, rather than a measure of set-formation or 
even strength of set.  
By comparing performance between these two probe stages, along with employing 
three interim consecutive ID stages to promote set-formation, reduces the total number of 
stages required for testing. The effects of two putative cognitive-enhancing drugs were also 
examined, with the hypothesis that one or both might i) ameliorate a set-formation deficit 
following a lesion; and/or ii) potentially improve overall performance in control rats. 
Modafinil and ORG49209 were selected as both have been previously shown to have 
effects on performance of the ASST (Turner, Clark, Dowson, Robbins, & Sahakian, 2004a; 
Xia, Tait & Brown; Chase, Tait & Brown, unpublished).  
4.1.1.1 Modafinil 
Modafinil (diphenylmethyl sulfinyl-2-acetamide; marketed as Provigil) is an 
atypical stimulant drug known for its unique wake-promoting mechanism, limited 
amphetamine-like side effects, and as an effective treatment for used in the treatment of 
narcolepsy, shift-work sleep disorder, sleep apnoea/hyponoea and excessive sleepiness 
(Bastoji & Jouvet, 1988; De Sereville, Boer, Rambert, & Duteil, 1994; Edgar & Seidel, 
1997). It has gained particular interest for its unique wake-promoting effects without 
exerting typical amphetamine-like side-effects such as sleep rebound, along with 
significantly less abuse liability than amphetamines (Deroche-Gamonet et al., 2002; Edgar 
& Seidel, 1997; Gold & Balster, 1996; Koob & Bloom, 1988; Leith & Barrett, 1976; 
Tourev, Sallanon-Moulin, & Jouvet, 1995).  
Traditional stimulants (e.g., methylphenidate) exert wake-promoting effects by 
targeting the reuptake and modulation of catecholamines, particularly dopamine, in the 
central nervous system, whereas modafinil exerts a different pharmacological profile 
(Nishino & Mignot, 1997; Scammell et al., 2000). For example, the application of α-
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methyl-p-tyrosine (αMPT; tyrosine hydroxylase enzyme inhibitor) significantly attenuated 
the effects of amphetamine, whereas the effects of modafinil were only slightly reduced 
after the same application (Lin et al., 1992). Modafinil is also structurally different to 
amphetamine, which likely contributes to the observed divergent profile of 
pharmacological and behavioural effects (for review see Minzenberg & Carter, 2008). 
Despite this, modafinil still has an affinity for catecholamines, most notable the dopamine 
transporter (DAT) and noradrenaline (NA); however the neurochemical effect and pattern 
of brain area activation differs from amphetamines (Mereu, Bonci, Newman, & Tanda, 
2013). Figure 4.2.1, which was adapted from Mereu et al. (2013), illustrates the complex 
involvement of the neurotransmitter systems and corresponding target brain areas 
implicated in modafinil and its application as a cognitive enhancer. In addition to inhibiting 
dopamine (DA) reuptake, modafinil dose-dependently increases 5-hydroxytryptamine 
(serotonin; 5HT) in the prefrontal cortex (de Saint Hilaire, Orosco, Rouch, Blanc, & 
Nicolaidis, 2001) and the central cortex of the amygdala and dorsal raphe nuclei (Ferraro et 
al., 2002).  
Modafinil has also gained interest as a putative cognitive-enhancer in humans – 
both in clinical populations and in healthy adults – and in experiments with rodents (for 
review see Minzenberg & Carter, 2008). In a controlled drug study in humans, modafinil 
enhanced performance for healthy male adults relative to a placebo group on several tests 
of executive function: improving digit span length, reducing errors in a test of visual pattern 
recognition memory, and facilitating tasks of spatial planning (Turner et al., 2003). It was 
speculated that this cognitive enhancement could be due to modafinil’s ability to inhibit 
pre-potent responses, as additionally – and dose-dependently – modafinil improved stop-
signal reaction time (SSRT) latency, whilst reducing the number of errors on “go” trials 
(trials which require a behavioural response) (Turner et al., 2003). An error during a “go” 
provides a measurement of anticipatory responding, and consequently suggesting that 
modafinil may help in reducing impulsive action.  
It appears that modafinil’s cognitive-enhancing effect may be subject to individual 
differences. Müller, Steffenhagen, Regenthal, & Bublak (2004) demonstrated that 
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modafinil only benefitted working memory performance for lower performing subjects. 
The authors observed a significant decrease in error rates when the difficulty of the working  
 
 
Figure 4.1.1: Brain areas and related neurotransmitter systems that are potentially 
involved in mediating the therapeutic actions of modafinil as a cognitive enhancer (adapted 
from Mereu et al. 2013). Solid lines indicate direct interactions; dashed lines indicate 
indirect interactions or those not yet been determined. NA noradrenaline, NAT 
noradrenaline transmitter, GABA gamma-amino-butyric-acid, DA dopamine, DAT 
dopamine transporter, GLU glutamate, 5HT serotonin, ACh acetylcholine. 
 
memory manipulation increased, and further that participants who were already good at the 
manipulation task remained good at it, exhibiting no benefit of modafinil administration 
(Müller et al., 2004). Further research illustrated that modafinil improved visuo-spatial 
planning and response inhibition, but only amongst ‘lower’ IQ and not ‘higher’ IQ 
participants (Randall, Shneerson, & File, 2005). It follows that the cognitive-enhancing 
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effects of modafinil would likely be more readily detected amongst lower levels of 
performance, where there is more notable room for improvement. 
Amongst clinical populations, modafinil has been shown to improve the planning 
and attentional deficits in adult patients suffering from ADHD, on tasks of digit span, 
visual pattern memory & spatial planning (Turner, Clark, Dowson, Robbins, & Sahakian, 
2004a). In patients with schizophrenia, modafinil improved both forward and backward 
digit span length compared to placebo, indexing a working memory improvement, and 
additionally it significantly reduced the typical high levels of attrition seen in the ID/ED 
task (placebo: 50% attrition; modafinil: 15%), along with reducing the total number of 
errors at the ED stage (Turner et al., 2004b). Similar to research in healthy volunteers, there 
was a correlation between the impairment level amongst patients with chronic 
schizophrenia and modafinil’s reported efficacy on restoring cognitive function, in that the 
most impaired groups derived the greatest benefit from modafinil treatment (Hunter, 
Ganesan, Wilkinson, & Spence, 2006; Spence, Green, Wilkinson, Hunter, & Hunter, 2005).  
In research with rodents, chronic administration of modafinil in mice has been 
shown to induce faster acquisition of spatial learning for rats in a T-maze, along with 
improving spatial reversal learning by facilitating a faster target win-shift strategy 
acquisition compared to vehicle-treated control rats, which suggested that modafinil may be 
important for the learning process, rather than simply aiding in inhibiting perseverative 
responses (Beracochea et al., 2002). Morgan, Crowley, Smith, LaRoche, & Dopheide 
(2007) found that performance on a sustained attention task for modafinil-treated rats, dose-
dependently, improved response accuracy, latency and impulse control, without affecting 
error rate and motor control.  
Unpublished observations from our lab have also demonstrated that modafinil may 
facilitate attentional set-formation in middle-aged rats (Chase, Tait & Brown, unpublished). 
It was found that 30mg/kg (i.p.) of modafinil exacerbated reversal learning deficits in aged 
rats, but reduced the number of trials required for the subsequent ID stage. Additionally, we 
have also observed a strong trend that modafinil may aid in ameliorating the set-formation 
deficit observed after subthalamic lesions, improving novel ID learning along with re-
establishing a positive cost of shifting set (Xia, Tait & Brown, unpublished). Modafinil 
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therefore presents as a pertinent cognitive-enhancing drug for the purpose of the current 
experiment.  
4.1.1.2 ORG49209 
ORG49209 (ORG) is a positive allosteric modulator (PAM) of the NMDA receptor 
with a similar chemical structure to pregnenolone sulphate – an endogenous neurosteroid 
(Paul & Purdy, 1992). The modulation of NMDA appears to be important in cognitive 
functioning, and reduced NMDA receptor functioning associated with aging has been 
implicated in a variety of cognitive deficits, including impaired ED shift performance in 
rats (Nicolle & Baxter, 2003), and impaired semantic fluency, working memory, set-
shifting and spatial planning in aged humans (Zahr, Mayer, Pfefferbaum, & Sullivan, 2008). 
Additionally, negative modulation of the NMDA receptor with a pharmacological 
antagonist impairs avoidance and reversal learning along with introducing memory and 
executive control deficits in mice and rats (Mathis, Vogel, Cagniard, Criscuolo, & Ungerer, 
1996; Palencia & Ragozzino, 2006). 
It has been shown that NMDA receptor activation is crucial to the induction of long-
term potentiation (LTP; for review see Bliss & Gardner-Medwin, 1973), which is a 
sustained increase in the efficiency of synaptic transmission as a consequence of a cascade 
of high-frequency stimulation to excitatory pathways, and is a fundamental mechanism of 
learning (Bliss & Collingridge, 1993). It logically follows that if attenuation of NMDA 
contributes to a variety of cognitive deficits, then perhaps its amplification should facilitate 
cognitive enhancement, however it has been demonstrated that increasing levels of 
extracellular NMDA results in excitotoxicity, and depending on the intensity of the original 
insult, can result in neuronal cell death (Bonfoco, Krainc, Ankarcrona, Nicotera, & Lipton, 
1995; Liu et al., 2007). It appears therefore that NMDA modulation requires a balance, and 
that either elevated or attenuated levels can result in adverse consequences.  
As an alternative, activation of the NMDA receptor via an allosteric binding site has 
gained interest as an option for positively modulating NMDA function without risking 
neurotoxicity. Activation of the NMDA receptor at the primary or ‘orthosteric’ binding site 
is accomplished by the binding of the agonist NMDA molecule, which mimics glutamate – 
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typically at the NR1 subunit – which results in channel-opening and signal transduction 
(Furukawa, Singh, Mancusso, & Gouaux, 2005). Orthosteric ligands bind to an agonist-
binding site, which initiates downstream receptor signalling, whereas allosteric ligands are 
structurally different from orthosteric ligands and bind to distinct sites that are spatially 
distant from the orthosteric site, for the purpose of modulating orthosteric ligands (De Smet, 
Christopoulos, & Carmeliet, 2014; May, Leach, Sexton, & Christopoulos, 2007). For 
example, the endogenous neurosteroid pregnenolone sulphate is a PAM of NMDA, which 
potentiates NMDA currents, yet does not produce the typical neurotoxic effects of 
extracellular NMDA similar to those observed from orthosteric modulation (Paul & Purdy, 
1992). Furthermore, pregnenolone sulphate has shown promise in ameliorating the 
cognitive impairments of NMDA receptor antagonism on avoidance learning (Cheney, 
Uzunov, & Guidotti, 1995; Mathis et al., 1996). Pregnenolone and its sulphated derivative 
may also present as a promising therapeutic agent for treating the negative symptoms (and 
potentially cognitive symptoms) of schizophrenia, which may partially stem from the fact 
that clozapine increases pregnenolone in the rodent hippocampus, which may also 
contribute to clozapine’s superior efficacy as an atypical antipsychotic (Marx et al., 2009).  
Pregnenolone sulphate presents with several limitations however, and – like many 
allosteric modulators – is not entirely selective. In addition to positively modulating 
NMDA allosterically, pregnenolone sulphate acts as an antagonist for gamma-amino-
butyrate-A (GABAA), which is an essential inhibitory neurotransmitter for mediating 
convulsant responses; it is likely that the observed convulsions in experimental animals 
following pregnenolone sulphate treatment was due to indirect GABAA antagonism (Gibbs, 
Russek, & Farb, 2006; Paul & Purdy, 1992).  
In the present experiment, we investigated the potential for cognitive-enhancing 
effects of ORG49209 (ORG) or (3β)-26,27-dinorergost-5-ene-3,24-diol, which is 
structurally very similar to the endogenous neurosteroid cerebrosterol. Cerebrosterol – 
otherwise known as 24(s)-hydroxycholesterol – is abundantly found in the CNS (hence its 
nomenclature) and is a major metabolite of cholesterol and is partly responsible for 
regulating the cholesterol activity in the brain (Björkhem, 2007). Cerebrosterol is also an 
NMDA PAM, and has gained interest for providing potent, direct, and selective positive 
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allosteric modulation with minimal overlap with other allosteric modulators, whilst not 
affecting GABAA-mediated responses (Paul et al., 2013a). In rats, cerebrosterol also 
enhances LTP, and reverses the LTP deficits following ketamine treatment to the 
hippocampus, highlighting potential clinical and cognitive-enhancing uses.  
Unpublished findings have suggested that ORG was able to increase an attenuated 
LTP effect in hippocampal slices, along with being more potent and selective than 
pregnenolone sulphate (Etherington, 2012, unpublished). Additionally, ORG presents as a 
choice candidate for the current experiment since the dominant postsynaptic subtype of the 
STN is glutamatergic (Galvan, Kuwajima, & Smith, 2006), and it has been demonstrated 
that NMDA receptors contribute to synaptic activity in the STN, which is likely modulated 
by other glutamate receptors (metabotropic glutamate receptors I & V; see Awad, Hubert, 
Smith, Levey, & Conn, 2000) providing an orthosteric cascade of activation (Swanger et al., 
2015). Behaviourally, our lab has shown that ORG treatment may ameliorate the age-
related deficits in reversal learning for middle-aged rats, with evidence supporting a 
potential improvement in set-shifting performance (Chase, PhD Thesis). This evidence 
lends promise to the possible ameliorative efficacy for ORG to aid in restoring a potential 
set-formation-induced deficit in the current experiment. 
4.1.1.3 Current experiment  
For the revised set-formation task introduced in this chapter (and any paradigm 
interested in measuring behaviour), administering a drug and ensuring bioavailability 
throughout the entire test session is essential. Ideally, we would want peak concentration to 
occur during the testing of key stages of interest. An important consideration pertains to the 
route of drug administration, which impacts the pharmacokinetics (e.g., absorption) and 
influences the timing and magnitude of any behavioural effect; however there are also other 
practical considerations when selecting a particular route of administration. For example, 
there may be secondary behavioural effects of giving the drug: an interruption of ongoing 
behaviour might distract or arouse the animal, such that behaviour after drug administration 
changes irrespective of any pharmacological effect of the drug (Meijer, Spruijt, van 
Zutphen, & Baumans, 2006). This is likely to be a particular problem if the route of 
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administration causes pain or discomfort, as is evident with needle-sticks and gavage. Oral 
gavage has been reported to induce significant increases in heart rate 2-5 hours post-gavage 
and increase faecal corticosterone (Bonnichsen, Dragsted, & Hansen, 2005; Walker et al., 
2012) – and stress-related arousal will have behavioural consequences.  
Drugs can be administered by a variety of routes, for example, intra-cerebrally (via 
implanted catheters in the brain); intraperitoneally (i.p.; via injection through the abdominal 
wall); subcutaneously (s.c.; via injection under the skin); transdermally (via a skin-patch or 
onto a mucous membrane); inhalation; orally (by gavage – insertion directly into the 
stomach – or through mixing with food or drink). Walker et al. (2012) showed that mice 
which voluntarily consumed a ‘pill’ made from ‘Transgenic Dough Diet’™ (Bioserve, Inc) 
did not show a stress response. The advantage of the dough diet is that it is readily sourced 
and the drug can be kneaded into the dough. The disadvantage of using this diet, however, 
is that it is designed for rodents with chewing, dental or mobility impairments and therefore 
whilst highly palatable, is also high in protein and fat. This makes it less useful for studies 
that measure behaviour motivated by food, and in instances where uptake may be affected 
by food in the gastrointestinal tract.  
In the current experiment, we present a refinement of this medium, which used a 
flavoured and palatable, but calorie-free “jelly” tablet, which can be designed to present an 
orally bioavailable drug in suspension. In regards to the drugs employed in the current 
experiment, our lab has previously observed that ORG is particularly difficult to inject, as it 
requires a high concentration of solvent (>40% hydroxy-propyl-ß-cyclodextrin; HPBCD) to 
put it into suspension (Chase, Brown & Tait, unpublished). Being an experimental drug, 
very little information regarding its oral bioavailability has been published, perhaps due to 
its structural similarity to cerebrosterol, making it difficult to assess levels of concentration 
in the brain. 
Modafinil, on the other hand, is orally bioavailable, and a pharmacokinetic analysis 
by Waters, Burnham, O’connor, Dawson, & Dias (2005) reported that gavage 
administration yielded a peak concentration of modafinil between 30-60 minutes post-
administration; however the authors did not observe any of the reported cognitive-
enhancing effects, and instead found that higher doses (128 mg/kg) of modafinil increased 
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impulsivity, which is contrary to previous findings (see Morgan, Crowley, Smith, LaRoche, 
& Dopheide, 2007). It is possible then that the stress-related arousal from gavage may have 
attenuated the expected behavioural effects of modafinil, suggesting that a reduced-stress 
method of drug administration should be sought prior to behavioural testing, in order to 
minimise any secondary effects. Therefore, the first part of this experimental chapter will 
orally administer modafinil via a palatable jelly and examine:  
i. bioavailability of modafinil, by measuring the time course of brain levels of 
the drug 
ii. the time course of modafinil’s behavioural effect, by measuring the time-
course of an expected increase in locomotor activity.  
Early studies that investigated the wake-promoting effects of modafinil reported that 
higher doses of modafinil (≥40 mg/kg) elicit an increase in locomotor activity (LMA) in the 
rat (Simon et al. 1996).  Subsequent research by Edgar and Seidel (1997) measured this 
increased LMA with an electroencephalogram (EEG) and determined that the increase was 
only in proportion to the expected time spent awake during LMA recordings (Simon et al. 
1996). Additionally, modafinil-treated rats show a normal (i.e., equivalent in magnitude to 
control vehicle-treated) habituation to the LMA apparatus, with an initial decrease in 
exploratory behaviour, and then significantly elevated activity at later time-periods 
(between 40 and 80 minutes post-administration) (Simon et al. 1996). We therefore 
predicted that: oral administration of 30 mg/kg modafinil would induce a similar significant 
increase in LMA, particularly at later time-periods, compared to vehicle-treated rats 
following habituation to an actimeter.  
The first part of this experiment was made possible by the work of Dr Shuang Xia, 
who assigned the timing of the sacrifice points, and assisted in the collection of brain tissue. 
Analysis of the tissue was generously completed by Dr Christoffer Bundgaard on behalf of 
H. Lundbeck, and special thanks to Miss Ellen Bowman for her innovation in choosing a 
suitable suspension for the drug. The data for the first part of this experimental chapter has 
been published in the peer-reviewed journal Psychopharmacology (Dhawan et al., 2018).    
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4.1.2 Methods 
4.1.2.1 Animals 
Forty-six (twenty-four male; twenty-two female), naïve Lister hooded rats (bred in-
house; University of St Andrews, from Charles River stock) were group-housed, but 
segregated by sex. Male rats (weight range upon sacrifice: 480-630g) were used to establish 
the pharmacokinetic profile in study I. The female rats were to assess modafinil’s effect on 
LMA in study II, and had a mean weight of 217g (range: 180-250g) at the start of the 
experiment. At completion of the experiment female rats had a mean weight of 292g 
(range: 233-328g). Husbandry and housing details are described in the General Methods 
(Chapter 2; section 2.1). Habituation to jelly-tablets was completed over one week (see 
habituation procedure below), and behavioural testing of LMA was completed over a 
period of 3 weeks.  
4.1.2.2 Apparatus 
LMA data was collected by a 7x15 LED infrared actimeter (Motor Monitor, 
Hamilton-Kinder, Ponway, CA, USA). The number of ambulations per time period was 
determined by the number of photo beams the rat crossed. A “rearing frame” was also 
attached to the actimeter, which added an additional measure of “vertical activity” since 
rearing in rats in indicative of exploratory behaviour and is a useful marker of 
environmental novelty (Lever, Burton, & O’Keefe, 2006). The software (HK Motor 
Monitor, Hamilton-Kinder, Ponway, CA, USA) designed for the actimeter, controlled 
operation of the five actimeters used in this experiment, along with collating raw data into 
output files.    
4.1.2.3 Drug preparation and habituation 
Modafinil was administered to the rats orally, suspended in a palatable gelatine 
tablet (jelly) as the vehicle. The jellies were made by heating a water bath to ~70°C, then 
placing into the water bath a beaker containing 50ml of flavoured, sugar-free, fruit juice 
concentrate (Robinsons Squash, Britvic PLC, UK), and 50ml of distilled water, and adding 
30g gelatine (Dr Oetker, UK). The mixture was stirred until the gelatine was fully dissolved. 
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Modafinil (Sequoia Research Products Ltd., UK) doses (30mg/kg) for individual rats were 
weighed out and added to the bottom of 2ml wells in a plastic mould. The gelatine solution 
was then pipetted into the wells (1.5ml/well), and the mixture carefully stirred with a small 
pipette tip to suspend the modafinil. Vehicle jellies were made using the same procedure, 
but without modafinil. The plastic mould was then placed in a fridge (3-5°C) overnight for 
the jellies to cool and set. Once the jellies were set, they were removed from the moulds 
and stored in the fridge in airtight containers. 
To prevent food neophobia from inhibiting eating, the rats were given jellies 
without modafinil on several occasions before data collection. Rats were placed 
individually in a large home-cage and presented with a jelly in a small ceramic pet food 
bowl and were left until they had fully consumed it. This was repeated once per day until 
rats had fully consumed the jelly within 5 minutes, which was typically on the third day. 
We had previously established that there was no evidence that the rats could detect when 
jellies contained modafinil (unpublished observations), therefore it was not necessary to 
expose them to modafinil prior to testing. 
4.1.2.4 The pharmacokinetic profile of orally-administered modafinil  
4.1.2.4.1 Drug administration 
On the day of the experiment, the 24 male rats were single-housed and presented 
with modafinil-containing jellies. The time at which a rat finished eating the jelly was 
recorded (typically no more than 5 minutes after it had started eating), and at specific time-
points after that (15, 30, 45, 60, 75, 90, 120 and 150 minutes; n=3 per time-point) rats were 
sacrificed by decapitation. After decapitation, brains were extracted from the skull, the 
cerebellum was removed, and then the remainder was bisected in the sagittal plane. Each 
hemisphere was weighed and then rapidly frozen by immersion in isopentane (Sigma-
Aldrich, UK) chilled by dry ice. The hemispheres were then wrapped in aluminium foil, 
individually placed in homogenisation tubes and stored at -80°C. 
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4.1.2.4.2 Post-mortem bioanalysis  
The following bioanalysis was generously completed by Dr Christoffer Bundgaard 
on behalf of H. Lundbeck in Denmark. Rat brain concentrations of modafinil were 
determined using Ultra Performance Liquid Chromatography (UPLC) coupled to tandem 
mass spectrometry (MS/MS). Brain samples were prepared by homogenising the brains 1:3 
(v/v) with a mixture of water, 2-propanol and dimethyl sulfoxide (DMSO; 50:30:20 v/v/v). 
Samples were precipitated with acetonitrile and DMSO (80:20 v/v) containing internal 
standard. Following centrifugation, 10µl was injected onto the chromatographic system 
consisting of an Aria TLX2 system (Thermo Fisher Scientific Inc., Massachusetts, USA) 
connected to a Thermo TSQ Quantum Ultra triple quadrupole mass spectrometer. 
Analytical separation was achieved using a Kinetex C18 column (50x2.1mm, 2.6 µm 
particles; Phenomenex, California, USA). The mobile phase consisted of 0.01% formic acid 
in acetonitrile and 0.1% formic acid in water pumped through the column using a 3 minute 
gradient. Modafinil was detected at a parent > daughter mass to charge ratio (m/z) of 
274.01 > 167.00. The retention time was 1.27 minutes. The peak area correlated linearly 
with the brain concentration of the analyte in the range of 40-4000ng/g brain. 
4.1.2.5 The effects of orally-administered modafinil on locomotion activity 
4.1.2.5.1 Testing procedure 
On the day of testing, the 22 female rats were habituated to the infrared actimeter 
for 60 minutes. Following actimeter habituation, a jelly was presented in a ceramic bowl 
directly into the actimeter. Habituation commenced four hours after lights-on, and jellies 
were administered five hours after lights-on (Circadian time 5 (CT-5), where CT0 is lights-
on), as it has been observed that sleep loss can impact stimulant drug efficacy (Edgar, 
Seidel, & Dement, 1991; Roehrs, Zwyghuizen-Doorenbos, Timms, Zorick, & Roth, 1989). 
CT-5 (in 12 hour light/dark schedule) in particular, yields the least interference from the 
high variability in wakefulness due to large amounts of sleep (<CT-5) and the normal 
circadian wakefulness found closer to lights-off (>CT-5) (Edgar & Seidel, 1997). Precisely 
10 minutes from the point the rat started eating the jelly (with all jellies consumed within 5 
minutes), the actimeter was reset, and testing commenced. This was done to ensure the 
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sacrifice points from the pharmacokinetic study fell within a measured time period of 
locomotive activity. The test sessions were 150 minutes, with LMA data compiled to 
investigate time-periods of interest (0-15, 15-30, 30-45, 45-60, 60-75, 75-90, 90-105, 105-
120, 120-135 and 135-150 minutes). 
4.1.2.5.2 Counterbalancing   
Each rat was tested twice, with 11 rats each receiving modafinil and vehicle jellies 
in each test, counterbalanced so that each rat received both modafinil and vehicle jellies. 
There was a minimum of five days between tests to allow for washout of modafinil. 
4.1.2.5.3 Data analysis  
The 150 minutes of LMA data were compiled into time-periods (0-15, 15-30, 30-45, 
45-60, 60-75, 75-90, 90-105, 105-120, 120-135 and 135-150 minutes) and analysed by 
repeated-measures ANOVA. The dependant variable was the total number of infrared 
beams crossed within the observed time period. There were two within-subjects factors: 
dose (two levels – drug and vehicle), and time period (ten levels). A second ANOVA, with 
two within-subjects factors: test (test 1 vs test 2) and time-period was used to confirm that 
overall, rats’ performance did not change between tests. Huynh-Feldt corrections were 
applied for sphericity violations. 
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4.1.3 Results 
4.1.3.1 The pharmacokinetic profile of orally-administered modafinil 
Modafinil was detected in brain tissue at all time-points (Figure 4.1.2). A rapid 
uptake in the brain was observed with average concentrations in the range of 300-400ng/g 
during the first hour after drug intake, followed by an observed gradual decrease in brain 
concentrations over time. 
4.1.3.2 The effects of orally administered modafinil on locomotion activity 
There was no effect of running the test twice: as a group, the rats were equally 
active in both tests (Test: F(1,42) = 1.42, n.s.; nρ
2
= 0.03) and the time course of activity was 
also similar in each test (Test by Time-period interaction: F(4.54, 190.76) = 1.1, n.s.; Huynh-
Feldt correction; uncorrected degrees of freedom df= 9,378; nρ2= 0.03). Overall, 
modafinil administration resulted in greater LMA compared to vehicle-treated rats (Dose: 
F(1, 21) = 49.3, p<0.05; nρ
2
= 0.70; Figure 4.1.2). Overall activity also decreased as time 
elapsed (Time-period: F(4.31, 90.49) = 19.32, p <0.05; Huynh-Feldt correction; uncorrected 
df= 9, 189; nρ2= 0.48), yet modafinil-treated animals remained more active across the 
time-periods (Dose by Time-period interaction: F(7.11, 149.28) = 3.66, p<0.05; Huynh-Feldt 
correction; uncorrected df= 9, 189; nρ2= 0.15). Further analysis by pairwise comparison 
(Bonferroni correction) determined that modafinil-treated rats were significantly more 
active at nearly all time-periods (15-30 minutes onwards) compared to vehicle-treated rats. 
As reported in previous studies (Simon, Hémet, & Costentin, 1996), the LMA of control 
rats decreased rapidly, whilst modafinil-treated rats remained more active at later time-
periods. 
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Figure 4.1.2: Top: Mean number of beams crossed (±SEM); modafinil-treated rats 
remained significantly more active from the 15-30 minute time-period and onward; white 
boxes p<0.05. Bottom: Pharmacokinetic profile of the mean concentration of modafinil in 
brain tissue ± SEM; Modafinil concentration reduces over time, although high variability 
at the early time-points may mask a true peak at the 60 minutes time-point 
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4.1.4 Discussion  
This study investigated the efficacy of a novel route of administration, in the form 
of a suspension in a palatable jelly tablet, for thermally stable, bio-orally available drugs. 
We have shown that modafinil is present in the brain up to at least 150 minutes after 
consumption of a 30mg/kg modafinil-containing jelly, and that LMA is affected by 
modafinil on a similar timescale. This range of bioavailability is also comfortably within 
the projected required test time in a more succinct task variant of the 11-stage task. The 
results obtained from the pharmacokinetic profile of modafinil concentration in brain tissue 
show a pattern comparable to previously published data from oral administration of 
32mg/kg modafinil via gavage (Waters et al., 2005).  
Our data also demonstrate that rats fed modafinil in jelly form show LMA that 
compares favourably to data from other administration methods, along with aligning with 
our reported pharmacokinetic profile. For example (Simon et al., 1996), report increased 
LMA after 40mg/kg modafinil administered via i.p. injection. As in that study, we have 
shown that following actimeter habituation, compared to control rats, modafinil-treated rats 
exhibited greater LMA overall and importantly, continuously after the first time-period. 
This behavioural evidence shows that this jelly method of administration presents as a 
viable option for delivering orally bioavailable drugs in a revised task investigating set-
formation.   
4.1.4.1 Conclusions 
In conclusion, the current data demonstrate that administration of modafinil in a 
jelly tablet is an alternative to oral gavage, with the benefit of being less stressful for the 
animal. The reported pharmacokinetic profile, which aligned with the increase in 
locomotive behaviour for modafinil-treated rats, presents this as a refinement in drug 
administration. Reducing the stress-related arousal during the administration of 
pharmacological agents may be essential to maximise the effects of modafinil on behaviour, 
which has been addressed through voluntary consumption of the drug.  
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4.2 Experiment II 
4.2.1 Introduction 
The introduction to this chapter (4.1.1) outlined that probe stages can present as a 
useful alternative to an ID/ED comparison in inferring set-formation, allowing for a 
measurement of both ‘pre-set’ and ‘post-set’ performance. The ID/ED comparison 
measures learning performance between two stages, whereas alternatively, the probe stage 
measures the level of distractibility of the irrelevant dimension, and how this ability 
changes as set is acquired. It is hypothesised here that an ‘early probe’ stage, placed at the 
outset of the task, should take longer to acquire than a ‘late probe’ stage which occurs after 
the multiple ID stages, and therefore the opportunity to form set. We hypothesised that: 
i. Data for control rats and lesioned rats should not differ at an early probe 
stage, in which set is likely not formed, and therefore TTC for both groups 
should be comparable to the preceding compound learning stage. 
ii. Lesioned rats will find a late probe stage more challenging than control rats, 
marked by increased TTC. Control rats should be able to ignore or inhibit 
responding to the irrelevant dimension by this point, and therefore acquire 
the stage without incurring any errors. 
The current experiment also examined whether the application of putative 
cognitive-enhancing drugs – namely modafinil and ORG – could improve performance in 
behaviour which is compromised in lesioned rats or control rats. As reported in experiment 
I, orally bioavailable compounds can be suspended in a palatable jelly tablet as a reduced 
stress route of administration. 
Two undergraduate students completed two sessions of testing on the standard 7-
stage task (data not reported here) in the interim period between drug-administered test 
sessions on the early/late probe task. This also reduced the risk of partial reinforcement, 
since certain stimuli would never be rewarded, owing to the absence of reversal stages in 
the early-late probe task.   
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4.2.2 Methods 
4.2.2.1 Animals 
Twenty male, Lister hooded rats (Charles River, UK Ltd) were used in this 
experiment, with twelve rats in the lesion group, and eight rats in the control group. Rats 
had a mean weight of 268g (range: 231-286g) at the start of the experiment. At completion 
of the experiment rats had a mean weight of 503g (range: 405-576g). Rats were previously 
tested as adolescent animals on the 7-stage task as part of another experiment 19 weeks 
prior to surgery, and 33 weeks prior to the start of behavioural testing on the current 
experiment.  
4.2.2.2 Apparatus 
The attentional set-shifting apparatus is described in the Chapter 2 (General 
Methods), section 2.2. 
4.2.2.3 Surgery and histology  
Ibotenic acid lesion surgery procedures are described in Chapter 2 (General 
Methods; see section 2.3.3).   
4.2.2.4 Experimental design  
A within-subjects design was used so all rats received vehicle, modafinil and 
ORG49209 jellies over 3 rounds of testing. The order of drug administration was 
counterbalanced, such that during a given test session one third of the rats received either: 
vehicle, modafinil, or ORG49209 jellies. Control and lesioned rats were paired and 
assigned to a drug condition, and order of presentation of stimulus pairings, the initial 
correct stimulus within a pairing, and ensuring an equal distribution of odour or media 
dimensions (in the absence of an ED shift) were counterbalanced across test sessions. In the 
absence of reversal learning stages in the early/late probe task, some stimuli will never be 
associated with reward, and in an attempt to control for this, an interim 7-stage task was 
employed to extinguish any conditioned associations with the stimuli.  
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4.2.2.5 Drug preparation and habituation   
Preparation of vehicle and drug jellies is described in experiment I (see section 
4.1.2.3).  
4.2.2.6 Behavioural training 
Rats were trained and tested as adolescent animals on the 7-stage task as part of 
another experiment, and were therefore not trained prior to testing in the current experiment. 
For training, see section 2.4.1 of the General Methods, Chapter 2. 
4.2.2.7 Behavioural testing – The early/late probe task  
Testing was conducted over a period of 10 weeks, commencing 2 weeks after 
surgery. The three rounds of testing on the probe task were conducted over 2 weeks, 1 week, 
and 3 weeks, respectively. Prior to testing, rats were placed in the set-shifting apparatus and 
given a jelly (vehicle, modafinil, or ORG49209) to consume within five minutes. 
Behavioural testing commenced thirty minutes following consumption of the jelly. The 
early/late probe, as the name implied, consisted of two probe stages, which replaces only 
the irrelevant dimension stimuli with novel stimuli. The task also presented multiple ID 
stages to aid in fostering set-formation. A total of four stimuli pairings were used, plus an 
additional two stimuli pairings reserved for the two probe stages. The probe stimuli 
pairings were counterbalanced for order of presentation within each drug group, and for 
each test session.  The full list of stimuli pairing used in the early-late probe task are 
summarised in table 4.2.1.  
The task started with a simple discrimination (SD) followed by a compound 
discrimination (CD) stage, in which a novel, yet irrelevant, dimension was added. The fact 
that this dimension was never predictive of reward, and therefore the CD stage here is also 
a ‘probe’ stage. However; the probe stage changes irrelevant dimension exemplars, whereas 
the CD stage introduces a novel dimension, and this introduction might attract attention. 
Therefore, the subsequent early probe (CDp) stage is a better comparison to the late probe 
stage. This stage retained the reward-relevant exemplars from the preceding CD stage, 
whilst the stimuli from the irrelevant dimension were changed with novel stimuli. The rats 
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Table 4.2.1: The list of stimuli pairings used in the early-late probe task, including the 
probe stage, which only replaced stimuli in the incorrect dimension.   
  
then completed three intradimensional acquisition stages (ID1, ID2, & ID3), each 
rewarding the same perceptual dimension. The late probe (ID3p) stage, was formally 
identical to the early probe stage, and retained the reward-relevant exemplars from the 
preceding ID3 stage. An example summary of the procedure of the early/late probe task is 
detailed in table 4.2.2. Testing was carried out with the help of two undergraduate student, 
as part of their undergraduate final year project work. 
4.2.2.8 Data analysis  
The early-late probe experiment was a 2x3x7 mixed factorial design, and data for 
trials to criterion were analysed by repeated-measures ANOVA. There was a within-
subjects factor of drug condition (three levels: vehicle, modafinil, and ORG49209), a 
within-subject factor of stage (seven levels), and a between-subjects factor of group (two 
levels: control or lesion). Upon completion of the experiment, data for each drug condition 
was combined from the three rounds of testing to form a complete set, thus comprising data 
for all rats in preparation for analysis.  
4.2.2.9 Histology  
NeuN/Cresyl violet immunohistochemistry procedures are described in Chapter 2 
(General Methods; see section 2.5). 
Media Odours
Pair I M1: Coarse tea M2: Fine tea O1: Cinnamon O2: Ginger
Pair II M3: Sand M4: Grit O3: Sage O4: Paprika
Pair III M5: Coarse shavings M6: Fine shavings O5: Turmeric O6: Cloves
Pair IV M7: Coarse cork M8: Fine cork O7: Fenugreek O8 Tarragon
Probe I M11: Cotton pads M12: Cigarette filters O11: Dill O12: Coriander
Probe II M13: Beads M14: Gravel O13: Thyme O14: Carroway seeds
 127 
 
 
Table 4.2.2: An example procedure of a typical test session in the early/late probe task. 
Odour and media as dimensions were counterbalanced, along with initial correct stimulus 
and order of presentation of probe stimuli.  
Discimination 
Relevant 
dimension
Discriminanda Mixed with
Simple 
Discrimination 
(SD) 
Medium 
Coarse tea , not 
fine tea 
Nothing
Compound 
Discrimination 
(CD) 
Medium 
Coarse tea , not 
fine tea 
Cinnamon or 
ginger 
Early Probe 
(CDp)
Medium 
Coarse tea , not 
fine tea 
Dill or coriander 
Intradimensional 
Acquisition I 
(ID1)
Medium Sand , not grit Sage or paprika
Intradimensional 
Acquisition II 
(ID2)
Medium 
Coarse 
shavings , not 
fine shavings
Turmeric or 
cloves 
Intradimensional 
Acquisition III 
(ID3)
Medium 
Coarse cork , not 
fine cork 
Fenugreek or 
tarragon
Late Probe   
(ID3p) 
Medium 
Coarse cork , not 
fine cork 
Thyme or 
carroway seeds 
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4.2.3 Results  
4.2.3.1 Histology  
Two lesioned rats were excluded from the final analysis: one rat failed to recover 
post-operatively, and the other was rat was euthanised due to the onset of spontaneous 
seizures. Consequently, the final group sizes were: lesion n=10; control: n=8.  
Lesion extent and cell loss was determined by NeuN/Cresyl Violet double staining, 
and of the ten rats, only five rats had identifiable lesions to the STN, one of which was 
unilateral. These rats had STN cell-loss restricted to the medial portion, and the lesion 
damage for one rat extended medially into PSth and the LHA. Figure 4.2.1 illustrates 
schematics of lesion extent, along with photomicrographs of the cell-loss found in the 
unilaterally-lesioned rat, the ‘typical’ cell-loss found amongst bilaterally lesioned rats, and 
photomicrographs of a control brain. Given that these rats did not present with signs of cell-
loss in the STN or ZI, these rats were removed prior to statistical analysis reducing the final 
group size for lesioned rats to five (4 with bilateral lesions; 1 with a unilateral lesion). The 
remaining five rats retained a visibly ‘intact’ STN with no observable signs of cell-loss, and 
consistent with Chapter 3, all rats given ibotenic acid infusions presented with evidence of 
calcification in the MGP, along with ‘chewing’ behaviour during recovery from surgery.  
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Figure 4.2.1: Schematics and example photomicrographs of brain sections (NeuN/Cresyl 
Violet). Top to bottom: schematics illustrate the minimum (dark grey) and maximum (light 
grey) extent of the lesion; photomicrographs of the ‘typical’ bilateral lesion and the 
unilaterally-lesioned rat (hashed outline indicates lesion extent); photomicrographs of a 
control brain. 
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4.2.3.2 Overall analysis   
Overall performance on the task improved as testing progressed, with the late probe 
stage requiring the fewest TTC (main effect of Stage: F(6,60)= 5.76, p<0.01; nρ
2
= 0.37; 
figure 4.2.2). A simple contrast determined that the late probe was acquired in significantly 
fewer trials than the early probe (F(1,10)= 5.8, p<0.05; nρ
2
= 0.37); however, there were no 
differences between the control and lesion groups, either overall or by stage, including both 
probe stages (Group: F(2,10)= <1, n.s.; nρ
2
= 0.04; Stage by Group interaction: F(12,60)= 1.78, 
p= 0.07; nρ2= 0.26). Furthermore, there were no differences between Modafinil or ORG 
administration compared to vehicle, either overall, or by group, or stage (Drug: F(2,20)= 2.79, 
n.s.; nρ2= 0.22; Drug by Group interaction: F(4,20)= 1.26, n.s.; nρ
2
< 0.2; Drug by Stage 
interaction: F(12,120)= 1.13, n.s.; nρ
2
= 0.1).   
 
Figure 4.2.2: Mean TTC (+SEM) for all rats across the 7 stages of the early/late probe task, 
illustrating a stage-wise improvement, and a significant reduction in TTC between the early 
and late probe stages; data for Drug and Group were combined as neither interacted 
significantly with stage.  
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4.2.3.3 Comparison of early and late probe stages  
Examination of the raw data (figure 4.2.3) revealed that more than half of the rats (8 
out of 13; 62%) exhibited a difference between the early and late probe stage performance 
(reduction in TTC between CDp and ID3p); however in some cases the difference was very 
small. Furthermore, we had expected that rats with an attentional set should perform the 
late-probe stage without any (i.e., in 6 TTC), or with very few, errors, but only a small 
minority did so. Overall, this was not a convincing demonstration that the rats had formed 
an attentional set and that the probe stage was no longer distracting. 
 
Figure 4.2.3: Boxplot illustrating difference between the probe stages, calculated by 
subtracting the late probe from the early probe (CDp-ID3p); hashed lines indicate the 
mean shift cost for rats by group; superimposed vertical point plot depicting the 
distribution of the data for each rat, with the red triangle illustrating the probe comparison 
for the unilaterally-lesioned rat; Nearly all of the rats exhibited a positive difference 
between stages, indicating the late probe was acquired in fewer trials than the early probe. 
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4.2.4 Discussion  
The current experiment introduced a novel manipulation using the bowl-digging 
paradigm, in which set-formation is inferred not by comparing the acquisition of ID and ED 
discriminations, but rather by observing the disruptive effect of changing the exemplars in 
the irrelevant dimension on an already-acquired discrimination. Early in testing, before an 
attentional set has formed, changing the irrelevant stimuli was expected to distract from 
performance of the learned discrimination, while later in testing, the change was expected 
to be unattended and therefore without disruptive effect. The evidence indicated greater 
disruption of performance of an early probe-stage compared to the later probe-stage. This 
difference suggests that the formation of attentional set-formation spares ongoing behaviour 
from the disruptive effects of a change of stimuli in the irrelevant dimension. However 
there are some limitations of this task, which will be discussed below. The current 
experiment also examined the effects of lesions of the STN and the potentially ameliorative 
or even cognitively-enhancing effect of modafinil and ORG49209. However, the lesion 
manipulation failed and furthermore both drugs were without behavioural effects.  
4.2.4.1 Limitations  
In the current experiment, as seen in Chapter 3, once again the lesion manipulation 
failed to result in consistent observable cell loss. Without verifiable and replicable lesions, 
it is not possible to draw any conclusion about the contribution of the STN to behaviour. 
Similar to Chapter 3, the data for the majority of the lesioned group needed to be discarded 
owing to unobservable cell-loss, despite evidence of calcification in the MGP, along with 
‘chewing’ behaviour during recovery from surgery 
Although the data are not reported here, there was also a surprising lack of 
difference between the ID and ED stages of the 7-stage task in the control group. The 
failure to find an ID/ED difference in the control rats in the 7-stage task, and hence, 
evidence of set-formation, suggests that the test might have been underpowered but 
nevertheless makes it difficult to draw any conclusions about lesion effects, even in the 
small number of rats who had visible damage. 
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Finally, there were no effects of either modafinil or ORG. It is possible that the 
early/late probe manipulation is not sufficiently sensitive to any enhancing effects (i.e., if 
there was little room for improvement). Although Xia, Tait & Brown (unpublished) 
reported that modafinil enhanced learning at an ID3 stage, this was only true for lesioned 
rats that were impaired at the task. Since it has been documented that modafinil only 
benefits lower-performing subjects on tasks of increased difficulty (see Müller, 
Steffenhagen, Regenthal, & Bublak, 2004; Randall, Shneerson, & File, 2005), it is possible 
that the present manipulation was insufficiently challenging for the rats. This consideration 
also implicitly supports the conclusion that the lesion damage was insufficient, or that the 
sample size was too small to evidence a reliable effect. It is likely that the intact tissue for 
the unilaterally-lesioned rat sustained performance, such that there was no impairment 
against which to measure ameliorative effects of the drugs, although there was only one 
unilaterally-lesioned rat. This consideration results in a similar conclusion for the four 
bilaterally-lesioned rats, in which there may have been an impairment in cognition which 
may have been amenable to the cognitive-enhancing effects of the drug; however the high 
variance obtained from small sample size (half of the group had a positive probe 
comparison, whilst half a negative comparison) makes it unadvisable to draw any 
conclusions regarding performance influenced by drugs, or regarding the construct validity 
of the early-late probe task. This likely extends to ORG-treated animals as well, since 
Chase, Tait & Brown (unpublished) reported that performance for ORG-treated aged rats 
only improved performance in aged-rats at previously impaired reversal stages: novel 
learning stages and attentional set-shifting were unaffected.  
During completion of the current experiment, a paper published by Caliph, Faassen, 
& Porter (2014) found that whilst ORG is orally bioavailable, its oral bioavailability is low, 
which may be due to its poor intestinal solubilisation or due to intestinal efflux. It is 
possible that a dose of 10mg/kg administered orally is too low. 
4.2.4.3 The early-late probe task 
The fact that there was a difference between the early and the late probe increases 
confidence that this is a sensitive measure of the change in attentional focus throughout the 
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task. The task began, in the same way as the 7-stage ASST, with a simple discrimination in 
which the bowls only differ on one dimension. The CD stage introduces a reward-irrelevant 
dimension, but the rewarded and unrewarded exemplars of the predictive, relevant 
dimension are unchanged. It might be expected that, having learned which stimulus is 
rewarded at the SD stage, rats would complete the CD stage without error, however, only 
about 35% of control rats do so (Tait, personal communication), indicating that, at the CD 
stage, attention is not solely focussed on the ‘correct’ exemplar. Nevertheless, because 
irrelevant exemplars are introduced at the CD stage, it is not directly comparable to a 
‘probe’ stage in which irrelevant exemplars are changed. For this reason, it is not surprising 
that acquisition of the CD stage required significantly more trials than the late probe and 
did not differ from the early probe.  
It is likely that the SD stage is not necessary, and the task could start with a CD 
stage, followed immediately by the early probe. However, the lack of difference between 
the CD and early probe is good evidence to suggest that an attentional set has not formed 
by this point in the test.  It might be informative to include an assessment of set-shifting 
performance following the late-probe stage, not least because this would provide evidence 
against the suggestion that the rats are simply ‘getting better’ with practice. It would be 
hypothesised that an ED stage following the ID3p would result in a cost of set-shifting, 
providing an additional – and robustly replicated – measure of attentional set. It would also 
be interesting to then to include an additional post-ED probe stage (EDp), as it is speculated 
that qualities/cues of this newly shifted-to dimension are still being learned, and therefore 
acquiring an EDp stage may exercise similar learning requirements of a CDp stage. This 
would also serve to strengthen the probe stage as a useful tool in the inference of set-
formation, along with increase our understanding of the mechanisms of attentional set-
formation.   
4.2.4.4 The efficacy of a palatable jelly tablet  
The refined delivery method introduced in this experimental chapter presents as a 
reduced-stress alternative to oral gavage – a forced oral route of administration, which 
elicits undesirable stress responses and is known to alter an animal’s response to a 
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xenobiotic (Brown, Dinger, & Levine, 2000; Roberts, Soames, James, Gill, & Wheeldon, 
1995). The first study in experiment I reported brain concentrations of modafinil, which are 
similar to previous observations by Waters et al. (2005), and both our data and that of 
Waters et al. demonstrate a rapid decrease in concentration after the 60 minutes time-point. 
Whilst our data shows a gradual decrease in modafinil concentration as time progresses, our 
data have high variability in the early time-points, with the greatest concentration actually 
at 60 minutes – the same as reported in Waters et al. Both our study and that of Waters et al. 
sampled three rats per time-point, and given the variability in their data at the highest 
concentrations reported (60 minutes), we do not think it reasonable to conclude that there is 
a substantial difference between the pharmacokinetic results. Furthermore, unpublished 
data from oral gavage using a dose of 64mg/kg show a concentration of 350ng/g modafinil 
in brain tissue at 60 minutes post administration, although again with high variability 
(Bundgaard, unpublished observations) – comparing favourably to our reported 383ng/g 
concentration at the same time-point. 
Rats fed modafinil in jelly form also exhibit behaviour that compares favourably to 
data from other administration methods, such as a sustained elevation in LMA (both i.p. 
and intracerebrally; Simon, Hémet, & Costentin, 1996). Both our data and that of Simon et 
al. illustrate a more rapid decline in LMA in vehicle-treated than modafinil-treated rats, 
followed by stabilisation during later time-periods. Our observations differ, however, in 
that after the first time-period, modafinil-treated rats are consistently more active than 
vehicle-treated – whereas Simon et al. report differences only at three time-periods (10-20, 
30-40 and 70-80 minutes). That we used more than the twice the number of subjects, and 
tested each twice, suggests that lower variability in our sample accounts for our more 
robust effect – rather than, for example, a gender or strain effect. 
As previously reported by Edgar & Seidel (1997), EEG recordings support the 
conclusion that modafinil causes an increase in LMA only in proportion to the expected 
time spent awake, and therefore “LMA intensity” (a measure of increased LMA per minute 
of time awake) is not affected by modafinil. In contrast, amphetamine-like stimulants not 
only increase LMA intensity, but also result in stereotyped behaviours such as “compulsive 
licking, sniffing, biting, chewing, grooming and head-waving” (Duteil et al., 1990). Even 
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300mg/kg doses of modafinil (Edgar & Seidel, 1997) do not yield increased LMA intensity 
in rats, and this is likely this is due to modafinil’s minimal involvement in the release of 
striatal dopamine (Akaoka, Roussel, Lin, Chouvet, & Jouvet, 1991; De Sereville, Boer, 
Rambert, & Duteil, 1994). 
Administering modafinil at CT-5 also aided in maximising stimulant efficacy by 
controlling the amount of prior sleep the animal received. Edgar, Seidel & Dement (1991) 
examined the sedative effects of triazolam (benzodiazepine) on CT-18 (12h light/dark 
schedule = 6 hours post lights-off) rats, CT-18 rats in constant darkness and CT-5 rats. 
They found that triazolam was most effective at promoting its hypnotic effects if 
administered during lights-off, high activity periods (CT-18), and actually found a 
reduction in total sleep if administered during lights-on (CT-5) (Edgar et al., 1991). This 
highlights the large impact prior sleep presents in pharmacological manipulation of 
sleep/wakefulness, in relation to circadian phases and a light/dark schedule, respectively. 
CT-5 was an ideal dosage time to examine the wake-promoting effects of modafinil, as CT-
5 is a lights-on, low-activity phase. This presents the opportunity to maximise the 
pharmacological effects of modafinil as a wake-promoting agent, whilst preventing natural 
circadian wakefulness from masking measurable effects.  
The reported jelly administration method presents as an alternative to both oral 
gavage, and the ‘pill’ method described in Walker et al. (2012). Rich palatability and a 
capacity to manufacture a higher volume of pills per batch, makes the ‘Transgenic dough 
diet’ a viable alternative to oral gavage, but the high fat and protein content is less desirable 
for food-motivated experiments, and where there is likely to be slower absorption of a drug 
because of gastrointestinal contents. Additionally, the dough diet requires the drug to be 
kneaded in (Walker et al., 2012), and therefore final concentration may be inconsistent as 
there may be irregular distribution within the dough unless pills are made individually. 
Some drugs also require a solvent to help dissolve them to aid in uniform distribution, and 
in some cases a thickening agent was added to the dough mixture to help finalise it for 
drying. The benefit, therefore, of the individualised jellies is that dosage can be customised 
to the weight of the rat without having to make a larger batch, thereby reducing wastage 
and being more cost-effective: the gelatine mixture is pipetted on top of the pre-weighed 
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drug, which can remain in crystalline form. As with the Walker’s pill method, any aversive 
taste the drug may have should be masked by the palatable flavour of the jelly. 
4.2.4.5 Conclusions 
In summary, the results reported in the current experiment suggested that 
acquisition of the late probe stage required fewer TTC than the early probe, regardless of 
group or drug administration. Despite this improvement, it is not parsimonious to interpret 
this as a formation of attentional set since control rats failed to evidence a robust ID/ED 
difference in the interim 7-stage task. Furthermore, lesion damage from a small sample size 
makes it difficult to conclude with any certainty how lesions of the STN contribute to 
behaviour here. This may be supported by the apparent lack of an effect of drug on 
cognitive-enhancement; modafinil and ORG did not facilitate learning in this experiment, 
which may have stemmed from an insufficient disruption in behaviour to yield an 
observable effect of the drugs. A refinement of the methodology in which the subthalamic 
cell population is modulated is therefore essential for determining the involvement of the 
STN in attentional set-formation.  
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Chapter 5 
 
Designer receptors transiently inhibit neuronal 
functioning in the STN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background: 
Designer receptors, engineered to be sensitive to a designer drug 
(clozapine n-oxide) can be virally-delivered to transduce a cell 
population to transiently inhibit neuronal functioning. This chapter 
investigated the best combination of serotype and promoter to 
transduce the cells of the STN, and to measure inhibition of 
neuronal function.  
Methods: 
The first experiment measured the efficacy of the CaMKII 
promoter with either AAV2 or AAV5 serotypes. The second 
experiment measured labelling of c-Fos in the STN following 
administration of clozapine n-oxide or a vehicle to either 
unoperated rats or those with designer receptors.  
Results: 
AAV5-CaMKII-promoted designer receptors transduced the cells 
of the STN (in some the ZIV), and that systemic administration of 
clozapine n-oxide significantly reduces c-Fos labelling in the STN. 
Conclusions: 
Designer receptors present as a viable alternative to lesion surgery 
to inhibit the functioning of the STN. It is also confirmed that in the 
absence of clozapine n-oxide, the designer receptors do not 
significantly influence neuronal functioning.  
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5.1 Introduction 
Results from Chapter 3 and 4 (Experiment II) of this thesis were disappointingly 
consistent, in that the cell damage following ibotenic acid infusions into the medial STN 
was variable and incomplete. This is in spite of observing reliable behavioural 
indicators (e.g., immediate post-operative ‘chewing’) that the infusion was located as 
intended and even observing some behavioural differences in task performance between 
infused rats and controls, but no differences between infused  rats with clear, verifiable 
lesion damage and infused rats without visible cell-loss. Various measures to improve 
the consistency of excitotoxin-induced lesions were unsuccessful. Therefore, in the 
current Chapter, I report the results of transducing the cells within the STN (and ZI) by 
using pharmacosynthetics or DREADDs (Designer Receptors Exclusively Activated by 
Designer Drugs). This relatively novel approach to control the elements of signal 
transduction utilises engineered G protein-coupled receptors (GPCRs) that can be 
selectively – and non-invasively – modulated by the pharmacologically-inert synthetic 
ligand clozapine N-oxide (CNO) (Urban & Roth, 2015). 
Modified human muscarinic acetylcholine receptors are engineered so that they 
are activated solely by CNO, and are insensitive to their endogenous ligand, 
acetylcholine (Ferguson & Neumaier, 2012; Rogan & Roth, 2011; Urban & Roth, 2015). 
Consequently, DREADDs do not themselves, in the absence of CNO, modulate 
neuronal signalling (Armbruster, Li, Pausch, Herlitze, & Roth, 2007; Farrell & Roth, 
2013). This allows for a transient and reversible control of signal transduction: only 
while CNO is present will the receptors be activated. The receptors are introduced either 
by packaging into adeno-associated viral (AAV) vectors which are then infused into the 
brain region of interest, or they can be expressed in a transgenic mouse on a particular 
population of cells, so that both spatial and temporal control of GPCR signalling 
cascades can be achieved using DREADDs. DREADDs can be either excitatory 
(hM3Dq) or inhibitory (hM4Di): depending on the G protein α subunit, they will either 
accentuate (Gq) or attenuate (Gi) cellular activity (figure 5.1). 
5.1.1 G protein-coupled receptors (GPCRs) 
GPCRs are a type of neurotransmitter membrane receptor with a distinct 
mechanism of action – each type of GPCR selectively interacts with specific G proteins,  
  
 
 
Figure 5.1: Illustrates the process by which DREADDs-engineered receptors are introduced and modulated in vivo  
1
4
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and not others, so lending specificity in cellular actions (Feldman, Meyer, & Quenzer, 
1997). All G proteins contain a common structure, including three subunits (α, β, and γ) 
with the α subunit playing a major role in the outcome cellular process (i.e., excitation 
or inhibition) and thus determining the nomenclature for that particular G protein (Gi, 
Gq, etc. with i and q denoting the α subunit) (Feldman et al., 1997). Gi proteins were one 
of the first G proteins discovered, and are of particular interest here as they exert an 
inhibitory effect on adenylyl cyclase, which is an enzyme that promotes intracellular 
signal transduction via synthesis of the important secondary messenger, cyclic 
adenosine monophosphate (cAMP), whilst Gs signalling results in an excitatory effect 
on cAMP (Feldman et al., 1997; for cAMP review see Robinson, Butcher & Sutherland, 
1971). This inhibition of signal transduction – and thus the potential silencing of the 
subthalamic population – following Gi DREADDs application is of particular 
importance for the current experiment. In the case of Gi DREADDs, the engineered 
human muscarinic M4 receptors – now selectively sensitive to CNO – couple to Gi 
subunits, which results in hM4Di DREADDs receptors. Following CNO administration 
these receptors can inhibit foskolin (cAMP agonist)-induced cAMP formation, along 
with facilitating a G protein inward-rectifying potassium channel (GIRK; see Dascal, 
1997) response in the hippocampus; GIRK effectively causes hyperpolarisation and 
inhibition of firing (Armbruster et al., 2007; Rogan & Roth, 2011).  
GPCRs can be found in a wide variety of neurotransmitter receptors, including 
the muscarinic ACh receptors, all known DA receptors, all known adrenergic receptors, 
all 5-HT receptors except 5-HT3, mGluRs, GABAB receptors, along with histamine 
receptors (Feldman et al., 1997). The dominant postsynaptic projections from STN to 
the cortex and thalamus are glutamatergic (Galvan, Kuwajima, & Smith, 2006), and 
activation of Group I mGluRs leads to Gq signalling, and a net excitatory response, 
along with increasing NMDA (Kuwajima, Hall, Aiba, & Smith, 2004), whilst Group II 
mGluRs are negatively coupled to adenylyl cyclase through Gi, and yield an inhibitory 
effect on signal  transduction (Conn & Pin, 1997; Kuwajima et al., 2004). As presented 
in the general introduction, in vitro electrophysiology studies have determined that both 
mGluR1 and mGluR5 receptor types are found on postsynaptic dendrites of the rodent 
STN (Awad, Hubert, Smith, Levey, & Conn, 2000), whereas mGluR2 and mGluR3 are 
presynaptically localised on STN terminals (Bradley et al., 2000). 
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Targeting these mGluRs in the medial STN area with DREADDs-engineered 
GPCRs should yield neuronal silencing for this population, along with potentially 
transducing neighbouring populations of GPCRs within the medial ZID. The cortical 
projections into this region overlap between the medial ZI and the STN, with some 
suggesting that there is also an overlap in functioning (Kita, Osten, & Kita, 2014). 
Furthermore, the predominant neurotransmitter of the ZI is GABA (see General 
Introduction), and the ZI also contains a population of G-protein coupled GABAB 
receptors, increasing the likelihood of transducing cells within this region (Mitrofanis, 
2005; Park, Hoffman, & Keller, 2014).  
5.1.2 Adeno-associated viral vectors 
The AAV itself is a virus responsible for infecting a target cell population for 
the purpose of delivering modified deoxyribonucleic acid (DNA), and for the current 
experiment,  DNA which is responsible for the replication and proliferation of the 
DREADDs-engineered receptors (Shevtsova, Malik, Michel, Bahr, & Kugler, 2005). 
AAV vectors are able to transduce a wide range of dividing and non-dividing cell types, 
along with providing long-term expression of transgenes – modified genetic material 
that has been transferred between organisms (Deyle & Russell, 2009). The removal or 
‘gutting’ of the endogenous genetic material of the AAV renders it non-infectious and 
unable to autonomically replicate, and therefore the AAV requires the help of an 
adenovirus to propagate the desired transgene – packaged as a plasmid (an 
independently-replicating DNA molecule) – for encoding, and the use of a ‘promoter’ to 
specify the target-cell population (Berns & Hauswirth, 1979; Muzyczka, 1992; Urban & 
Roth, 2015). Utilising a cell-type specific promoter, combined with selecting the 
appropriate ‘serotype’, which controls the ‘spread’ or tropism of the viral application, 
maximises the likelihood of restricting viral transgene proliferation to a desired target 
cell population (Rogan & Roth, 2011). For the present experiment, introducing AAVs 
containing DREADDs-engineered receptors into the rat STN in an effort to achieve 
localised transduction of the cells within medial area was a challenge; particularly since 
there are no existing surgical protocols for this novel application to the rat STN, and 
therefore it was necessary to find an appropriate combination of both serotype and cell-
specific promoter.  
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5.1.3 Serotype 
The serotype of an AAV provides a method of classification based on the viral 
tropism exhibited, viral tissue type, and the organisation/frequency of the cell surface 
viral antigens; early AAV vectors were all based on the AAV2 serotype (Kaplitt et al., 
1994; Korecka et al., 2011). The AAV2 serotype is renowned for its relatively 
conservative tropism compared to other serotypes – such as AAV1 and AAV8 – whilst 
still exerting a higher transduction percentage of a variety of cell types compared to 
AAVs with a more widespread distribution (Burger et al., 2004; Paterna, Feldon, Büeler, 
& Bu, 2004; Vandenberghe et al., 2011; Wang, Wang, Clark, & Sferra, 2003). This 
conservative tropism makes the AAV2 serotype a prospective candidate for transduction 
of the cells in the relatively compact medial STN; however a comparison of AAVs with 
serotypes 1-8 indicated that the novel AAV5 serotype was the most effective overall, by 
yielding the highest percentage of transduction for dorsal root ganglion neurons, along 
with a robust green fluorescent protein (GFP) expression (Mason et al., 2010). Paterna 
et al. (2004) conducted a titre-matched comparison of the transduction profiles for 
AAV5 and AAV2 serotypes in the rat nigrostriatal system, and determined that AAV5 
application resulted in a larger GFP-expressing area than AAV2 for neurons in the 
striatum, along with the dopaminergic neurons in the substantia nigra pars reticulata 
(SNr) and pars compacta (SNc).  
Further evidence suggests that AAV5 and AAV2 are comparable in their 
efficiency in transducing a variety of neurons in the rat CNS – including the 
hippocampus, substantia nigra, striatum, globus pallidus and spinal cord – yet AAV5 
rats exhibited higher transduction frequencies, which translates into a larger tropism 
than AAV2 rats (Burger et al., 2004). Given that both AAV2 and AAV5 serotypes 
transduce cells within the CNS with comparable efficacy, yet the latter induces a larger 
tropism, both serotypes could serve as suitable candidates for transducing the cells 
within the medial STN for the current experiment. Successful transduction of these cells 
can be further controlled by coupling these two serotypes with the correct promoter. 
5.1.4 Promoter 
The promoter is a sequence of genetic code found in the DNA – and in the case 
of DREADDs, the transgene DNA – and is responsible for binding to the ribonucleic 
acid polymerase (RNAP) and commencing transcription; essentially the promoter 
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indicates the starting point for gene expression (which varies depending on the promoter 
type), and in the case of a viral vector, the promoter drives the translation of the 
transgene (Losos, Mason, Singer, Raven, & Johnson, 2008). AAV administration of 
DREADDs, developed by Dr Bryan Roth, is currently limited to four promoters: human 
elongation factor-1-alpha (Ef1a); glial-fibrillary acidic protein (GFAP); human synapsin 
(hSyn); and Ca
2+
/calmodulin-dependent protein kinase II alpha (CaMKIIa) (Urban & 
Roth, 2015).  
The GFAP promoter expresses in mainly non-neuronal glial cell types (Urban & 
Roth, 2015), and Ef1a is responsible for cell growth, protein synthesis and cytoskeleton 
organisation (Becker, Kuhse, & Kirsch, 2013; Kim, Uetsuki, Kaziro, Yamaguchi, & 
Sugano, 1990). Therefore, neither were considered well suited to this particular target 
population. The hSyn promotor has shown promise in conferring a neuron-specific, 
long-term transgene expression, lending a pan-neuronal application by transducing the 
variety of neurons/neurotransmitter systems found in the striatum, thalamus, 
hippocampus and the SNc, whist sparing glial cells (Kügler, Kilic, & Bähr, 2003). By 
transducing all neuronal cell-types, the hSyn promoter is more applicable to the current 
experiment than GFAP or Ef1a; however CaMKIIa – which is a Ca2+-activated enzyme 
that is highly abundant in the CNS – is central to the regulation of glutamatergic 
synapses (for review see: Lisman, Schulman, & Cline, 2002).  
The major postsynaptic density (PSD) protein found at glutamatergic synapses is 
CaMKII (Kennedy, Bennett, & Erondu, 1983). PSD is a protein that is found on the 
postsynaptic membrane, and is responsible for regulating synaptic adhesion, organizing 
neurotransmitter receptor clustering, and modulating receptor sensitivity (Kennedy, 
1993). Furthermore, it has been determined that CaMKII phosphorylates the glutamate 
receptor (GluR), and that PSD CaMKII is critical in strengthening postsynaptic GluR 
responses (McGlade-McCulloh, Yamamoto, Tan, Brickey, & Soderling, 1993). It is 
important to note that CaMKII also phosphorylates GABAA receptors as well, which are 
found throughout the rodent ZI, suggesting that CaMKII transcription may regulate 
GABAA receptor activity (Houston, He, & Smart, 2009). Therefore, a CaMKII-
promoted DREADDs application was regarded the most likely to result in refined 
targeting of the STN, compared to other available promoters. Even so, transducing only 
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the cells within the medial STN, without any activity outside the STN itself, is likely not 
possible with this technology.  
5.1.5 Efficacy of DREADDs inhibition 
hM4Di DREADDs receptors have demonstrated robust efficacy for – selectively, 
non-invasively (compared to optogenetics), and transiently – attenuating cellular 
activity after CNO administration, in a variety of cell types which are not limited to the 
CNS (Armbruster et al., 2007; Kätzel, Nicholson, Schorge, Walker, & Kullmann, 2014; 
Ray et al., 2011; Sasaki et al., 2011). Kätzel et al. (2014) found that silencing the rat 
forelimb area of the primary motor cortex – via hM4Di DREADDs – significantly 
supressed focal seizures induced by a chemoconvulsant, presenting a novel therapeutic 
approach for intractable focal epilepsy. Furthermore, in vitro transduction of cultured 
hippocampal neurons with hM4Di induced membrane hyperpolarisation, along with 
neuronal silencing (Armbruster et al., 2007). The use of hM4Di aided in establishing 
that serotonergic neurons regulate life-sustaining respiratory and thermoregulatory 
networks (Ray et al., 2011): after application of hM4Di to the serotonergic neurons of 
the brainstem, CNO-treated mice showed no increase in respiration as CO2 
concentration increased and exhibited a decrease in core temperature, whilst saline-
treated rats increased their respiration in response to rising CO2 levels, with no 
noticeable change in thermoregulation. 
Targeting the corticostriatal neurons originating from the striatum with hM4Di, 
followed by chronic CNO administration, resulted in decreased synaptogenesis (the 
formation of synapses) by day 15 of treatment, which persisted into adulthood at day 28 
(Farrell & Roth, 2013; Kozorovitskiy, Saunders, Johnson, Lowell, & Sabatini, 2012). 
This also demonstrated that DREADDs+CNO can be used to provide chronic neuronal 
modulation, and that recurrent network activity along this pathway is crucial in 
synaptogenesis and healthy development. Transient inactivation of neurons via hM4Di 
in the rat dorsal striatum impaired learning acquisition in a simple operant lever 
pressing task, which also demonstrated that dysregulation of striatal circuits may 
contribute to the development of aberrant reward and reinforcement learning (Ferguson 
& Neumaier, 2012). Being a relatively novel investigative tool, little research has been 
published regarding the application of DREADDs to the BG for the purpose of 
investigating cognition. 
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5.1.6 Clozapine N-oxide 
DREADDs engineered receptors have been designed to selectively interact only 
with CNO, which is a pharmacologically inert metabolite of the antipsychotic drug, 
clozapine (Alexander et al., 2009; Guettier et al., 2009). Developers of DREADDs 
technology elected to use CNO as a tool for cellular modulation for several key reasons, 
primarily since CNO’s parent compound, clozapine, has a high affinity to M3 
muscarinic receptors, and thus fewer genetic mutations would be required to engineer 
the receptors (Armbruster et al., 2007). Furthermore, CNO is also highly bioavailable in 
humans and rodents. It has been shown that in rats, clozapine penetrates the blood-brain 
barrier faster than CNO, yet concentrations of CNO and clozapine are comparable for 
time periods >60 minutes (Bender, Holschbach, & Stöcklin, 1994; Chang et al., 1998; 
Guitton, Abbar, Kinowski, Chabrand, & Bressolle, 1998a). Perhaps most importantly, 
CNO was selected since it is a pharmacologically inert molecule in rodents, lacking 
appreciable (<1 µM) affinity for receptors (Armbruster et al., 2007; Weiner et al., 2004); 
however in humans, CNO undergoes extensive back-metabolism to clozapine (Chang et 
al., 1998; Guitton, Abbar, Kinowski, Chabrand, & Bressolle, 1998).  
CNO modulation of DREADDs receptors illustrates a rapid onset of excitation 
or inhibition, followed by a prolonged and sustained effect on signal transduction 
(Guettier et al., 2009; Ray et al., 2011; Rogan & Roth, 2011; Sasaki et al., 2011). In 
humans the mean elimination half-life of CNO is more than 7 hours (Guitton et al., 
1998b), but in mice, plasma levels determine that CNO half-life it is much shorter (~2 
hours), yet despite this, the interaction of CNO with DREADDs results in significant 
behavioural and electrophysiological modulation ranging from 6-10 hours (Alexander et 
al., 2009; Guettier et al., 2009; Wess, Nakajima, & Jain, 2013). In the aforementioned 
study, Ray and colleagues (2011) successfully inhibited the serotonergic neurons of the 
rat brainstem within 10 minutes of CNO application (i.p.), and sustained this inhibition 
for nearly 12 hours, causing decreased core temperatures, and a blunted response to 
increased CO2 concentrations.  
 There is evidence suggesting that the dosage of CNO required depends on the 
type of DREADD subtype (Gq vs Gi) utilised, in that hM3Dq DREADDs are very 
effective at depolarising neurons, thus requiring a relatively low dose of CNO (0.03 – 1 
mg/kg: Alexander et al., 2009; Boender et al., 2014; Guettier et al., 2009), whereas 
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hM4Di is reportedly less effective at inhibiting neuronal firing, necessitating the usage 
of a higher CNO dose (10 mg/kg in rats: Ray et al., 2011; 5 mg/kg in mice: Sasaki et al., 
2011; see Farrell & Roth, 2013). Experiments in this thesis should therefore utilise a 
higher dosage of CNO.  
5.1.7 Fluorescent proteins 
All AAV DREADDs are engineered and tagged with a fluorescent protein 
(AAV5: mCherry; AAV2: mCitrine; Roth Lab, UNC Vector Core), which can be 
enhanced with an anti-body and imaged via fluorescence microscopy to determine viral 
tropism. Both mCherry and mCitrine are fluorophores – chemical compounds that 
absorb light (excitation: mCherry: 587nm; mCitrine: 516nm) at one wavelength, then 
emit (emission: mCherry: 610nm; mCitrine: 529nm) it at another – and in the case of 
mCherry, and mCitrine, of the red and yellow wavelength class, respectively (Losos et 
al., 2008; Shaner, Steinbach, & Tsien, 2005; Tsien, 1998). Furthermore, mCherry has 
been praised as the best general-purpose red monomer owing to its superior 
photostability – a resistance to photobleaching which arises from prolonged excitation – 
thus increasing long-term viability of the fluorophore (Shaner et al., 2004; 2005).  
5.1.8 Current experiment  
The purpose of the current experiment was to determine the most efficacious 
combination of serotype to be used with the CaMKIIa promoter to transduce the cells 
within the STN to provide an inhibitory effect on neuronal transmission. The first study 
of this experimental chapter will target infusions of both AAV2 and AAV5 serotyped, 
CaMKIIa-promoted, hM4Di DREADDs into the medial STN, with the same stereotaxic 
coordinates as employed in Chapter 3 and 4 (Experiment II). Previous experiments have 
determined that the required volume of the injected virus is similar to that of a 
neurotoxin in lesion surgery, for example, Kätzel et al. (2013) transduced the cells 
within layer 5 of the forelimb area of the rat right primary motor cortex with 1.5µl of 
AAV5, whilst Boender et al. (2014) utilised 1µl to transduce the dopaminergic neurons 
that project from the VTA to the nucleus accumbens (Acb). In both experiments, the 
target brain regions occupied a larger spatial area than the medial STN, and therefore 
the current experiment should employ a viral volume less than 1µl. Detection of 
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transduction will be determined by validation of tropism by detecting the tagged 
fluorescent proteins via fluorescence microscopy.  
The second study in this chapter will evaluate the inhibitory effects of 
DREADDs delivered to the medial STN by measuring and comparing the levels of c-
Fos immunoreactivity. The gene c-Fos is expressed within neurons following voltage-
gated calcium entry into the cell, which leads to a rapid and transient induction of c-Fos; 
the transcription of which can be identified by immunohistochemical techniques, and 
used as a marker for neuronal activity (Bullitt, 1990). A Latin square design was used 
for this study, which compared c-Fos transcription in unoperated rats with DREADDs-
infused animals, both with and without CNO treatment. Since spontaneous c-Fos 
expression is relatively low in the STN (Sgambato, Abo, Rogard, Besson, & Deniau, 
1997; Turner, Gray, Mickiewicz, & Napier, 2008), finding a way to endogenously 
augment c-Fos transcription in the STN was necessary. A study by Gompf and 
colleagues (2010) found that rats placed in a novel, environmentally complex setting 
with other rats spent over 300% more time awake, compared to their routine activity at 
that time of day. A subsequent study by Qiu, Chen, Huang, & Lu (2014) found that rats 
exposed to this ‘active-wake’ condition for 2 hours expressed significantly higher 
counts of c-Fos transcription in several areas of the BG, including the STN. We 
therefore hypothesise that following an ‘active-wake’ environment, DREADDs+CNO 
rats will express a reduction in c-Fos transcription owing to inhibition of neural 
transmission, whereas c-Fos levels for unoperated rats and DREADDs+vehicle rats 
should be comparable, as it is hypothesised that CNO treatment should not influence c-
Fos transcription.  
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5.2 Materials and methods  
5.2.1 Animals 
Sixteen male, Lister hooded rats were used in this experimental chapter. Four 
rats (bred in-house; University of St Andrews, from Charles River stock) were used in 
experiment I, to investigate the most efficacious combination of promoter and serotype. 
These rats had a mean weight of 387g (range: 369-414g) at the start of the experiment, 
and a mean weight of 392g (range: 377-415g) upon sacrifice. Twelve rats (Charles 
River, UK) were used in experiment II, with six rats receiving bilateral, DREADDs 
infusions targeting the medial STN, whilst the remaining six rats were unoperated. Rats 
had a mean weight of 346g (range: 325-361g) at the start of the experiment, and a mean 
weight of 394g (range: 363-425g) upon sacrifice. All rats were experimentally naïve 
prior to testing in experiment II, which was completed over two days, three weeks post-
surgery. 
5.2.2 Surgery 
The protocol for pharmacosynthetic surgery was nearly identical to ibotenic acid 
lesion surgery, with some key exceptions. Briefly, rats were anaesthetised with an 
isoflurane (5% at induction, maintained at 1-2%) and oxygen mixture. Similar to 
ibotenic acid surgery, rats were given 0.05ml 5% carprofen (s.c.), but were not given 
any diazepam as there was no administration of an excitotoxin that would require 
sedation post recovery from the anaesthesia. After drilling burr holes in the skull, the 
rats were infused with the viral vectors: for study I, two rats were given AAV5-
CaMKIIa-hM4D(Gi)-mCherry (UNC Vector Core, University of North Carolina, USA), 
whilst another two rats were given AAV2-CaMKIIa-HA-hM4D(Gi)-IRES-mCitrine 
(UNC Vector Core, University of North Carolina, USA). For study II, six rats received 
AAV5-CaMKIIa-hM4D(Gi)-mCherry only. Infusions were made bilaterally (0.5µl per 
site) using a Hamilton syringe (Aldrich Chemical Company, Milwaukee, WI, USA) 
with a 30 gauge round-tipped needle at the stereotaxic coordinates AP:  – 3.8mm, ML: 
±2.3mm, DV: – 7.8mm (Paxinos & Watson, 1986). Infusion of the viral vector were 
completed over three minutes, and the needle was left in situ for a further three minutes. 
Rats were returned to pair-housing the day after surgery and were given three weeks to 
allow for transduction of the viral vector prior to sacrifice.  
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5.2.3 Apparatus 
The ‘active-wake’ condition previously described (Gompf et al., 2011; Qiu et al., 
2014) employs a novel, environmentally-enriched setting with other (previously 
unpaired) rats to engage with, in order to increase social and motor activity. Previous 
experiments employed different apparatuses: either a sleep-recording chamber (Gompf 
et al.) or an open-field environment (Qiu et al); similarly, we designed a large wooden 
enclosure (66 cm x 66 cm x 40 cm) to serve as an open-field, which could comfortably 
contain two small home cages without cage lids for study II (see section 2.1 for cage 
dimensions). The cages were filled with sawdust, and environmental enrichment was 
presented in the form of cardboard houses, wooden chew-bars, and shredded cardboard. 
5.2.4 Habituation  
Three days before behavioural testing, rats were habituated to i.p. injections by 
being administered 2ml/kg saline (0.9% NaCl) each day, for two days. This was done to 
reduce secondary behavioural effects associated with the stress of injection (Meijer, 
Spruijt, van Zutphen, & Baumans, 2006). 
5.2.5 Behavioural testing 
Rats were assigned to groups in order to complete the open-field manipulation, 
and were grouped so that no rat was presented alongside its cage-mate, in order to 
maximise social novelty. Four rats were tested during a given test session: two rats had 
DREADDs infusions to the medial STN, and two were unoperated; of this, one rat per 
surgery condition received CNO (10mg/kg in 5mg/ml of 0.9% saline; Sequoia Research 
Products Ltd., UK), whilst the other received a vehicle injection (0.9% saline). We have 
previously observed that high concentration doses of CNO (10 mg/ml) causes skin 
irritations, manifesting as lesions in some rats (unpublished observations); therefore a 
concentration of 5 mg/ml was used in the present study with no observable adverse 
effects.  
Thirty minutes prior to behavioural testing, rats were given an i.p. injection of 
either CNO (n=6) or vehicle (n=6) and were placed in a small home cage until the 
commencement of behavioural testing. Rats were introduced to the open-field thirty 
minutes following administration of the injection, and were left to explore the 
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environment and engage with other rats for a duration of two hours. After two hours had 
elapsed, rats were removed from the open-field and transcardially perfused.  
5.2.6 Histology  
Tissue was collected as described in section 2.5 of the general methods chapter. 
Briefly, rats were transcardially perfused with PBS and paraformaldehyde and the 
brains were removed and refrigerated overnight at 4°C in 20% sucrose solution. Brains 
were then set in egg yolk in a formaldehyde bath to maintain tissue structure during 
slicing. Sections were sliced into 50µm sections, subdividing tissue collection into eight 
collected sets, such that one section was collected every 400µm per set. Tissue was 
stored in an anti-freeze solution at -20°C, until staining for immunohistochemistry. 
Fluorescent immunoreactivity was detected by examining the extent of either 
mCherry or mCitrine fluorescent proteins, and the case of the latter, by targeting the 
human influenza haemagglutinin (HA) tag that was part of the AAV2-CaMKIIa-HA-
hM4D(Gi)-IRES-mCitrine DREADD. Sections were washed with PBS in 9-hole net 
wells, five times for three minutes each. Sections were then placed on a stirrer for 1 
hour in blocking solution (20% normal goat serum, 0.1% triton in 0.1M PBS) and then 
washed again. Sections were then incubated in the primary antibody, either rabbit anti-
mCherry (1:2000; Abcam, Cambridge, UK) or rabbit anti-HA tag (1:2000; ChIP grade, 
Abcam, Cambridge, UK) in 3ml histology pots, suspended in ADS, and left on a stirrer 
overnight. The following day sections were washed five times for five minutes each in 
9-hole net wells. Sections were then returned to foil-wrapped histology pots and 
incubated in the secondary antibody, either preadsorbed goat anti-rabbit IgG H&L 
(1:500; Alexa Fluor 594, Abcam, Cambridge, UK) or goat anti-rabbit IgG H&L 1:500; 
Alexa Fluor 488, Abcam, Cambridge, UK) in ADS for one hour. Sections were washed 
five times for five minutes each in 9-hole net wells, and then mounted to glass slides. 
Vectashield antifade mounting medium with DAPI counterstain (DAPI: 4',6-diamidino-
2-phenylindole; Vector Laboratories Ltd., Peterborough, UK) was pipetted on to the 
slides, which were then coverslipped and the edged sealed with nail polish. DAPI binds 
to A-T rich sequences of DNA and emits a blue fluorescent stain, aiding in visualisation 
of nuclear cell bodies (Kapuscinski, 1995). Fluorescence microscopy was completed 
with a confocal microscope (Zeiss, Cambridge, UK) using Novell ZENworks software 
(Micro Focus, Newbury, UK). 
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For c-Fos/DAB immunoreactivity, sections were first washed with PBS in 9-
hole net wells, five times for three minutes each. Sections were then placed on a stirrer 
for 1 hour in blocking solution (20% normal goat serum, 0.1% triton in 0.1M PBS) and 
then washed again. Sections were then placed in histology pots and incubated with 5ml 
of the primary antibody, biotinylated rabbit anti-c-Fos (1:10000;Calbiochem, San Diego, 
USA) suspended in antibody diluting solution (ADS: 0.1M PBS, 1% normal goat serum, 
0.1% triton) and left on a stirrer overnight. The following day, sections were returned to 
9-hole net wells and washed and incubated in vector IgG solution (anti-rabbit IgG; 
5µl/ml; Vector Laboratories Ltd., Peterborough, UK) on a stirrer for one hour. Sections 
were then washed again, and incubated in reagents A & B (10µl/ml each) of Vectastain 
ABC complex (Vector Laboratories Ltd., Peterborough, UK) for another hour. Sections 
were washed again and treated with DAB (Sigma Chemical Company, St Louis, MO, 
USA) for approximately 10-15 minutes, until tissue was stained with a dark-brown 
colour, with minimal background staining. Sections were then washed again and 
mounted on gelatine-subbed glass slides. Sections were then de-fatted with xylene 
before being coverslipped with DPX mountant as described in section 2.5 of the 
General Methods chapter; however sections were not stained with cresyl violet. c-Fos 
transcription was determined with light microscopy at 2.5x and 10x magnifications. 
5.2.7 Data analysis 
For study II, c-Fos positive cells in four discrete sections of the STN were 
counted by hand following microscopy, with a transparent grid superimposed over the 
image to reduce the possibility of ‘repeat-counting’. The design followed a 2x2x2x4 
mixed factorial design, and c-Fos labelled cells were analysed by repeated-measures 
ANOVA. There were two within-subjects factors: side (two levels: left hemisphere and 
right hemisphere), and brain section (four levels), and two between-subjects factors: 
CNO (two levels: CNO or vehicle), and surgery (two levels: DREADDs transduction or 
unoperated).  
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5.3 Results  
5.3.1 Study I 
Neither of the two AAV2-mCitrine rats expressed GFP when targeting the HA 
tag. These sections illustrated minimal background staining with sparse evidence of 
GFP cells in the STN or ZI. Conversely, mCherry was detected in all rats administered 
AAV5-mCherry. The AAV5 profile included robust transduction of the medial STN 
area, whilst sparing the lateral STN; furthermore, viral tropism extended medially into 
the LH and dorsally into the ZIV (figure 5.1). Given this evidence, AAV5-CaMKIIa-
hM4D(Gi)-mCherry was selected as the best-suited DREADD for transducing the cells 
within the STN. 
 
Figure 5.2: Schematic illustrating the largest (light grey) and smallest (dark grey) area 
of viral transduction, presented with photomicrographs depicting the mCherry (red) 
fluorescent protein, with DAPI counterstain of DNA nuclei (blue). White hashed lines 
indicate the outline of the STN cell population.  
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5.3.2 Study II 
5.3.2.1 Viral tropism 
Fluorescence microscopy revealed that all six rats which received bilateral 
DREADDs to the medial STN expressed mCherry in this area. Results indicated a 
robust transduction of the medial STN, whilst sparing the lateral STN; furthermore, 
viral tropism extended medially into the LH and dorsally into the ZIV (figure 5.3). 
However, given that transduction of these adjacent regions was minimal, and mostly 
near the dorsolateral border of the STN, counting of c-Fos was only conducted in the 
STN. 
 
Figure 5.3: Schematic illustrating the largest (light grey) and smallest (dark grey) area 
of viral transduction, presented with photomicrographs depicting the mCherry (red) 
fluorescent protein, with DAPI counterstain of DNA nuclei (blue). White hashed lines 
indicate the outline of the STN cell population 
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5.3.2.2 c-Fos 
The rodent STN in particular has a very dense population of neurons, compared 
to the human or monkey brain (Hardman et al., 2002), and given the compact size of 
this region, taking a total count of c-Fos might incur the possibility of duplicate 
counting from adjacent tissue without applying a corrective algorithm (see Hedreen, 
1998). To account for this potential issue (commonly referred to as ‘lost caps’), I report 
a total count of c-Fos from four sections (200µm apart) through the STN roughly 
between Bregma -3.6 mm and -4.3 mm.  
A repeated-measures ANOVA revealed that the most caudal STN section 
presented with reduced c-Fos labelling compared to the remaining three sections, which 
was expected as the spatial area of the STN varies by section (main effect of Section: 
F(2.94,23.51) = 3.47, p<0.05; Huynh-Feldt Correction; Bonferroni-corrected pairwise 
comparison; uncorrected df= 3,24; nρ2= 0.30). However, this decrease in c-Fos 
labelling in the most caudal section was consistent for both surgery groups and was 
observed irrespective of CNO treatment (Section by Surgery group interaction: F(2.93, 
23.51) = <1, n.s.; uncorrected df= 3,24; nρ
2
= 0.03; Section by CNO interaction: F(2.93, 
23.51) = 1.01, n.s.; uncorrected df= 3,24; nρ
2
= 0.11). This analysis also determined that 
c-Fos labelling was comparable in both hemispheres of the brain, and that receiving 
either DREADDs and/or CNO did not influence this (main effect of Side: F(1,8) = 1.67, 
n.s.; nρ2= 0.17; Side by Surgery group interaction: F(1,8) = 2.61, n.s.; nρ
2
= 0.25; Side by 
CNO interaction: F(1,8) = 4.67, p=0.063; nρ
2
= 0.37).  
Although DREADDs-infused rats exhibited less c-Fos labelling overall, and that 
CNO treatment led to reduced c-Fos labelling as well, a Bonferroni-corrected pairwise 
comparison revealed that only DREADDs-infused animals that had also received CNO 
expressed a marked reduction in c-Fos labelling (main effect of Surgery group: F(1,8) = 
8.06, p<0.05; nρ2= 0.50; main effect of CNO: F(1,8) = 13.07, p<0.01; nρ
2
= 0.62; 
Surgery group by CNO interaction: F(1,8) = 6.42, p<0.05; nρ
2
= 0.45; figure 5.4: A & B). 
This result suggested that DREADDs were capable of inhibiting neuronal transmission 
in the STN, and that in the absence of CNO, they do not exert a significant effect on 
signal transduction in this area.  
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Figure 5.4a: Mean counts (+SEM) of c-Fos labelling in the STN; counts were taken 
from four sections of tissue between Bregma -3.6mm to -4.3mm; application of CNO 
significantly reduced c-Fos expression but only for DREADDs-infused animals.   
 
     
 
 
 
 
 
 
 
  
 
 
Figure 3.4b: Photomicrographs and schematics of the STN for DREADDs-infused animals; Staining for c-Fos illustrated a visible 
reduction in transcription following CNO application, compared to vehicle treatment. 
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5.4 Discussion 
The present experiment explored the efficacy of a relatively novel, investigative 
tool – DREADDs – in providing transient control of signal transduction in the STN. The 
first study reported that application of an AAV5 serotype, CaMKIIa-promoted, 
inhibitory-type DREADD resulted in an mCherry expression profile originating from 
the medial area of the STN. The results of the mCherry immunofluorescence illustrated 
that transduction of the cells within the STN with AAV5-CaMKIIa-hM4D(Gi) 
DREADDs was successful. This was replicated in study II, which further demonstrated 
that the application of CNO to DREADDs-infused animals provided neuronal silencing, 
as indicated by significantly decreased c-Fos transcription. This study also validated 
that in the absence of CNO, the functioning of STN in these DREADDs-infused 
animals does not differ from unoperated animals. Furthermore, it is reported that CNO 
by itself, lends no observable impact on signal transduction in the STN.  
Although the surgical procedure – and therefore the volume of the virus – was 
identical, AAV2 subtype rats did not express notable GFP expression. Despite work by 
Jara et al. (2012) illustrating that AAV2 undergoes retrograde transduction (for 
corticospinal motor neurons), a titre-matched comparison of serotypes by Burger et al 
(2004) claim that AAV2 undergoes minimal retrograde transport, and in fact, found that 
AAV1 and AAV5 do so, more robustly. Therefore, in the current experiment, the 
inability to visualise GFP for AAV2 may have stemmed from conservative tropism for 
this serotype, or a less potent viral batch titre; unfortunately, with only two rats per 
surgery group in study I, it is difficult to ascertain precisely why we failed to visualise 
an AAV2 transduction profile.  
5.4.1 Conclusions 
The current experimental chapter presented that AAV infusions of DREADDs to 
the medial STN results in a transduction profile similar to ibotenic acid lesions, and that 
systemic application of CNO results in significant decreases in neuronal functioning, 
consistent with an inhibitory effect. This work reported here also presents as a surgical 
protocol for subsequent work in this thesis, which will allow for a more precise 
experimental manipulation of the STN, to further investigate its involvement in 
attentional set-formation.  
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Chapter 6 
 
Pharmacosynthetic inhibition of the STN and 
ZI/LHA-area impairs the formation of attentional 
set 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background: 
Inhibition of the cellular activity within the STN with designer 
receptors will allow us to measure the role of this region in set-
formation with the 11-stage task.  
Methods: 
18 rats were given bilateral DREADDs infusions to the STN; 
during testing, half of the group received clozapine n-oxide, whilst 
half received a vehicle.   
Results: 
CNO-treated rats did not present with evidence for an attentional 
set; there was neither a set-shifting cost, nor an improvement across 
multiple ID stages. The probe stage indicated that these rats were 
still attending to the irrelevant dimension, and the bi-conditional 
stage suggested this was due to configural learning, which may 
have ultimately attenuated the reversal costs.   
Conclusions: 
The STN is important in attentional selectivity, and that inhibiting 
this region impairs the ability to parse relevant from irrelevant. 
Results from the reversal stages suggest more work is needed to 
explore the relationship between reversal learning and attentional 
shifting as mediated by the STN.  
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6.1 Introduction  
Chapter 5 illustrated that infusion of AAV5, CaMKIIa-promoted DREADDs to the 
medial STN led to the expression of Gi-coupled designer receptors in subthalamic neurons. 
Viral expression was found primarily in the medial STN, whilst sparing the lateral STN, 
along with viral expression in the ventral portion of the ZIV and the most lateral portion of 
the LHA. In a follow-up experiment, systemic administration of CNO resulted in decreased 
neuronal activity in the STN, as evidenced by reduced c-Fos labelling compared to vehicle-
treated rats. Together, these results suggest that AAV5-CaMKIIa-hM4D(Gi) DREADDs 
present as a refinement to ibotenic acid lesions of the STN to modulate neuronal activity. 
The current experiment builds on the results from Chapter 5 to investigate the involvement 
of the STN in the formation of attentional set, using the 11-stage task (see Chapter 3) to 
compare various hypotheses about the processes that might be compromised when the STN 
is inhibited. 
Briefly, the 11-stage task introduced five ID stages to promote set-formation, of 
which, data from the last ID stage can be compared with the ED stage to ascertain the cost 
of shifting attentional set to an unattended stimulus dimension. The task also presented two 
reversal stages – one with one interim stage between compound learning and reversal, and 
one with three interim stages – with the hypothesis that if memory for reward-relevant 
exemplars were disrupted by new stimuli, then reversals (particularly when there is 
significant interference by the presentation of multiple sets of novel stimuli) would be 
treated as if they were new learning. Finally, the task also introduced ‘probe’ stage which 
measured the suppression of attention to the irrelevant dimension, thereby providing 
additional inference of attentional set. In the probe stage, the rewarded status of the relevant 
(and, presumably, differentially attended) exemplars from the preceding ID stage remained 
the same, whilst the stimuli from the irrelevant dimension (which ought to be unattended) 
were replaced with novel stimuli.  
As an adjunct to the 11-stage task, in a bi-conditional discrimination stage, the 
combination of exemplars from both dimensions indicated the baited bowl (see description 
in Chapter 3, Section 3.2.5.2). The bi-conditional discrimination, where the baited bowl is 
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signalled by both stimulus dimensions, should be more readily solved by animals who are 
learning the stimulus configurations – which may be the result of being unable to form set 
or may be the cause of it – compared to those who have had experience in attending to only 
one of the stimulus dimensions at a time.  
 The 11-stage task is typically completed by rats in fewer than 4 hours, which is 
comfortably within the time frame of the transient CNO inactivation (10-12 hours; see 
Chapter 5).  
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6.2 Materials and methods  
6.2.1 Animals 
Eighteen male, Lister hooded rats (Charles River, UK) were used in this experiment, 
with all rats receiving infusions targeted on the medial STN. Rats had a mean weight of 
398g (range: 363-428g) at the start of the experiment. At completion of the experiment rats 
had a mean weight of 525g (range: 484-575g). All rats were experimentally naïve prior to 
testing and husbandry conditions and housing details are described in the General Methods 
chapter (Section 2.1). Behavioural testing was completed 3-12 weeks post-surgery. A 7-
stage task was completed over 4 weeks, starting at 3 weeks post-surgery, the 11-stage task 
was completed over 3 weeks, with rats tested at least 10 days after completion of the 7-
stage task.  
6.2.2 Apparatus 
Behavioural testing was completed in the attentional set-shifting apparatus, which is 
described in section 2.2 of the general methods chapter.  
6.2.3 Surgery  
The protocol for pharmacosynthetic surgery is described in Chapter 5 (Section 
5.2.2). 
6.2.4 Behavioural training  
The procedure for behavioural training employed in the current experiment is 
described in section 2.4.1 of the General Methods chapter.  
6.2.5 Behavioural testing 
6.2.5.1 The 7-stage task  
Rats were first tested on the 7-stage task without CNO to familiarise them with the 
behavioural requirements of the ID/ED task, so that on subsequent, CNO-administered tests, 
behavioural data could be collected within the peak availability period for CNO (see: Ray 
et al., 2011). As stated in section 3.2.6, repeat testing on the attentional set-shifting task 
results in a similar performance profile (i.e., costs associated with reversal learning and set-
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shifting), but the overall time to complete the test reduces, which is advantageous here 
given the length of the 11-stage task and the transient effect of the CNO.  
A detailed explanation of the stages and list of stimuli for the 7-stage task can be 
found in Section 2.4.2 of the General Methods chapter, and an example summary of the 
procedure found in Chapter 3 (table 3.1; Section 3.2.5.1). Counterbalancing controlled for 
the order of presentation of stimulus pairings, shift type (e.g., medium to odour or vice 
versa), and the initial correct stimulus within a pairing. 
6.2.5.2 The 11-stage task 
Three days before behavioural testing, rats were habituated to i.p. injections by 
being administered 2ml/kg saline (0.9% NaCl) each day, for two days. This was done to 
reduce secondary behavioural effects associated with the stress of injection (Meijer, Spruijt, 
van Zutphen, & Baumans, 2006). Thirty minutes prior to behavioural testing, rats were 
given an i.p. injection of either CNO (n=9; 10mg/kg in 5mg/ml of 0.9% saline; Sequoia 
Research Products Ltd., UK) or a vehicle (n=9; 0.9% saline). Following injection, rats were 
placed in a small home cage (see section 2.1 for cage dimensions) until the commencement 
of behavioural testing. Testing began thirty minutes following injection. The list of stimuli 
and procedure of the 11-stage task can be found in Chapter 3 (section 3.2.5.2).   
6.2.6 Histology 
Tissue was collected as described in Section 2.5 of the General Methods chapter. 
Two immunohistochemistry procedures were completed, on two sets of tissue; the first 
determined the extent of viral tropism in the STN with mCherry/DAB and the second 
procedure determined the extent of nuclear transduction with colocalised 
immunofluorescence of neuronal nuclei and mCherry.   
For mCherry/DAB immunoreactivity, sections were first washed with PBS in 9-
hole net wells, five times for three minutes each. Sections were then placed on a stirrer for 
1 hour in blocking solution (20% normal goat serum, 0.1% triton in 0.1M PBS) and then 
washed again. Sections were then placed in histology pots and incubated with 5ml of the 
primary antibody, biotinylated rabbit anti-mCherry (1:2000; Abcam, Cambridge, UK) 
suspended in antibody diluting solution (ADS: 0.1M PBS, 1% normal goat serum, 0.1% 
 166 
 
triton) and left on a stirrer overnight. The following day, sections were returned to 9-hole 
net wells and washed and incubated in vector IgG solution (anti-rabbit IgG; 5µl/ml; Vector 
Laboratories Ltd., Peterborough, UK) on a stirrer for one hour. Sections were then washed 
again, and incubated in reagents A & B (10µl/ml each) of Vectastain ABC complex (Vector 
Laboratories Ltd., Peterborough, UK) for another hour. Sections were washed again and 
treated with DAB (Sigma Chemical Company, St Louis, MO, USA) for approximately 10-
15 minutes, until tissue was stained with a dark-brown colour, with minimal background 
staining. Sections were then washed again and mounted on gelatine-subbed glass slides. 
Sections were then de-fatted with xylene before being coverslipped with DPX mountant as 
described in section 2.6 of the General Methods chapter; however sections were not stained 
with cresyl violet. mCherry expression was determined with light microscopy at 2.5x and 
10x magnifications, examining the extent of transduction, including axonal projections.  
For colocalised immunofluorescence, sections were washed with PBS in 9-hole net 
wells, five times for three minutes each. Sections were then placed on a stirrer for 1 hour in 
blocking solution (20% normal goat serum, 0.1% triton in 0.1M PBS) and then washed 
again. Sections were then placed in histology pots and incubated in a 3ml mixture of the 
primary antibodies: biotinylated rabbit anti-mCherry (1:1000; Abcam, Cambridge, UK) and 
mouse anti-NeuN (1:1000; Chemicon International, Temecula, CA, USA) suspended in 
ADS and left on a stirrer overnight. The following day sections were washed five times for 
five minutes each in 9-hole net wells. Sections were then returned to foil-wrapped histology 
pots and incubated in a 3ml mixture of the secondary antibodies: preadsorbed goat anti-
rabbit IgG H&L (1:250; Alexa Fluor 594, Abcam, Cambridge, UK) and preadsorbed goat 
anti-mouse IgG H&L (1:250; Alexa Fluor 488, Abcam, Cambridge, UK) in ADS for one 
hour. Sections were washed five times for five minutes each in 9-hole net wells, and then 
mounted to glass slides. Vectashield antifade mounting medium (Vector Laboratories Ltd., 
Peterborough, UK) was pipetted on to the slides, which were then coverslipped and the 
edges were sealed with nail polish. Fluorescence microscopy was completed with a 
microscope (Zeiss, Cambridge, UK) using Novell ZENworks software (Micro Focus, 
Newbury, UK).  
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6.2.7 Data analysis  
The procedure for data analysis for the bi-conditional discrimination and 7-stage/11-
stage tasks are described in Chapter 3 (Section 3.2.7). To quantify the level of colocalised 
transduction, photomicrographs were analysed by an irregular shape calculator tool (Dobbs, 
2011) and the area of colocalised region (for every section and hemisphere) was calculated 
and divided by the total area of the respective region of interest (e.g., STN, ZIV, ZID & 
LHA) to determine a ‘percent transduced’ by area. Data were analysed by repeated-
measures ANOVA with a within-subjects factor of Brain Region (four levels: STN, ZIV, 
ZID, & LHA), a within-subjects factor of Side (two levels: left or right), a within-subjects 
factor of Section (three levels: -3.6mm, -3.8mm, -4.16mm), and a between-subjects factor 
of CNO (two levels: CNO and vehicle). In order to correlate behavioural performance with 
levels of transduction, total observed transduction was computed by summing the 
transduction percentages across each hemisphere, section and brain region for each animal, 
which could then be compared with manipulations of interest (e.g., shift-cost, probe, etc.). 
This correlational analysis was also done for each region to determine in any region-
specific effects of transduction influenced behaviour.    
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6.3 Results  
6.3.1 Histology  
Preliminary examination of viral tropism with mCherry/DAB staining determined 
that two rats – one from the CNO and one from the vehicle treatment group – expressed 
unilateral mCherry expression. The data for these two rats were included in all analyses in 
this chapter, as excluding the unilateral CNO-treated rat did not influence the statistical 
outcome; this will be evaluated separately in the subsequent sections. All other rats 
expressed bilateral mCherry expression in the STN, including the medial region. This 
mCherry/DAB staining approach revealed the total spread of the virus, including non-
cellular transduction (i.e., in axons and dendrites); it was found that the virus was trafficked 
into the ZIV in all animals (n=18), but only a subset of rats exhibited mCherry in the ZID 
(n=8) and LHA (n=12; figure 6.1).   
Colocalised immunofluorescence (NeuN/mCherry) was used to determine the extent 
of nuclear transduction of the brain regions identified by the mCherry/DAB staining (figure 
6.2). Colocalisation was illustrated by yellow labelling (Green-NeuN + Red-mCherry) in 
respective brain regions. In order to quantify this labelling, the area of this yellow region 
(for every section and hemisphere) was calculated by an irregular shape calculator (Dobbs, 
2011) and divided by the total area of the respective region of interest to determine a 
‘percent transduced’. This was done in lieu of cell counting as the strength of the 
fluorescence signal made it difficult to distinguish the cell perimeter in regions with high 
cell density (e.g., STN); this was likely owing to the thickness of the tissue in this 
experiment (50µm); a consideration which will be evaluated in the discussion. Therefore 
this ‘percent’ measure was an approximation of colocalised spatial area within a region. 
Despite clear labelling of non-cellular transduction (i.e., fibres of passage) in the 
colocalised photomicrographs (labelled in red), owing to the thickness of the sections (and 
therefore the volume of the ‘z-axis’), there is still a possibility that not all of the cells within 
a particular transduced region were colocalised, as their detection was obfuscated by a 
superimposed cell. However, since colocalised labelling (yellow) is only visibly present 
when the cell body (NeuN-green) is labelled, it is argued that the current approach is a 
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reasonable alternative to cell-counting to provide a comparative measure of colocalised 
viral transduction.    
The analysis of the colocalised transduction suggested that transduction occurred 
uniformly within the STN, originating from the medial region in all animals (n=18; albeit 
unilaterally for 2 rats) and transducing an average of approximately 40% of the nucleus; in 
contrast, extraneous transduction to the ZI (n=10) and LHA (n=10; a different subgroup 
than the ZI-rats) varied by rat in terms of transduction percentage and frequency of 
occurrence (Table 6.1). Viral transduction centred on the medial area of the STN, and 
extended laterally to the lateral STN (range of STN transduction: 25-65% of nucleus) in all 
animals, whilst for some rats transduction extended medially to the LHA (range: 5-33%), 
and/or dorsally to the ZIV (range: 5-40%) and ZID (n=7; range: 5-36%; figure 6.3). The 
percentage of colocalised transduction for a given brain region did not significantly differ 
between sides of the brain (main effect of Side: F(1,16)= <1, n.s.; nρ
2
= 0.02), nor did 
transduction vary rostro-caudally, between sections (main effect of Section: F(1.49,23.8)= 1.23, 
n.s.; Huynh-Feldt correction; uncorrected df = 2, 32; nρ2= 0.02); furthermore, transduction 
patterns were consistent between CNO treatment groups (main effect of CNO group: F(1,16)= 
<1, n.s.; nρ2= 0.03).  
As expected, analysis revealed that percentage of transduction differed between 
brain regions (main effect of Region: F(2.66,42.48)= 73.8, p<0.01; Huynh-Feldt correction; 
uncorrected df = 3, 48; nρ2= 0.82), with the STN significantly achieving the greatest 
percentage of colocalised transduction (M: 40.2% of region transduced); an effect which 
held for each section of tissue (Region by Section interaction: F(2.2,35.2)= 4.12, p<0.05; 
Huynh-Feldt correction; uncorrected df = 6, 96; nρ2= 0.21; Bonferroni-corrected pairwise 
comparison). In contrast, extraneous transduction to the neighbouring ZIV (13.3% of 
nucleus transduced), ZID (8.5%), and LHA (10.7%) was not uniform and varied by rat: 8 of 
the 18 rats  presented with no nuclear transduction of the ZI, whilst a different subset of 8 
rats did not present with any nuclear transduction of the LHA, whereas transduction in the 
STN was present in all rats (with 4 rats presenting with colocalised transduction exclusive 
to the STN: 1 CNO-treated; 3 vehicle-treated). The amount of transduction of the ZI and 
LHA also varied considerably between rats, with some rats presenting with high 
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percentages of bilateral transduction (e.g., 60% of nucleus), others had minimal unilateral 
transduction (e.g., 10-15% of nucleus), whilst some had no extraneous transduction at all. 
Subsequent behavioural analyses will evaluate any behavioural effects in light of these 
differences in transduction, and the details of such analyses will be described in their 
respective sections.  
Anatomical/tracing studies have suggested that the medial third (33%) of the STN 
functionally subdivides the nucleus, with this area being responsible for limbic and 
associative (cognitive) tasks owing to a direct connection with cortical areas implicated in 
cognition (i.e., mPFC & lateral OFC; Groenwegen & Berendse, 1990; Heimer et al., 1995; 
Janssen, Visser-Vandewalle, & Temel, 2010; but see Kita et al., 2014); consequently, this 
area was the surgical target throughout this thesis. Based on the percentage of STN 
transduction in this experiment (40%), it is parsimonious to conclude that this area was 
transduced (to a varying degree) in all animals (apart from the one hemisphere for the two 
unilaterally-transduced animals).   
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Figure 6.1: Schematic illustrating the largest (light grey) and smallest (dark grey) area of 
mCherry viral transduction, presented with photomicrographs of brain sections stained 
with DAB, which included staining for both neuronal and non-neuronal nuclei; hashed 
lines indicate the outline of the STN cell population. 
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Figure 6.2: Schematics and example photomicrographs of colocalised sections, stained for 
NeuN (green) and mCherry (red) with nuclear-viral colocalisation illustrated in yellow. 
Schematics illustrate the minimum (dark grey) and maximum (light grey) extent of the viral 
transduction, with photomicrographs of a ‘typical’ brain from 2.5x and 10x magnification. 
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Table 6.1: Summary of colocalised transduction results separated by brain region, 
illustrating the distribution of rats (CNO/vehicle) by extent of transduction (bilateral vs 
unilateral vs none); colocalised transduction was uniform in the STN and prevalent in 
every animal, yet the pattern for extraneous transduction to the ZI and LHA varied by rat. 
Rats with mean transduction percentages exceeding 33% were deemed to have 
transduction extending into the lateral STN.   
 
 
 
 
 
 
Bilateral Unilateral None
medial STN 
(n=18)
8/8 1/1 0/0
lateral STN 
(n=17)
8/7 1/1 0/1
ZIV              
(n=10)
5/2 2/1 2/6
ZID            
(n=7)
4/2 1/0 4/7
LHA             
(n=10)
4/4 1/1 4/4
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Figure 6.3: A schematic of the STN, ZIV, ZID, & LHA, with coloured shading denoting 
extent (to one or more extraneous regions) and proportion (by region) of colocalised 
transduction for all rats; colocalised transduction was found in the STN in all rats (n=18; 
CNO n=9), whilst transduction varied in the ZI and LHA: 10 rats had transduction in the 
ZIV (CNO n=7), which extended dorsally to the ZID in 7 animals (CNO n=5), and of these 
animals, 6 (CNO n=4) also had transduction of the LHA.   
 
 
STN 
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6.3.2 Baseline assessment using the standard 7-stage task 
The 7-stage task tests novel and reversal leaning and therefore performance did, as 
expected, differ as a function of stage (main effect of stage, F(6,102)= 21.4, <0.01; nρ
2
= 
0.58). The ‘cost’ of shifting set can be expressed as the difference in TTC between the ID 
and ED stages: a Bonferroni-adjusted pairwise comparison determined that rats required 
significantly more trials to acquire the ED stage (M: 13.8; SD: 2.44) compared to the ID 
stage (M: 7.8; SD: 1.82; p<0.01; figure 6.4). This matched the established pattern of 
behaviour for typical control rats in the attentional set-shifting task (Birrell & Brown, 2000; 
Tait et al., 2016), along with the demonstrating that in the absence of CNO administration, 
DREADDs-transduced rats formed an attentional set, as inferred by the significant cost of 
shifting away from that set. 
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Figure 6.4: Mean trials to criterion (+SEM) demonstrated that rats (n=18) exhibited a 
significant cost of shifting set from an attended stimulus dimension (ID), to an unattended 
stimulus dimension (ED); **p<0.01.  
6.3.3 CNO-treatment impairs set-formation on the 11-stage task 
The 11-stage task also includes new learning and reversals and, as expected 
performance differed as a function of stage (repeated measures ANOVA, main effect of 
stage: F(8.8,140.1)= 21.9, p<0.01; Huynh-Feldt correction; uncorrected df= 10,160; nρ
2
= 
0.58). More interesting, however, are the stage-specific effects of CNO. It was not expected 
that CNO would impair simple acquisition (SD), but, as expected, some stages were solved 
in fewer trials and other stages were required additional trials, compared to control 
performance (interaction of CNO and Stage: F(8.8,140.1)= 18.4, p<0.01; Huynh-Feldt 
correction; uncorrected df= 10,160; nρ2= 0.54). Figure 6.5 shows the origin of this 
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interaction, which was explored in more depth using planned and Bonferroni-corrected 
pairwise comparisons. As detailed in the histology section, one CNO-treated rat presented 
with unilateral transduction, but was included in the analysis above since excluding this 
animal had no effect on the statistical outcome here (interaction of CNO and Stage: 
F(7.9,117.9)= 17.6, p<0.01; Huynh-Feldt correction; uncorrected df= 10,150; nρ
2
= 0.52).  
 
 
Figure 6.5: Mean trials to criterion (+SEM) illustrating that CNO-treated rats required 
significantly more trials on all ID learning stages and the probe stage, however required 
fewer trials on the ID1R and ED stages, along with the adjunct bi-conditional stage. 
6.3.3.1 Examining shift-cost: ID5 vs ED 
To examine the cost of set-shifting, a restricted analysis of the ID5 and ED stages 
was conducted using a repeated-measures ANOVA, correcting the F-values using the error 
terms from the omnibus analysis (Winer, 1971). CNO-treated rats did not exhibit a cost of 
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shifting set between these stages, whilst vehicle-treated rats illustrated the expected ID-ED 
difference (Stage by CNO interaction: F(1,140.1)= 39.7, p<0.01; uncorrected df= 1,160; nρ
2
= 
0.90; figure 6.6). Vehicle-treated rats acquired the ID5 stage with significantly fewer TTC 
than CNO-treated rats, illustrating the benefit of selective attention to the reward-relevant 
dimension, whilst conversely, CNO-treated rats completed the ED shift acquisition in fewer 
trials than vehicle-treated rats (Bonferroni-adjusted pairwise comparison; all ps <0.01). 
Due to the decreased TTC at the ED stage, and increased TTC at the ID stage, performance 
between ID and ED stages did not differ for the CNO-treated rats, suggesting a failure to 
form an attentional set. Similar to the omnibus analysis, excluding the data for the one 
unilaterally-transduced CNO-treated rat had no effect on the statistical outcome (Stage by 
CNO interaction: F(1,117.9)= 33.7, p<0.01; uncorrected df= 1,150; nρ
2
= 0.89). Furthermore, 
inspection of the ID5-ED comparison suggested that this unilaterally-transduced animal did 
not form a set, as it required two more TTC for ID5 than ED.   
Results from the colocalised transduction analysis revealed that only one CNO-
treated rat exhibited viral transduction solely limited to the STN, and therefore any analysis 
which attempted to draw a conclusion from data with a group size to 1 would be unreliable. 
Consequently, CNO-treated rats with ‘minimal’ extraneous transduction [i.e., rats with only 
STN transduction, plus only unilateral transduction of only one extraneous brain region 
(either the ZIV, ZID or LHA): range of transduction for extraneous region = 0-35%] were 
separated (n=4) from CNO-treated rats with ‘moderate’ transduction (i.e., rats with only 
STN transduction, plus bilateral transduction of one or more extraneous brain regions; n=5; 
range or transduction for extraneous region = 0-60%). With this new group assignment, a 
repeated-measures ANOVA was conducted to determine transduction-specific effects, such 
as a reduced impairment in shift-cost for minimally-transduced rats compared to 
moderately-transduced rats; the data for vehicle-treated rats was not reclassified as in the 
absence of CNO, the DREADDs are not activated and therefore their specific location 
could be of no relevance. It was found that all of the CNO-treated rats, irrespective of any 
additional transduction to extraneous areas, did not exhibit a cost of shifting set between the 
ID5 and ED stages (Stage by Revised CNO interaction: F(2,128.39)= 10.53, p<0.01; Huynh-
Feldt correction; uncorrected df= 2,150; nρ2= 0.95); furthermore acquisition of the ID and 
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ED stages did not differ between the ‘minimal’ and ‘moderately’ transduced CNO-treated 
rats, suggesting that set-shifting performance and novel learning acquisition, did not differ 
between animals with a high amount of extraneous transduction to the ZI and LHA, and 
animals with minimal extraneous.  
An alternative analysis correlated the total amount of observed transduction with 
shift cost to determine whether rising levels of transduction may correlate with a smaller 
shift cost (or a ‘negative’ shift cost), or perhaps the inverse, whether less transduction 
correlates with a reduced impairment in shift-cost. Total observed transduction was 
computed by summing the transduction percentages across each hemisphere (i.e., L + R), 
section (i.e., -3.6 + -3.8…) and brain region (i.e., STN + ZIV…) for each animal, and 
subsequently these total values per animal were correlated against the shift-cost data for 
each rat. Results of a Pearson correlation indicated no relationship between the total amount 
of transduction and the magnitude of shift-cost (r = 0.07; n=9; n.s.). Furthermore, there was 
no relationship between the amount of transduction for each region and the magnitude of 
shift-cost: differences in transduction within the ZIV (r = 0.05; n=9; n.s.), ZID (r = 0.01; 
n=9; n.s.), and LHA (r = −0.38; n=9; n.s.) did not significantly correlate with ID5-ED 
behaviour following CNO treatment. It appears therefore that transduction of extraneous 
areas near the STN, such as the ZIV, ZID and LHA may play a minimal role in the 
mediation of the behavioural deficit observed here, which may be largely due to 
transduction of the STN.    
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Figure 6.6: Mean trials to criterion (+SEM) for vehicle and CNO-treated rats for the ID5 
and ED stages; evidence of set-formation was observed for vehicle-treated rats only, 
demonstrated by a significant positive cost of shifting attentional set; **p<0.01. 
6.3.3.2 Performance across multiple ID stages 
To test the hypothesis that CNO-treated rats would not benefit, by forming an 
attentional set, from repeated experience of novel discriminations, the 11-stage task 
includes five novel ID discriminations. Restricting the analysis to these five ID stages, it 
was clear that the CNO-treated rats showed no benefit and required more TTC than vehicle-
treated across all of the ID stages, while the vehicle-treated rats showed a gradual decrease 
in TTC across the five ID stages (CNO by Stage interaction: F(4,140.1)= 2.65, p<0.05; 
uncorrected df= 4,160; nρ2= 0.14) Further analysis using Bonferroni-corrected pairwise 
comparisons determined that vehicle-treated rats showed a significant improvement 
between ID1 (M: 13.1) and ID5 (M: 8.7, p<0.01), whilst performance for CNO-treated rats 
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did not differ across the five ID stages (p>0.05; figure 6.7). Also, removing the data for the 
unilaterally-transduced CNO-treated animal had no effect on the statistical outcome (CNO 
by Stage interaction: F(3.7,117.9)= 2.69, p<0.05; uncorrected df= 4,150; nρ
2
= 0.14); CNO-
treated rats exhibited no improvement, and furthermore, the data the for unilateral rat was 
no different than the remaining bilaterally-transduced group: performance for this rat at ID1 
(15 TTC), ID2 (19 TTC), and ID3 (21 TTC) worsened considerably before improving 
slightly by ID5 (13 TTC).   
Similar to the analysis of colocalised transduction presented for the shift-cost above, 
the same sub-groups of CNO-treated rats (e.g., ‘minimal’ vs ‘moderate’) were employed 
for the current analysis to determine transduction-specific effects, and whether increased 
extraneous transduction in the ZI and LHA will worsen performance across the multiple ID 
stages. Despite subdividing rats, performance between the two groups of CNO-treated rats 
did not differ (n.s.); both ‘minimally-’ and ‘moderately-transduced’ groups of CNO-treated 
rats still required more TTC than vehicle-treated across all of the ID stages, along with 
evidencing no significant improvement between any stages, including the ID5 and ID1 
stages (Revised CNO by Stage interaction: F(8,128.39)= 2.26, p<0.05; uncorrected df= 8,150; 
nρ2= 0.24; Bonferroni-corrected pairwise comparison). Results of a Pearson correlation 
between total transduction percentage and the mean trial difference between ID5 and ID1 
(ID5−ID1) revealed no relationship (r = 0.43; n=9; n.s.), suggesting that increasing the 
level of transduction does not influence performance between these two stages, or less 
transduction does not correlate with less impairment. Also, there was no relationship 
between the amount of transduction for each region and the impairment across the multiple 
ID stages: differences in transduction within the ZIV (r = 0.38; n=9; n.s.), ZID (r = 0.48; 
n=9; n.s.), and LHA (r = 0.15; n=9; n.s.) did not significantly correlate with ID behaviour 
following CNO treatment. Therefore, the conclusion drawn here can be similar to the one 
regarding the shift-cost: higher levels of colocalised transduction of extraneous areas near 
the STN, such as the ZIV, ZID and LHA had a minimal impact on performance across 
multiple ID stages.  
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Figure 6.7: Mean trials to criterion (+SEM) illustrating that performance for vehicle-
treated rats improved across the five ID stages, aiding in the inference of set-formation; in 
contrast, CNO-treated rats did not demonstrate an improvement in ID discrimination 
learning, and required more trials overall; *p<0.05; **p<0.01. 
6.3.3.3 Delayed reversal learning with intermediary stages 
A ‘reversal cost’ was clearly evident in vehicle-treated rats, even with multiple 
intervening stages (figure 6.8). By contrast, there was no obvious evidence of a ‘reversal 
cost’ in CNO-treated rats: reversal stages appeared to require about the same number of 
trials as new learning [i.e., there was no significant difference between ID1 and its reversal 
(ID1R) or between ID2 and its reversal (ID2R); Stage by CNO interaction: F(3,140.1)= 15.3, 
p<0.01; uncorrected df= 3,160; nρ2= 0.44);  Bonferroni-corrected pairwise comparison 
revealed that vehicle-treated rats required significantly more TTC for both reversal stages 
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compared to the respective novel learning stages, indicating a ‘reversal-cost’, which was 
not found for CNO-treated rats]. This effect remained even if the unilaterally-transduced 
CNO-treated rat was removed from the analysis (Stage by CNO interaction: F(3,117.9)= 14.2, 
p<0.01; uncorrected df= 3,150; nρ2= 0.42; Bonferroni-corrected pairwise comparison).   
 The intervening stages were included to test the hypothesis that a failure to 
demonstrate a significant reversal-cost following CNO administration could be due to 
memory impairment: if the presentation of new stimuli essentially disrupts memory of 
previous stages, all stages would be treated as novel. Although the rats appeared to have no 
reversal cost, there was nevertheless evidence that that the rats did not have a memory 
impairment: the probability of rats committing an error during the first four ‘exploratory’ 
trials of the reversal stages was not the same as for new learning. Although CNO-treated 
rats were less likely to make an error in the initial trials of a reversal than vehicle-treated 
rats (main effect of CNO: F(1,16) = 8.25, p<0.05; nρ
2
= 0.33; Bonferroni-corrected pairwise 
comparison; figure 6.9), nevertheless, they were significantly more likely to choose the 
previously rewarded stimulus, indicating that they clearly did remember the discrimination. 
Furthermore, there was no difference between the groups in the number of times they 
rejected the previously incorrect stimulus (i.e., having approached a bowl, they did not dig 
if the stimulus was the previously-incorrect stimulus, but rather moved away from it; figure 
6.10). This was true for both reversal stages (repeated measures ANOVA; no main effect of 
CNO: F(1,16) = <1, n.s.; nρ
2
= 0.02; no interaction of CNO by reversal stage: F(1,16) <1, n.s.; 
nρ2< 0.01). Similar to the TTC data, removing the error data for the unilaterally-transduced 
CNO-treated rat did not change the fact that CNO-treated rats still made fewer errors (main 
effect of CNO: F(1,15) = 7.04, p<0.05; nρ
2
= 0.32; Bonferroni-corrected pairwise 
comparison), whilst not differing from control rats in the number of times they rejected the 
previously incorrect stimulus stages (repeated measures ANOVA; no main effect of CNO: 
F(1,15) = <1, n.s.; nρ
2
= 0.02; no interaction of CNO by reversal stage: F(1,15) <1, n.s.; nρ
2
< 
0.01).  
The evidence that CNO-treated rats remembered previously rewarded stimulus 
suggested that the observed deficit did not likely stem from a dysfunction in memory, 
notwithstanding the lack of a reversal-cost following CNO treatment. The attenuation of a 
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reversal-cost may be the result of less efficient, or less thorough, learning due to an 
impairment in attentional set which would increase the cognitive load of the discrimination 
learning.  
Similar to the results for the shift-cost and multiple ID stages, reclassifying CNO-
treated rats based on their transduction profile (i.e., either ‘minimal’ or ‘moderate’) did not 
significantly influence statistical outcome: there was still no evidence of a ‘reversal-cost’ in 
either minimally- or moderately-transduced CNO-treated rats (Stage by Revised CNO 
interaction: F(5.23,128.39)= 9.82, p<0.01; uncorrected df= 6,150; nρ
2
= 0.48; Bonferroni-
corrected pairwise comparison). Furthermore, both minimally- and moderately-transduced 
CNO-treated rats were still less likely to make an error in the initial trials of a reversal than 
vehicle-treated rats (main effect of CNO: F(2,15) = 2.06, p<0.05; nρ
2
= 0.35; Bonferroni-
corrected pairwise comparison), and as above, there was no difference between any of the 
groups in the number of times they rejected the previously incorrect stimulus (CNO: F(2,15) 
= <1, n.s.; nρ2= 0.09).  
Results of Pearson correlations found that amount of overall transduction 
percentage by rat did not influence the number of errors incurred during the exploratory 
trials (i.e., first four trials) of Rev1 (r = 0.40; n=9; n.s.) or Rev2 (r = −0.23; n=9; n.s.), nor 
were there any region-specific effects of increasing transduction within the ZIV (Rev1: r = 
0.44; Rev2: r = −0.34; n.s.), ZID (Rev1: r = 0.29; Rev2: r = −0.28; n.s), and LHA (Rev1: r 
= 0.34; Rev2: r = −0.14; n.s), respectively, on the generation of errors for either stage. 
Similarly, the mean number of times rats rejected the previously incorrect stimulus for both 
Rev1 (r = −0.23; n=9; n.s.) and Rev2 (r =−0.31; n=9; n.s.) was also not influenced by 
changes in overall transduction percentage, nor by changes in transduction within the ZIV 
(Rev1: r = −0.34; Rev2: r = −0.25; n.s.), ZID (Rev1: r = −0.28; Rev2: r = −0.29; n.s), or 
LHA (Rev1: r = −0.14; Rev2: r = −0.36; n.s). These findings align with the aforementioned 
analyses from this chapter and suggest that extraneous transduction to ZI and LHA 
minimally influenced the behavioural outcome during the reversal stages.   
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Figure 6.8: Mean trials to criterion (+SEM) illustrating that vehicle-treated rats exhibited 
a cost for reversing for both reversal stages. In contrast, CNO-treated exhibited no 
difference between novel and reversal discrimination learning, and reversed faster than 
vehicle-treated rats in the ID1R stage; *p<0.05; **p<0.01.    
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Figure 6.9: Mean ±SEM probability of an error for the first four trials of ID1R and ID2R, 
combined. CNO treatment reduced the probability of an error at the reversal stages.  
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Figure 6.10: Mean ±SEM probability of a rejection (i.e., errors where the rewarded bowl 
was encountered and rejected before the rat dug in the incorrect bowl), for the first four 
trials of ID1R and ID2R, combined. CNO treatment did not influence the probability of 
observing this error type.  
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6.3.3.4 Probe and bi-conditional learning stages 
A restricted analysis of the probe stage (figure 6.11) determined that CNO-
treated rats required significantly more TTC than vehicle-treated rats (one-way ANOVA; 
F(1,140.1)= 30.6, p<0.01; uncorrected df=1,160; Huynh-Feldt correction). Seven out of 
nine (78%) vehicle-treated rats obtained criterion in the expected minimum required 
(six) TTC, whilst the remaining two rats completed the stage with only one mistake. In 
contrast, it appeared that the change in the irrelevant dimension disrupted performance 
for CNO-treated rats. At this stage, all rats that were administered CNO made at least 
two errors before reaching criterion, with 4 out of 9 (44%) rats incurring at least four 
errors. Consequently, CNO-treated rats (M: 12.3 trials) took twice as many trials to 
acquire the probe, compared to vehicle-treated rats (M: 6.3 trials). Furthermore, 
performance for CNO-treated rats on the probe stage did not differ from two of the ID 
stages, including the preceding ID5 stage (planned comparison of ID1-ID5p stages; 
Repeated-measures ANOVA Stage by CNO interaction: F(4.7,140.1)= 2.61, p<0.05; 
Bonferroni-corrected pairwise comparison; nρ2= 0.14).  
Excluding the unilaterally-transduced CNO-treated rat from the analysis did not 
influence the statistical outcome (one-way ANOVA; F(1,117.9)= 28.5, p<0.01; uncorrected 
df=1,150; Huynh-Feldt correction), with the probe data for this unilateral CNO-treated 
rat (11 TTC; 3 errors) being comparable to the TTC for the remaining bilaterally-
transduced CNO-treated animals. Aligned with previous analyses, reclassifying CNO-
treated rats as animals with either ‘minimal’ or ‘moderate’ transduction had no effect on 
the statistical outcome (one-way ANOVA; F(2,128.39)= 15.7, p<0.01; uncorrected 
df=2,150; Bonferroni-corrected pairwise comparison), with no difference in 
performance between both transduction-groups of CNO-treated rats. Furthermore, 
changes in transduction percentage did not correlate with behavioural performance at 
the probe stage (r = 0.24; n=9; n.s.); higher percentages of transduction did not 
correlate with increases in impairment. There was also no relationship between the 
amount of transduction for each region and performance at the probe stage: differences 
in transduction within the ZIV (r = −0.03; n=9; n.s.), ZID (r = 0.10; n=9; n.s.), and 
LHA (r = 0.47; n=9; n.s.), respectively, did not significantly correlate with probe TTC 
following CNO treatment  
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Analysis of the bi-conditional discrimination (figure 6.11) revealed that CNO-
treated rats required significantly fewer TTC than vehicle-treated rats (one-way ANOVA; 
F(1,17)= 76.9, p<0.01). The rapid bi-conditional acquisition by CNO-treated rats 
compared to vehicle-treated rats supported the hypothesis that CNO-treated rats were 
attending to both dimensions and likely learning the entire configuration of the stimulus 
as an approach to solve compound discriminations. Conversely, vehicle-treated rats 
required considerably more trials, with seven out of nine rats (78%) requiring over 
twenty TTC. Nevertheless, the vehicle-treated rats did ultimately learn to attend to 
exemplars in both dimensions to learn the discrimination.  
Excluding the data unilaterally-transduced rat from the analysis did not 
influence the statistical outcome (one-way ANOVA; F(1,15)= 70.2, p<0.01); furthermore, 
the 12 TTC required by this rat for this discrimination was comparable to the remaining 
8 bilaterally-transduced CNO-treated rats, of which, 3 also completed this 
discrimination in 12 TTC. It was also found that reclassifying CNO-treated rats as 
animals with either ‘minimal’ or ‘moderate’ transduction had no effect on the statistical 
outcome (one-way ANOVA; F(2,128.39)= 53.8, p<0.01; uncorrected df=2,150; Bonferroni-
corrected pairwise comparison), with no difference between the two groups of CNO-
treated rats. Furthermore, a change in transduction percentage did not correlate with 
acquisition of the bi-conditional discrimination (r = −0.24; n=9; n.s.); increasing 
transduction throughout the ZI and LHA does not correlate with a facilitation in 
acquisition. Similar to the probe, there was also no relationship between the amount of 
transduction for each region and the acquisition of the bi-conditional discrimination: 
differences in transduction within the ZIV (r = −0.19; n=9; n.s.), ZID (r = −0.25; n=9; 
n.s.), and LHA (r = −0.04; n=9; n.s.), respectively, did not significantly correlate with 
performance following CNO treatment. These findings, coupled with the similar results 
from this chapter have found that the behavioural data for rats with more robust 
transduction profiles of the ZI and LHA did not differ from rats with colocalised 
transduction limited to the STN and minimally to surrounding tissue.   
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Figure 6.11: Mean trials to criterion (+SEM) for vehicle and CNO-treated rats in the 
probe and bi-conditional stages. CNO-treated rats were impaired at the probe 
discrimination, in which only the irrelevant dimension stimuli were changed. 
Conversely, CNO-treated rats completed the bi-conditional discrimination faster than 
vehicle-treated rats, in which configural learning rather than an established attentional 
set would aid in discrimination; **p<0.01.  
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6.4 Discussion  
The data from the current experiment demonstrated that pharmacosynthetic 
transduction of the cells within the medial region of the STN and ZI/LHA area with a 
designer receptor did not disrupt performance at any stage of the 7-stage task in the 
absence of the designer drug, CNO. Administration of CNO did abolish the expected 
ID/ED difference in the 11-stage task. The inclusion of additional stages in this task 
enabled the conclusion that set-formation deficit was not the result of a memory 
impairment. Neither could ‘slow’ acquisition of set account for the deficit. Rather, the 
deficit was due to a failure to attend selectively to the dimensions comprising the 
stimuli resulting in the rat processing the stimuli configurally. 
This set-formation impairment was characterised as a disruption of the typical 
improvement in ID learning performance as a function of experience with ID learning 
(i.e., no decrease in the number of trials to criterion with successive IDs). The same rats 
acquired the ED discrimination in fewer trials than vehicle-treated rats, thus not 
showing the typical ‘shift-cost’, still seen in vehicle-treated rats, when required to shift 
set between the final ID (ID5) stage and the ED shift stage. 
The fact that CNO-treated rats acquired the ED stage in fewer trials than 
vehicle-treated rats, would at first appear to be an improvement in set-shifting behaviour, 
and indeed, theoretically, a decrease in trials to solve the ED could stem from an 
enhanced ability to shift attentional set (Lapiz, Bondi, & Morilak, 2007), yet this claim 
still requires a positive ID-ED difference, otherwise (e.g., Tunbridge, Bannerman, Sharp, 
& Harrison, 2004) it is not possible to conclude that an attentional set was present to be 
shifted away from. Furthermore, if novel ED learning is acquired as quickly as novel ID 
learning (or faster), this would introduce the likelihood of ‘error shifts’, or the shifting 
of set when it does not require shifting, which ultimately diminishes the benefit of an 
attentional set.   
6.4.1 Memory impairment vs attentional selectivity  
Despite the lack of an apparent reversal cost for CNO-treated rats, and that these 
rats incur fewer errors during a reversal, which supports the hypothesis for memory 
impairment, there was nevertheless evidence that these rats did not have a memory 
impairment. CNO-treated rats did not differ from controls in the number of times they 
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rejected the previously incorrect bowl, and furthermore, these rats were significantly 
more likely to choose the previously rewarded stimulus, indicating that they 
remembered the original discrimination.  
The attenuation of an observable reversal cost could have then resulted from the 
larger number of correct/incorrect contingencies that discrimination learning would 
have demanded, resulting in an increase in cognitive load. This information would have 
to be retained in memory, whilst learning about novel discriminations presented during 
the interim stage(s). Theoretically then, increasing the number of interim stages may 
introduce the possibility of increasing cognitive load to the point which it may attenuate 
the memory of the original discrimination, yet this was not observed in the current 
experiment after 3 interim stages (ID2R).  
In the current experiment, the hypothesis of attentional dysregulation was 
investigated by the probe stage, whilst the bi-conditional discrimination stage tested for 
the potential strategy that CNO-treated rats might have to employ/resort to, in order to 
complete the task. CNO-treated rats were impaired at a probe stage, which was 
presented at a point in the test (after the 5
th
 ID) when the ID performance of vehicle-
treated rats was clearly improved as a result of selective attention to the relevant 
dimension. Whilst all of the vehicle-treated rats performed with no more than 1 error 
(7/9 with no errors), none of the CNO-treated rats performed at this level. This indicated 
that these rats were not attending selectively to the rewarded stimulus dimension: the 
change in the irrelevant dimension essentially rendered the entire compound stimulus 
‘new’, so requiring as many trials to learn as a novel ID stage. This conclusion may at 
first suggest that CNO-treated rats were simply ‘distracted’ by the stimuli change at the 
probe stage, yet the data from the bi-conditional discrimination stage illustrated that 
CNO-treated were, in fact, not distracted by the irrelevant dimension stimuli. Reasoning 
that, in lieu of forming set, CNO-treated rats may be treating the stimuli as novel 
configurations, the bi-conditional stage was included as a direct test and, indeed, CNO-
treated rats solved this discrimination in fewer trials than vehicle-treated rats. This result 
indicated that CNO-treated rats benefitted when neither dimension predicted reward, 
such that attending to stimuli holistically was the most adaptive strategy, and therefore 
was likely employed to solve the task. This also indicated that the STN may play a role 
in managing the assignment of relevant and irrelevant stimulus information crucial to 
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attentional set-formation, perhaps by mediating response selection that would be 
derived from this information, which aligns with its role in action selection (see Frank, 
2006; but also Zénon et al., 2016).  
In the absence of forming set, employing configural learning may reconcile the 
noted attenuation of reversal costs; having to retain configurations of stimuli in memory, 
including those presented during the intervening stages, may have been increased the 
cognitive load. In light of these findings, the relationship between reversal learning and 
attentional set merits further investigation, for as it stands associative and attentional 
shifting are regarded as separate processes, mediated by separate regions of the PFC 
(Dias, Robbins, & Roberts, 1996). This relationship will be further explored in the 
subsequent experimental chapter (7). 
6.4.2 Evaluating DREADDs technology  
The present experiment utilised a novel, pharmacosynthetic tool to transiently 
modulate neuronal activity in the target region of the medial STN. Consistent with 
Chapter 5, we have demonstrated that application of AAV5-CaMKIIa DREADDs 
infused to the medial area of the STN resulted in expression of Gi-coupled designer 
receptors in subthalamic neurons, including transduction of the cells within the medial 
STN, whilst largely sparing the lateral STN. Studies have suggested that the medial 
third (33%) of the STN functionally subdivides the nucleus, bestowing a ‘cognitive’ 
role for the medial region, and a more ‘motor’ role for the lateral (Groenwegen & 
Berendse, 1990; Heimer et al., 1995); however it is worth noting that the overlap 
between the cortical projections which are implicated these two behaviours overlap in 
this nucleus (Janssen, Visser-Vandewalle, & Temel, 2010).  
In this chapter, bilateral transduction of the medial STN was achieved in nearly 
all rats (apart from the unilaterally-transduced animals), however extraneous 
transduction was incurred to the neighbouring ZIV, ZID and LHA, differentially 
between rats of both treatment groups. Microscopy revealed that both the mCherry and 
GFP (NeuN) channels imaged even individually were too ‘noisy’ in areas with high cell 
density (e.g., medial STN) making it difficult to distinguish the perimeter of the cell in 
some cases. This was likely due to the thickness of the tissue (and therefore a larger z-
axis), which would have increased the amount of signal resulting in overlapping/unclear 
cell boundaries along the z-axis. This effect remained for imaging at higher 
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magnification, and was exacerbated by colocalisation. In order to compare the level of 
transduction quantitatively, spatial area of colocalised transduction was calculated in 
order to provide an approximate ‘percent transduced’ value. To determine whether this 
extraneous transduction impacted behaviour when CNO was administered, rats were 
assigned to either a ‘minimal’ or ‘moderate’ transduction subgroup. Reclassifying nine 
rats into smaller subgroups increases the risk of Type I error, so to account for this, the 
mean transduction for each region per rat and total observed transduction per rat was 
also correlated with a given manipulation of interest. Overall, reclassifying rats into 
subgroups had no effect on the outcome as rats with ‘minimal’ and ‘moderate’ 
transduction performed comparably. There was no correlation between the level of 
transduction of a given region (e.g., ZIV) and any behaviour of interest, and similarly, 
increasing overall transduction levels to encompass more extraneous regions (or perhaps 
combinations of regions: i.e., ZI+LHA) does not correlate with levels of impairment for 
any of the behavioural measures for set-formation in this experiment. These findings are 
not wholly unexpected as previous work has detailed that including animals with 
extraneous lesion damage to the ZI in studies with STN-lesioned rats does not influence 
the behaviour of interest, nor statistical outcome (Baunez et al., 1995; Baunez & 
Robbins, 1999; Phillips & Brown, 1999; Phillips & Brown, 2000). Furthermore, there is 
currently no data supporting a robust cognitive role for the ZI and LHA, unlike the STN 
(see section 1.8). Based on these findings, it was concluded that level of transduction to 
neighbouring regions, such as the ZI and LHA, had little effect on the behavioural 
deficits noted in this chapter.  
Since level of extraneous transduction to the ZI and LHA had a minimal impact 
on behaviour, and that data for CNO-treated rats with no transduction of the ZI/LHA 
did not differ from rats with robust bilateral transduction of these regions, it can be 
postulated that the deficits observed here likely result from inactivation of the STN. 
Furthermore, analysis of colocalised transduction revealed that the STN was 
significantly more transduced than any other region, supporting the notion that 
inhibition of this area was driving the behavioural outcome. Subsequent work with a 
larger sample of rats with localised transduction to the STN (and less extraneous 
transduction) would bolster the assertion that the STN is indeed driving this behaviour; 
however based on the (lack of a) relationship between rising transduction values and 
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behavioural deficits reported here, it may be unlikely that further refining transduction 
will yield a divergent behavioural profile.  
Although electrophysiological data were not collected to directly investigate 
STN inhibition, evidence of decreased c-Fos labelling in DREADDs-infused, CNO-
treated animals in Chapter 5, along with compelling behavioural data reported in the 
current chapter, indexing a robust difference between treatment groups, and colocalised 
immunofluorescence illustrating nuclear transduction of the STN, provides support that 
inhibition of the STN was achieved. CNO application in the current experiment yielded 
significant differences in behaviour at several expected stages of the task, and that 
furthermore, the magnitude of these effects were more robust than previously observed 
effects after ibotenic acid lesions of the STN (Xia, Dhawan, Tait & Brown, 
unpublished). The lack of a neurotoxic effect in the current experiment may partially 
contribute to this difference, along with the specificity of the CaMKIIa-promoted viral 
vector. CaMKIIa has been identified as a key enzyme in the facilitation of LTP (Lledo 
et al., 1995; Pettit, Pernman, & Malinow, 1994), which drives learning, and CaMKIIa 
transcription may be important in consolidation of memory (Lisman, Schulman, & 
Cline, 2002). The specific targeting of CaMKIIa-positive cells, and the subsequent 
inhibition of these cells via CNO, may have bolstered the results in this experiment. 
This assertion may also serve to reconcile the observation that one rat with unilateral 
transduction of the STN exhibited a comparable behavioural profile to animals with 
bilateral transduction. This must be interpreted with hesitation as only one rat in the 
CNO group had unilateral transduction, however based on previous work with STN 
lesions, we have seen that animals with unilateral lesion damage present with a milder 
impairment in cognition compared to the more profound impairment in cognition 
observed in bilaterally-lesioned rats (see section 3.4.1.1). In order to claim that 
unilateral transduction of the STN is comparable to bilateral, which is not being 
suggested here, a subsequent study with a larger group of unilaterally-transduced 
animals would be needed, although based on the extant literature, albeit in other 
cognitive tasks (e.g., visuo-spatial attention, reaction-time, etc.), there is no evidence 
that unilaterally-inactivated rats should perform comparably to bilaterally-inactivated 
ones, apart from the data from one rat from this experiment.  
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 The inhibition/excitation of designer receptors with the designer drug CNO 
undergoes extensive back-metabolism to clozapine in in mice and humans (Chang et al., 
1998), yet Armbruster et al. (2007) demonstrated that CNO lacked appreciable affinity 
for receptors in rats. Recent research by Maclaren et al. (2016) claimed that CNO may 
not be inert in rats, and found evidence of clozapine back-metabolism in the Long-
Evans strain. In mice (Bender, Holschbach, & Stöcklin, 1994) and in schizophrenia 
patients (Chang et al., 1998), back-conversion of CNO to clozapine results in higher 
concentrations of clozapine than CNO, yet this was not observed in Maclaren et al. At 
peak concentration (30 min), Maclaren et al. reported that plasma levels of clozapine 
were considerably lower than CNO (0.3µM clozapine compared to 2.2 µM CNO; 
5mg/kg CNO).  
Maclaren et al. (2016) argued that CNO may also induce a behavioural effect, 
and presented data suggesting that CNO in unoperated rats, dose-dependently, 
influenced the magnitude of an acoustic startle response, but only for louder tone cues. 
Interestingly, this effect was only observed for the 1mg/kg dose group, and no effect 
was found at higher doses (2 and 5mg/kg). In addition, our lab has observed completely 
different behavioural profiles following inhibitory DREADDs application in the STN, 
the mPFC (Whyte, Tait & Brown, unpublished), and the OFC (Tait & Brown, 
unpublished) after CNO administration. Furthermore, the deficits evidenced in OFC- 
and mPFC-DREADDs rats are consistent with the observed deficits from lesion studies 
(Birrell & Brown, 2000; McAlonan & Brown, 2003), further suggesting that CNO 
offers minimal behavioural impact. The results reported in Chapter 5 also illustrate that 
CNO administration in unoperated animals does not influence c-Fos labelling in the 
STN.  
To reduce any secondary behavioural effects – particularly those associated with 
stress – in future experiments with DREADDs, the route of CNO administration can be 
refined. Since CNO is orally bioavailable (Wess, Nakajima, & Jain, 2013), utilising a 
palatable jelly (as described in Chapter 4; Whyte, Tait & Brown, unpublished) would 
reduce the stress associated with intraperitoneal administration.  
6.4.3 Conclusions 
In summary, this chapter reports that inhibition of the cells within the STN, ZI 
and LHA with a designer receptor results in an impairment in attentional set-formation 
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on the 11-stage task, which may largely be derived from inhibition of the cells of the 
STN. These data illustrate that CNO-treated rats do not evidence a cost of shifting set, 
nor the expected improvement across multiple ID stages. Data from the reversal stages 
indicated that CNO-treated rats clearly remembered the original discrimination, which 
refuted the hypothesis that these animals had a memory impairment, and instead the 
attenuated reversal cost likely arose from an increase in cognitive load during 
discrimination learning. The impaired probe stage performance indicated that CNO-
treated rats were still attending to the irrelevant dimension, and the bi-conditional 
discrimination inferred that this was due to rats responding to the stimuli holistically.   
These findings suggest that the STN plays a role in parsing relevant from 
irrelevant stimulus information. The findings from the reversal stages suggest that 
associative learning may be intimately linked with set-formation, and therefore more 
research is needed to examine this relationship. This research would expand our current 
understanding of the role the STN plays in attentional set, and may elucidate the 
processes which contribute to set-formation.  
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Chapter 7 
 
Examining the relationship between 
associative and attentional processes with 
the Overtraining Reversal Effect  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Background: 
Reversal and attentional processes are thought to be doubly 
dissociated by different regions of the PFC. Evidence from Chapter 
6 suggests that these processes may be jointly mediated by the 
STN. This relationship is explored via the overtraining reversal 
effect (ORE); a theory which describes that overtraining (OT) a 
compound discrimination facilitates reversal learning owing to the 
formation of attentional set.      
Methods: 
22 unoperated rats were used to examine the effects of OT in the 
bowl-digging paradigm in experiment I. In experiment II, the same 
18 DREADDs-infused rats from Chapter 6 were used for two test 
sessions: one with OT, and one without (trained to criterion only).     
Results: 
OT facilitated reversal acquisition in experiment I; experiment II 
revealed that OT exacerbated reversal performance for CNO-
treated rats, compared to when these rats were trained to criterion 
only; this likely resulted from an inability to form attentional set.    
Conclusions: 
CNO-treatment prevents the detection of an ORE; OT strengthens 
the association of the stimulus configuration with reward, which 
exacerbates reversal learning. Associative and attentional processes 
do not operate in parallel, and can be mediated by a single brain 
region.  
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7.1.1 Introduction  
As discussed in the General Introduction (see section 1.3; page 28), lesions to the 
monkey lateral PFC (or rat mPFC) impair ED performance but not reversal learning, whilst 
lesions of the OFC impair reversal learning but not ED performance (Dias et al., 1996a) 
(Birrell and Brown, 2000 and McAlonan et al., 2002). This demonstration of a ‘double 
dissociation’ suggested that reversal learning and ‘attentional’ shifting were independent, 
operating either in a hierarchy or in parallel (see Dias et al., 1996). However, Chase et al. 
(2012) demonstrated that there was an impairment in attentional set-formation in OFC-
lesioned rats and this was why ED performance was not impaired: when additional ID 
stages were included to encourage set formation, ED performance was impaired. This 
evidence suggest that reversal learning performance and ED performance are inter-related.  
In the case of OFC-lesion deficits, set appeared to be slow to form, but with 
sufficient experience, it did form. In the case of the STN, the set-formation deficits seem to 
be far more profound. Although it is not possible to conclude that no amount of additional 
experience would result in set formation, there is no reason to believe that it would. The 
implication of this is that the STN-mediated deficit reflects a fundamental impairment in 
the ability to attend selectively to the stimulus dimensions of multidimensional stimuli. The 
experiments reported in the current chapter exploit a phenomenon called the ‘overtraining 
reversal effect’ (ORE) to examine this further.  
The ORE was first described by Reid (1953), who trained rats on a simple black-
white discrimination and then gave an extra 150 trials of overtraining. Rather than taking 
longer to reverse the discrimination than rats without overtraining – as might have been 
expected (intuitively) due to a stronger stimulus-reward association – the opposite effect 
was found: ‘overtraining’ (OT) resulted in more rapid learning of the reversal than control 
rats. Sutherland (1959) suggested that OT facilitated reversal learning by increasing the 
salience of the predictive cues. Mackintosh (1963a) showed that rats with OT of a 
brightness discrimination reversed more rapidly and spent a smaller proportion of trials 
responding to irrelevant cues (i.e., responding at chance level) compared to control rats. On 
the basis of this observation, Sutherland & Mackintosh (1971) suggested that OT had the 
effect of reducing or eliminating the number of ‘error factors’ (i.e., cues that might be 
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tested as predictive of reward but which are, in fact, irrelevant), essentially inhibiting the 
processing of, or down-regulating attention to, irrelevant information. Sutherland and 
Mackintosh (1971) made 2 predictions about behaviour if the OT resulted in increased 
attentional focus on the relevant, relative to irrelevant, cues: first, that there would be an 
increase the number of perseverative responses at the outset of reversal learning; and, 
second, that there would be a lower probability of responding to irrelevant cues, hence 
fewer trials of chance responding. Mackintosh’s two-stage learning theory, in which the 
association of stimuli and reward strengthens/weakens attentional ‘analysers’, explains the 
ORE as the result of the differential strength of the analysers and, thus, is evidence of 
attentional set.   
Sutherland and Mackintosh (1971) review the literature pertaining to the ORE, and 
concluded that while there is strong evidence for the ORE, there were also a significant 
number of studies – at least 35 – that failed to replicate the effect. Mackintosh (1969) 
demonstrated that the ORE was not generated during an easy spatial discrimination learning 
task and only for a more difficult visual discrimination when the reward was large. He also 
noted that ‘problem difficulty’ was not defined with respect to the absolute number of 
errors or trials to criterion, but rather the initial probability of responding to the relevant 
dimension.  
In the first experiment reported here, we sought to determine the parameters for 
observing the ORE in the bowl-digging paradigm as this has not previously been 
demonstrated. We expected that OT would be an effective manipulation based on the 
observation by Garner et al. (2006), who reported that OT at the ID-reversal increased TTC 
of the subsequent ED (suggestive of enhanced attentional set), although they did not 
overtrain an acquisition or demonstrate an ORE. In the second experiment, we explored the 
effect of inactivation of the STN and the ZI/LHA, using DREADDs, on the ORE. CNO-
treated rats do not form attentional set (see Chapter 6), therefore they should also not show 
an ORE if it results from the same attentional mechanisms. Furthermore, if CNO-treated 
rats are solving the discriminations ‘configurally’, then it would also be expected that OT 
may actually retard reversal performance as a result of a rigid stimulus-response 
contingency.  
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7.1 Experiment I 
7.1.2 Materials and methods 
7.1.2.1 Animals 
Twenty-two experimentally naïve female Lister hooded rats (bred in-house; 
University of St Andrews, from Charles River stock), with a mean starting weight of 217g 
and ending weight of 292g, were used. Husbandry and housing details are described in the 
General Methods (see section 2.1). 
7.1.2.2 Apparatus and testing 
See section 2.2 of the General Methods chapter.  
7.1.2.3 Design 
A number of designs were considered and piloted (including adding a third 
dimension, which we later dropped) before arriving at the design presented here (see table 
7.1.1). We used compound odour and media stimuli (with the rewarded dimension 
counterbalanced) and we omitted the initial SD stage. Thus, the 3 stages were: CD (with 
(n=11), or without (n=11), 30 additional trials of OT); Rev1; acquisition of a novel 
compound discrimination (NCD), with the relevant dimension being the previously 
irrelevant one.  The stimuli were the first two stimulus pairings used in the bowl-digging 
paradigm (see section 2.4.2).   
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Table 7.1.1: An example procedure of a typical test session; thirty additional “overtraining” 
trials were administered at the CD stage for rats in the OT condition. 
Discimination 
Relevant 
dimension
Discriminanda Irrelevant
Compound 
Discrimination (CD) 
Medium 
Coarse tea , not 
fine tea 
Cinnamon or ginger 
Compound Reversal 
(Rev1)
Medium 
Fine tea , not 
coarse tea 
Cinnamon or ginger 
Novel Compound 
Discrimination (NCD) 
Odour Sage , not paprika Sand or grit
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7.1.3 Results 
Rats with OT reached criterion at the reversal stage in significantly fewer trials (M: 
11.2) than rats trained to criterion only (M: 16.5; Stage by OT interaction: F(2,40)= 3.78, 
p<0.05; nρ2= 0.16; figure 7.1.1). A Bonferroni-corrected pairwise comparison determined 
OT influenced only TTC at the reversal stage: there was no effect on the novel acquisition.  
 
Figure 7.1.1: Mean trials to criterion (+SEM) demonstrating that overtraining rats at 
facilitated a faster reversal learning acquisition, than being trained to criterion only; 
**p<0.01. 
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7.1.4 Conclusion 
The findings from Experiment 1 demonstrated that 30 OT trials of a compound 
discrimination resulted in faster learning of its reversal, compared to rats just trained to 
criterion. This procedure is therefore a useful tool to further investigate the relationship 
between attention and associability and the role the STN.  
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7.2 Experiment II 
7.2.2 Materials and methods  
7.2.2.1 Animals  
The rats used were the same eighteen male, Lister hooded rats (Charles River, UK) 
(mean starting weight of 398g and a mean end weight of 525g) tested in Chapter 6 (see 
section 6.2.3 for details of surgery and section 6.2.6 for histology). Rats were assigned to 
receive CNO (n=9) or vehicle (n=9), according to which they had received in Chapter 6: 
rats previously given CNO were given vehicle here, and vice-versa.  
7.2.2.2 Design  
Experiment 2 used the 7-stage task (see Table 2.2 for exemplar pairings), with the 
omission of the SD. Each rat completed 2 test sessions, with approximately 10 days 
between tests, first with overtraining (OT) at just the CD stage and then with learning to 
criterion only (non-OT). Shift-type, initial correct stimulus and order of presentation were 
all counterbalanced between groups and test. 
7.2.2.3 Data analysis  
The current study was a 2x2x6 mixed factorial design, and trials to criterion (TTC) 
data were analysed by repeated-measures ANOVA. There was a within-subjects factor of 
Stage (six levels); a within-subjects factor of Condition (two levels: OT (test 1) and non-
OT (test 2) and a between-subjects factor of Treatment group (two levels: CNO or vehicle). 
Error-type was analysed at the reversal stages, with the number of errors prior to the first 
correct response classified as ‘perseverative’, and subsequent trials after the first correct 
response but before the final 6-correct responses, were classified as ‘at chance’ responses.
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7.2.3 Results 
7.2.3.1 Histology   
As stated for the histology results for Chapter 6 (section 6.3.1), two rats – one from 
the CNO and one from the vehicle treatment group – expressed unilateral mCherry 
expression, and that the data for these two rats were included in all analyses in this section, 
as the inclusion of the data for the unilateral CNO-treated rat here did not influence 
statistical outcome; as in Chapter 6, this will be evaluated separately in the subsequent 
behavioural data results. Also, the results of the colocalised transduction analysis are the 
same as Chapter 6 and are reported in detail in section 6.3.1, with some exceptions owing 
to the change in in CNO administration for the current experiment. Briefly, 8 of the 18 rats 
(6 CNO-treated, 2 vehicle-treated) presented with no nuclear transduction of the ZIV or the 
ZID, whilst a different subset of 8 rats did not present with any nuclear transduction of the 
LHA (4 CNO-treated, 4 vehicle-treated); conversely, transduction in the STN was present 
in all rats (with only four rats presenting with exclusive transduction of the STN: 3 CNO-
treated; 1 vehicle-treated). 
Similar to the behavioural analyses presented for Chapter 6, since any group with an 
n of 3 (exclusive STN transduction) would under-power analyses, similar to Chapter 6, 
CNO-treated animals for this experiment were assigned to a ‘minimally-transduced’, and a 
‘moderately-transduced’ group. Rats in the ‘minimally-transduced’ group (n=5) had STN 
transduction, plus only minimal unilateral transduction of only one extraneous brain region 
(either the ZIV or LHA; range of transduction for extraneous region = 0-15%). Conversely, 
rats in the ‘moderately-transduced’ group (n=4) had STN transduction, plus bilateral 
transduction of one or more brain regions (range of transduction for extraneous region = 0-
50%). The total amount of observed transduction per rat was also calculated by summing 
the transduction percentages across each hemisphere, section and brain region for each 
animal, which could then be compared with manipulations of interest for the current 
experiment. This correlational analysis was also done for each region to determine in any 
region-specific effects of transduction influenced behaviour.    
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7.2.3.2 Overtraining impairs reversal learning  
 Overall, both Condition (OT vs non-OT) and Treatment group (CNO vs vehicle) 
differentially changed performance at different stages of the task as expected (Stage by 
Condition by Treatment group interaction: F(3.6,57.6) = 3.34, p<0.05; Huynh-Feldt 
correction; uncorrected df= 5,80; nρ2= 0.17).  Also, removing the data for the unilaterally-
transduced CNO-treated rat from the analysis did not change the three-way interaction of 
Condition, Stage and Treatment group (F(3.6,54.3) = 2.98, p<0.05; Huynh-Feldt correction; 
uncorrected df= 5,75; nρ2= 0.17). Therefore, analysis of simple interactions and simple 
main effects was undertaken. 
For the vehicle treatment group, OT of the initial CD discrimination reduced the 
overall TTC at Rev1, as expected, and also at Rev2 (the reversal following the ID 
discrimination, which was not overtrained), compared to when they were trained to 
criterion only (p<0.05), thereby generating evidence of a long-lasting ORE (Restricted 
analysis of Reversal stages: Treatment group by Condition by Stage interaction: F(2,57.58) = 
3.90, p<0.05; uncorrected df: 2,80; nρ2= 0.45; Bonferroni-corrected pairwise comparison; 
figure 7.2.1). Numerically, the TTC for Rev1 and Rev2 was exactly the same in the OT 
condition (12.78 for both). There was no effect of OT on Rev3 (the reversal following the 
ED discrimination). 
Responses (errors) prior to the first correct response were deemed perseverative, 
while the number of trials from the first correct response to the error trial preceding the 
final 6-correct trials were considered to be ‘at chance’ responding. For rats with more than 
1 trial of ‘at chance’ responding, the mean proportion of correct responses to trials was 
calculated; for vehicle-treated rats, the ratio of correct responses to total ‘at chance’ trials 
for Rev1 did not differ between OT (Mean responses ‘at chance’: 0.89; proportion: 0.5) and 
non-OT (Mean responses ‘at chance’: 5.33; proportion: 0.51) conditions. These findings 
support the contention that the rats were indeed responding at chance. 
The pattern of errors for the vehicle treatment group changed as a result of OT, with 
OT significantly increasing the number of perseverative responses for Rev1 (but not Rev2), 
and also significantly reducing the number of responses made at chance, for both Rev1 and 
Rev2 compared to rats trained only to criterion (Condition by Response Type by Treatment 
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group by Stage interaction: F(2,32) = 7.04, p<0.05; Bonferroni-corrected pairwise 
comparison; nρ2= 0.31; figure 7.2.2). At Rev1, as a result of OT, 5 out of 9 vehicle-treated 
rats (56%) made only perseverative responses, immediately followed by the final 6-correct 
responses thus showing no evidence of ‘at chance’ responding. Of these 5 rats, 2 also 
showed no ‘at chance’ responding for Rev 2.  
Conversely, in the CNO-treatment group, OT impaired reversal learning 
performance at Rev1 (p<0.01; figure 7.2.3). The Rev1 mean TTC for the non-OT condition 
was 14.67, which is very similar to value for the vehicle-treatment group (14.78) 
(Bonferroni-corrected pairwise comparison, n.s.). This pattern indicated that not only did 
CNO treatment prevent an ORE, but OT actually increased TTC, to a mean of 18.78, at 
Rev1. Rev2 showed neither benefit nor cost of CD-OT: the mean TTC for OT was 15.78 
and for non-OT was 15.22. The increase in TTC as a result of OT was not due to an 
increase in perseverative errors in the CNO-treatment group, but rather to an increase in the 
number of responses ‘at chance’ (p<0.05; Bonferroni-corrected pairwise comparison; 
figure 7.2.4). Removing the data for the unilaterally-transduced animal had no effect on the 
statistical outcome or conclusion of this section: CNO-treated rats were still impaired at 
Rev1 when CD-OT was given, compared to being trained to criterion only (p<0.05; 
Bonferroni-corrected pairwise comparison), and that this impairment was driven by an 
increase in the number of responses ‘at chance’ (p<0.05; Bonferroni-corrected pairwise 
comparison). Furthermore, the Rev1 TTC data for this rat for the OT condition (19 TTC) 
indicates a marked impairment compared to when it was trained to criterion only (14 TTC), 
suggesting that performance worsened following OT, which is consistent with the 
remaining bilaterally-transduced animals.  
Reclassifying CNO-treated rats as animals with either ‘minimal’ (n=5) or ‘moderate’ 
(n=4) transduction had no effect on the statistical outcome for the omnibus ANOVA (Stage 
by Condition by Revised Treatment group interaction: F(7.4,55.61) = 2.15, p<0.05; Huynh-
Feldt correction; uncorrected df= 10,75; nρ2= 0.22), and performance between these two 
transduction groups did not differ for any stages of the task (Bonferroni-corrected pairwise 
comparison). Consequently, OT still impaired reversal learning for both CNO-treated 
transduction groups. Furthermore, a Pearson correlation revealed that increasing levels of 
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transduction to areas outside the STN (i.e., in the ZI & LHA) did not influence performance 
for the reversal when OT (r = 0.24; n=9; n.s.); that is, higher levels of transduction are not 
correlated with exacerbated reversal performance following CNO and OT. Furthermore, 
there was no relationship between the amount of transduction for each region and the level 
of impairment at Rev1 when OT: differences in transduction within the ZIV (r = −0.04; 
n=9; n.s.), ZID (r = −0.07; n=9; n.s.), and LHA (r = −0.27; n=9; n.s.), respectively, did not 
significantly correlate with Rev1 behaviour following CNO treatment. Overall, reversal 
data for rats with more robust transduction profiles of the ZI and LHA did not differ from 
rats with colocalised transduction limited to the STN and minimally to surrounding tissue; 
this further supports that inactivation of the STN is driving the impairments observed here. 
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Figure 7.2.1: Mean trials to criterion (+SEM) for vehicle-treated rats on the modified six 
stage task, for the OT (+30 post-criterion trials), and non-OT test sessions; OT 
significantly improved reversal learning performance for Rev1 and Rev2; *p<0.05. 
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Figure 7.2.2: Mean number of trials (+SEM) of perseverative and ‘at chance’ responses 
for vehicle-treated rats; OT increased the number of perseverative responses (errors) at 
Rev 1, but decreased the number of ‘at chance’ responses for Rev1 and Rev2.    
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Figure 7.2.3: Mean trials to criterion (+SEM) for CNO-treated rats on the modified six 
stage task, for the OT (+30 post-criterion trials), and non-OT test sessions; OT 
significantly retarded reversal learning performance; **p<0.01. 
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Figure 7.2.4: Mean number of trials (+SEM) of perseverative and ‘at chance’ responses 
for CNO-treated rats; OT increased the number of responses made at chance for Rev 1, but 
did not influence the number of perseverative responses incurred. 
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7.2.3.3 CNO-treated rats did not form an attentional set  
To investigate the cost of shifting set, a restricted analysis of the ID and ED stages 
was conducted. There was a very clear main effect of Treatment group, with a large and 
significant effect of Stage in the vehicle treated group (Stage by Treatment Group 
interaction: F(1,80) = 155.20, p<0.01; Bonferroni-corrected pairwise comparison; nρ
2
= 
0.90) and not in the CNO-treated rats. Condition (OT vs non-OT) had no effect on the size 
of the shift cost and, furthermore, the CNO-treated rats did not form an attentional set 
regardless of Condition (Condition: F(1,16) = <1, n.s.; nρ
2
= 0.03). Shift-cost data are 
illustrated for CNO- and vehicle-treated rats below, in figure 7.2.5 for the OT session, and 
figure 7.2.6 for the non-OT session.  
There was a significant difference between the ID and ED stages in the CNO-
treatment group, with ID requiring significantly more TTC than ED (Bonferroni-corrected 
pairwise comparison; p<0.05). Conversely, vehicle-treated rats acquired the ID 
discrimination in significantly fewer trials than the CNO-treated rats (Bonferroni-adjusted 
pairwise comparison, p<0.05), further illustrating the benefit of selective attention to the 
reward-relevant dimension. Consistent throughout this chapter (and in Chapter 6), 
removing the unilaterally-transduced rat from the analysis did not influence the statistical 
outcome of the ID-ED analysis: CNO-treated rats still did not exhibit signs of set-formation 
regardless of Condition (Bonferroni-corrected pairwise comparison), and that the ID 
required significantly more TTC than ED for this group of rats (Bonferroni-corrected 
pairwise comparison; p<0.05). Furthermore, the raw data for this unilaterally-transduced 
animal revealed that the ID required more TTC than the ED in both Conditions (OT ED−ID 
= -2; non-OT ED−ID = -3).    
Reclassifying CNO-treated rats as animals with either ‘minimal’ or ‘moderate’ 
transduction had no effect on the statistical outcome of the ID-ED comparison: vehicle-
treated rats still presented with a robust shift-cost, whilst both groups of CNO-treated did 
not (Stage by Revised Treatment Group interaction: F(2,75) = 77.94, p<0.01; Bonferroni-
corrected pairwise comparison; nρ2= 0.92). Furthermore, both groups of CNO-treated rats 
still acquired the ID in significantly more TTC than the ED, whilst demonstrating no 
between-group differences in performance for either stage (Bonferroni-corrected pairwise 
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comparison; p<0.05). A Pearson correlation revealed that increasing amount of 
transduction to areas outside the STN (i.e., in the ZI & LHA) did not influence the 
magnitude of the shift-cost for CNO-treated rats when OT (r = −0.54; n=9; n.s.), nor when 
trained to criterion only (r = −0.22; n=9; n.s.); essentially, higher levels of transduction did 
not influence a more rapid acquisition of the ED (nor was it exacerbated). Similarly, there 
was no relationship between the amount of transduction for each region and the magnitude 
of the ID-ED difference when CNO-treated rats were given OT or non-OT: differences in 
transduction within the ZIV (OT: r = −0.44; non-OT: r = −0.12; n.s.), ZID (OT: r = −0.46; 
non-OT: r = −0.09; n.s.), and LHA (OT: r = −0.31; non-OT: r = −0.44; n.s.) did not 
significantly correlate with shift-cost performance. 
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Figure 7.2.5: Mean trials to criterion (+SEM) for vehicle- and CNO-treated rats at the ID 
and ED stages for the OT test session. ‘#’ indicates that vehicle-treated rats exhibited a 
significant positive cost of shifting attentional set between the ID and ED stages. ‘β’ 
indicates that CNO-treated acquired the ED stage in fewer trials than ID. CNO-treated 
rats were impaired at the ID, but completed the ED in fewer trials than vehicle-treated rats. 
**p<0.01.    
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7.2.6: Mean trials to criterion (+SEM) for vehicle- and CNO-treated rats at the ID and ED 
stages for the non-OT test session. ‘#’ indicates that vehicle-treated rats exhibited a 
significant positive cost of shifting attentional set between the ID and ED stages. ‘β’ 
indicates that CNO-treated acquired the ED stage in fewer trials than ID. CNO-treated 
rats were impaired at the ID, but completed the ED in fewer trials than vehicle-treated rats. 
**p<0.01.    
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7.2.4 Discussion 
The current study found, in two experiments, that rats given 30 OT trials perform a 
subsequent reversal in fewer trials than if trained only to criterion. When the STN, ZI and 
LHA were inactivated by administration of CNO in DREADDs-transduced animals, OT 
resulted in an impairment in reversal learning that was not seen when the same rats were 
not given OT trials. This suggests that CNO administration – with the consequent inhibition 
of these areas – prevents an ORE, and provides further support for the hypothesis that rats 
with inhibition of the STN fail to form set. Furthermore, irrespective of training condition, 
control rats demonstrated a significant cost of set-shifting (comparison of ID and ED 
stages), whilst CNO-treated rats did not.   
Garner et al. (2006) reported that mice given 50 post-criterion trials at Rev2 require 
significantly more trials at the subsequent ED stage, compared to mice trained only to 
criterion. In the current experiment, 30 OT trials at the CD had no effect on the size of the 
shift cost, namely OT did not facilitate ID acquisition, or elevate ED performance with 
respect to non-OT vehicle-treated rats. Consistent with Sutherland & Mackintosh (1971) 
however, OT increased the number of perseverative responses in vehicle-treated rats at the 
first reversal, but also decreased the number of trials spent responding at chance for both 
the first and second reversal. According to their theory, OT strengthens an ‘analyser’ (i.e., 
increases the predictiveness of a stimulus dimension), and owing to this, rats are less likely 
to respond to an irrelevant dimension during a reversal, and consequently spend fewer trials 
at chance. Consequently, the finding that OT did not increase perseverative responding at 
Rev2 likely results from the fact that rats were not given OT at the ID stage, however the 
noted decrease in responses made at chance supports that OT facilitated learning for Rev2 
as well. 
The previous chapter demonstrated that CNO-treated rats solve the discriminations 
by learning about the stimuli holistically (see section 6.3.3.4), which may be the result of 
being unable to form set or may be the cause of it. This approach to discrimination learning 
likely contributed to the impairment in reversal learning following OT reported here; by 
responding ‘configurally’ (and being unable to inhibit responding to the irrelevant 
dimension), OT retarded reversal performance, likely as a result of a rigid stimulus-
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response contingency, and the continual strengthening of a configuration with reward. 
Furthermore, during a reversal stage, these rats will spend more trials responding at chance, 
learning the ‘new combination’ of stimuli that are now reward-relevant.  
  The findings in this chapter demonstrated that the ORE results from the same 
mechanisms as attentional set-formation. This challenges the established ‘double 
dissociation’ of reversal and attentional processes, by demonstrating that reversal learning 
and attentional set-formation are not independent processes operating at different levels of 
response selection. Instead, these findings suggest that reversal and attentional processes 
are manifestations of a common process of attention and associability, in which response 
attachments serve to strengthen an attentional set towards a relevant dimension and away 
from an irrelevant one. These data also expand on the findings of Chase et al. (2012), who 
found that lesions to the OFC not only impaired reversal learning, but also impaired set-
formation, which led to the conclusion that both impairments were likely due to a single 
cognitive deficit.  
This experiment used the same cohort of DREADDs-transduced animals as Chapter 
6, but with a change in the CNO treatment, such that vehicle-treated rats in Chapter 6 
received CNO in this experiment, and vice versa. This arrangement allowed us to test all 
rats with and without CNO to determine that transiently modifying neuronal signalling in 
the STN produces detrimental behavioural changes in all animals, and that in the absence of 
CNO, vehicle-treated rats exhibit typical control-like behaviour. Findings from Chapter 6 
also determined that extraneous transduction in the ZI & LHA did not significantly 
influence behaviour during any of the manipulations of the 11-stage task (see section 
6.4.2); similarly here, CNO-treated rat that were subdivided into groups with either 
‘minimal’ and ‘moderate’ extraneous transduction did not differ in any measures of 
behaviour, including the impaired Rev1 performance following OT, along with shift-cost. 
Furthermore, there was no correlation between the level of transduction of any given region 
(e.g., ZIV) and behaviour of interest in this experiment, and that CNO-treated rats without 
extraneous transduction to the ZI/LHA performed similar to rats with robust bilateral 
transduction of these regions. Similarly, increasing overall transduction levels to encompass 
more extraneous regions (i.e., globally increasing transduction, or transducing 
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combinations of regions) does not correlate with levels of impairment for any of the 
behavioural measures for set-formation in this experiment, suggesting that robust, 
extraneous transduction to the ZI and LHA had a minimal impact on the behavioural 
deficits observed here. Previous work has detailed that including animals with extraneous 
lesion damage to the ZI in studies with STN-lesioned rats does not influence the behaviour 
of interest, nor statistical outcome (Baunez et al., 1995; Baunez & Robbins, 1999; Phillips 
& Brown, 1999; Phillips & Brown, 2000). Furthermore, there is currently no data 
supporting a robust cognitive role for the ZI and LHA, unlike the STN (see section 1.8). 
The CNO treatment arrangement between Chapter 6 and the current experiment has 
allowed us to determine that varying levels of extraneous transduction to the ZI and LHA 
may play a minimal role in the set-formation deficit in this thesis, which may be largely 
driven by the area which expressed the most robust, and consistent transduction, the STN.  
One animal from each CNO dosing group had unilateral transduction of the STN, 
and as described in Chapter 6, the inclusion of the unilaterally-transduced CNO-treated rat 
did not influence the outcome of any of the behavioural analyses of the 11-stage task, nor 
the acquisition of the bi-conditional discrimination. Switching the CNO treatment groups 
for the current experiment assigned the unilaterally-transduced vehicle-treated rat from 
Chapter 6 to the CNO group here, and similar to Chapter 6, excluding the data for this rat 
had no effect on the outcome of the CNO-treated group. Again, this must be interpreted 
with hesitation as only one rat in the CNO group had unilateral transduction, however 
based on previous work with STN lesions, we have seen that animals with unilateral lesion 
damage present with a milder impairment in cognition compared to the more profound 
impairment in cognition observed in bilaterally-lesioned rats (see section 3.4.1.1). 
Furthermore, the transduction profiles of the two unilaterally-transduced rats are nearly 
identical, except transduction is found in the opposing hemispheres: colocalised 
transduction of the STN encompassed between 40-45% of the nucleus, with minimal (10%) 
transduction of the ZIV.  
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7.2.4.1 Conclusions 
In summary, the current experiment illustrated that transient inactivation of the STN 
and ZI/LHA prevents the ORE, leading to impairment in reversal learning, and 
consequently the ability to form and shift attentional set. The impairment in reversal 
learning following OT in CNO-treated rats results in more trials in which the rats respond 
‘at chance’. Conversely, following OT, vehicle-treated rats spend fewer trials responding at 
chance, but incur more perseverative errors, owing to the formation of attentional set. These 
findings provide evidence that the associative processes of reversal learning and attentional 
processes in set-formation are inherently linked as a unified process of attention and 
associability, rather than independent processes. It was also revealed that extraneous 
transduction to the ZI and LHA may have a minimal role in this behaviour, which may be 
mediated by the STN. 
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Chapter 8 
 
General Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ability to attend selectively allows us to enhance our focus 
towards relevant information, whilst filtering out irrelevant 
information; this process ultimately leads to the formation of an 
attentional set. The work presented throughout the experimental 
chapters examined the involvement of the STN in this process. 
Modifications to the task design with manipulations that aid in 
inferring set-formation, along with a relatively novel approach to 
manipulating cellular activity, led to the findings that inhibition of 
the STN, and perhaps to some degree the ZI & LHA, leads to a 
disruption in attentional selectivity. It was found that inhibition of 
this region results in configural learning which may arise as a result 
of being unable to form set, or may be the cause of it. The findings 
from Chapter 7 suggest that impairments in reversal learning and 
attentional selectivity can originate from a single brain region, and 
these findings align with Mackintosh’s two-stage learning theory. 
The involvement of STN in set-formation raises several theoretical 
questions, including whether this region participates with others to 
form a network of brain areas involved in the mediation of set-
formation. In this chapter, I will evaluate how the STN may 
participate in selecting actions which ultimately facilitates the 
formation of attentional set.    
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The experiments conducted in this thesis sought to explore the involvement of 
the STN in processes that are considered to represent ‘executive functions’. The general 
protocol applied throughout this thesis is identical the approach taken in 
neuropsychopharmacology research, which follows several fundamental steps in order 
to assess whether a brain region (and/or a cognitive-enhancing drug) may influence 
observable behaviour. These steps include: 
1. Select the most suitable animal model to investigate the cognitive function of 
interest,  
2. Choose an appropriate and reliable behavioural task, 
3. Manipulate the brain area of interest and/or administer treatment, 
4. Look for changes in task performance relative to control animals.  
In the current section, the experimental chapters presented throughout this thesis 
will be evaluated in light of these four steps. To examine set-formation, and how the 
STN may contribute to the processes that lead to it, the majority of the experiments in 
this thesis involved modifying an existing behavioural task (i.e., the ASST). At the 
outset of this thesis, we knew that animals can be trained to respond to one set of stimuli 
in compound, evidencing an associative relationship between stimulus and reward, and 
that through ‘sufficient experience’, an attentional set is formed (Lawrence, 1949; 
Sutherland & Mackintosh, 1971), yet exactly how it arises, or why this occurs is still not 
well understood. This position underscored that step 2 required careful consideration in 
order to design manipulations which accurately measures behaviours reflective of set-
formation, rather than solely inferring this behaviour from the inability to demonstrate a 
cost of set-shifting.  
8.1 Findings 
The first study reported in Chapter 3 attempted to replicate, and expand on 
recently published findings (Tait et al., 2016), which reported an impairment in 
attentional set-formation following STN/ZI-area lesions; however this impairment may 
have resulted from an impairment in discrimination learning at early stages of the task. 
To reconcile this, subsequent (unpublished) findings with lesions that spared the lateral 
portion of the STN have found that despite unimpaired early discrimination learning 
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stages, lesioned rats still do not demonstrate a robust cost of shifting set. Unfortunately, 
in an effort to replicate this effect, the histological results from Chapter 3 revealed that 
predominantly unilateral STN lesions were insufficient to produce pronounced 
behavioural deficits, and that furthermore control rats did not exhibit robust evidence 
for attentional set-formation either. This asymmetry in lesion damage suggested the 
minimum conditions for step 3 in the aforementioned protocol (manipulation of the 
brain area of interest) were not met, which likely led to minimal comparable differences 
between lesioned and control rats (step 4). This limitation resulted in a similar outcome 
for the second study in Chapter 3, which presented a modified 11-stage task. This task 
examined several hypotheses relevant to the inference of set-formation, including: 
whether additional experience would aid in set-formation (multiple ID stages), examine 
if the set-formation impairment stemmed from a memory impairment (delayed reversal 
stages), and assess the degree to which rats were still attending to the irrelevant 
dimension (‘probe’ stage). The task also included an adjunct bi-conditional stage, which 
investigated whether lesioned rats were learning the stimuli as configurations, rather 
than attending to a stimulus dimension. A mild cognitive deficit induced by mostly 
unilateral lesions, coupled with a significantly reduced sample size is likely what led to 
the failure in producing a pronounced behavioural deficit in attentional set-formation.  
The research reported in Chapter 4 further attempted to explore the possibility 
that lesions of the STN impaired the formation of attentional set by utilising an 
alternative behavioural approach in the form of a succinct revision to the 11-stage task, 
and investigating whether putative ‘cognitive-enhancing’ drugs – modafinil and 
ORG49209 – might restore performance in either lesioned or control animals. To more 
effectively deliver these drugs, the first experiment in Chapter 4 reported that a reduced-
stress jelly tablet was an efficacious method in delivering orally bioavailable drugs, and 
reported that voluntary consumption of modafinil yielded brain concentrations 
comparable to that of oral gavage. Consistent with previous findings, this study also 
evidenced that modafinil increased LMA, but only at later time-points, replicating that 
modafinil does not increase LMA intensity, and rather exerts an alternative ‘wake-
promoting’ effect. The second experiment in Chapter 4 utilised these jelly-tablets to 
deliver either ORG or modafinil in the modified ‘early-late probe’ task, which – as the 
name implied – utilised two ‘probe’ stages, in which only the irrelevant dimension 
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stimuli were changed. Instead of evaluating the cost of shifting set via an ID/ED 
comparison, the early-late probe task tested the (potentially) disruptive effects of 
changing the stimuli in the irrelevant dimension, with the hypothesis that an ‘early 
probe’ stage, presented before an attentional set has formed, would provide a greater 
distraction than a ‘late probe’ stage, in which an attentional set would aid in inhibiting 
responding toward an unattended dimension. The results determined that the late probe 
indeed was acquired in fewer trials than the early probe; however, since control rats did 
not exhibit an ID/ED difference during an interim 7-stage task, it was not parsimonious 
to interpret this improvement between the probe stages as evidence for the formation of 
attentional set. Similar to the results reported for Chapter 3, the majority of lesions in 
Chapter 4 were undetectable, thereby significantly reducing the sample size, and it was 
therefore also not possible to draw any conclusion about the contribution of the STN to 
this behaviour. The intact tissue in the unilaterally-lesioned rat, and the high variance 
for the four bilaterally-lesioned rats may partially explain the lack of an observable 
effect for either drug on performance; this tissue likely sustained performance, such that 
there was no impairment against which to measure ameliorative effects of the drugs. 
Therefore, owing to an ongoing challenge in manipulating the STN (step 3), we were 
again unable to ascertain how lesioned rats may express a behavioural deficit compared 
to control rats (step 4), and also unable to robustly validate the efficacy of the early-late 
probe task (step 2). 
  The inability to visualise lesion damage following ibotenic acid infusions to the 
STN presented in Chapters 3 and 4 were addressed in Chapter 5 by introducing a 
relatively novel investigative tool – DREADDs. This approach provided increased 
experimenter control of neuronal functioning by delivering a viral vector which 
transduced the cells within the STN with an inhibitory designer receptor; this allowed 
for transient inhibition following administration of a designer drug (CNO). The 
experiments reported in this chapter firstly demonstrated that an efficacious 
combination of serotype (AAV5) and promoter (CaMKII) yielded transduction of the 
cells within medial, and not within the lateral, STN; furthermore transduction also 
included a relatively small proportion of neighbouring regions (e.g., ZI and LHA). The 
second experiment in Chapter 5 reported that application of CNO to animals with 
DREADDs infusions to the medial STN expressed a reduction in c-Fos labelling in the 
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STN, providing an index of inhibition of cellular activity. This chapter detailed that 
DREADDs present as a refinement in how the cells of the STN are manipulated (step 3) 
compared to excitotoxic lesion surgery.  
Using the surgical protocol reported in Chapter 5, Chapter 6 found that 
inhibition of the STN, ZI, & LHA resulted in behavioural deficits consistent with an 
attentional set-formation impairment on the 11-stage task. This was inferred from 
several manipulations presented in the task: CNO-treated rats did not demonstrate a cost 
of shifting attentional set, nor did they exhibit an improvement in learning across 
multiple ID stages. The error data from the first four trials of the delayed reversal stages 
allowed us to reject the hypothesis that the subthalamic-mediated set-formation 
impairment stemmed from impairment in memory. It was evident that CNO-treated rats 
remembered the stimuli from the original discrimination, illustrating a reversal cost, 
despite requiring fewer trials to learn the reversal. Furthermore, the probe stage 
indicated that these rats were distracted by changes in the irrelevant dimension, whereas 
control rats completed this stage with little detriment on performance. The results 
reported for the adjunct bi-conditional discrimination suggested that CNO-treated rats 
were processing the stimuli holistically and that by responding to the configurations of 
the stimuli, they were able to complete the task with relatively little impairment. This 
served to reconcile the reversal learning data; having to retain multiple configurations of 
stimuli in memory (e.g., the reward pairing of four distinct stimuli) increased the 
cognitive load for discrimination learning, compared to retaining one rule (e.g., ‘the 
bowl smelling of cinnamon is baited’). Less effective learning about each of the four 
stimuli might mean that they (or their response costs) are less well retained and, with 
further interference from the novel stimuli of the intervening stages, fewer trials were 
required to learn the new stimulus-reward relationships than were required to learn a 
new rule (e.g., ‘the bowl smelling of ginger is baited’). It was also found that higher 
levels of extraneous transduction to the ZI and LHA did not serve to exacerbate, nor 
facilitate behavioural performance, and that irrespective of level of colocalised 
transduction to these areas, all CNO-treated rats exhibited a similar pattern of 
behavioural deficits, perhaps owing to consistent transduction of the STN.  
To investigate the relationship between the processes of associative learning and 
set-formation further, Chapter 7 explored the ORE – a paradoxical phenomenon 
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formalised by Sutherland & Mackintosh (1971) detailing that OT leads to a faster 
reversal acquisition due to the formation of an attentional set. The first half of the 
chapter replicated the ORE in the rodent bowl-digging paradigm in unoperated rats. The 
second experiment in Chapter 7 used the same cohort of DREADDs-transduced rats 
from Chapter 6, and reported that OT facilitated reversal learning for Rev1 and Rev2 for 
control rats only; CNO treatment prevented the ORE, resulting in impaired reversal 
learning performance. This indicated that OT impairs reversal learning when set cannot 
be formed, and that owing to configural learning, OT continuously strengthening the 
associative relationship between the correct configurations and reward. These finding 
also suggested that STN-mediated set-formation impairment is profound, likely 
resulting in a permanent inability to form set.  This also illustrated that reversal learning 
and set-shifting are not independent ‘types’ of learning, and instead are a manifestations 
of a common process of attention and associability. Finally, increased extraneous 
transduction to the ZI and LHA did not impact behavioural performance in this 
experiment as well, and irrespective of level of colocalised transduction in these areas, 
all CNO-treated rats exhibited a similar pattern of behavioural deficits; these findings 
coupled with the identical null results from Chapter 6 suggested that the impairment in 
attentional set-formation here may be predominantly derived from the inactivation of 
the STN.  
8.2 The role of the STN in attentional set-formation 
The experiments summarised above have elevated the role of the STN in 
cognitive functioning, along with expand our understanding of the processes involved in 
attentional set-formation. As a recently identified behavioural deficit, our current 
inference of an attentional set-formation impairment has relied on the lack of a shift-
cost, which conversely, is actually a measure of set-shifting behaviour. By using this 
approach, we have previously observed a lack of a shift-cost in the 7-stage task after 
ibotenic acid lesions to the OFC (McAlonan & Brown, 2003; Chase, Tait, & Brown, 
2012), basal forebrain (Tait & Brown, 2008), and STN/ZI (Tait, Phillips, Blackwell, & 
Brown, 2016) and in the 4ID task, after quinolinic acid lesions of dorsomedial striatum 
(Lindgren, Wickens, Tait, Brown, & Dunnett, 2013). The work in this thesis sought to 
expand on how we measure set-formation by introducing several manipulations 
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sensitive to its inference, in an effort better understand set-formation as a process. As it 
stands, we don’t fully understand why set is formed. In the absence of set, an individual 
can remain cognitively flexible, being able to rapidly shift behaviour to changing 
circumstances, and in the current thesis – particularly Chapters 6 and 7 – this was 
illustrated by decreases in the number of trials required for ED acquisitions. However in 
the absence of set, all the benefits of selectively attending are lost, such as the 
enhancement of novel learning when it can be predicted – as illustrated by the reduction 
in multiple ID stages for vehicle-treated rats in Chapter 6.  
The deficit in set-formation presented in this thesis has illustrated this pattern; 
namely an increase in ID learning, and a decrease in ED with respect to control rats. It 
was found that in the absence of attending to stimulus dimensions, subjects learned that 
configurations of stimuli best predicted reward, which allowed them to complete the 
task with relatively little impairment, compared with control animals. Despite this, the 
inability to form set and instead treat complex stimuli configurally would beset a series 
of challenges to daily life. For example, as an occasional consumer of Coca-Cola, I 
would find it quite easy to pick out a diet Coke when navigating the soft drink aisle at 
my local newsagent, owing to my experience and knowledge of certain aspects of a 
Coke bottle as a multidimensional stimulus (i.e., cap colour, bottle shape, manufacturer 
font/script, etc.). In the past I could readily select a diet Coke owing to the distinct white 
cap colour, which has recently been changed to red – the same colour as normal Coke – 
and thus I find myself having to re-check the label to ensure that I have selected the 
right product; essentially this change has prompted a shift in my attention to other 
pertinent predictors of ‘diet Coke’. If I possessed a dysregulated STN, and an 
impairment in set-formation that has been compensated by (or resulting from) holistic 
processing, I would attempt to process all of the multidimensional qualities of a diet 
Coke bottle, which owing to its relative complexity, and similarity to other soft drinks at 
the newsagent, may result in me vacillating between drink options with similar qualities 
(i.e., normal Coke, Dr Pepper, etc.). Furthermore, the recent change in cap colour would 
also yield disruption in this processing, or delayed learning in acquiring what now 
constitutes a diet Coke bottle.  
The above is merely a qualitative example of what may arise from subthalamic 
dysregulation; however, patients who undergo HFS for treatment of Parkinson’s 
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symptoms exhibit cognitive declines in various processes of executive control, such as 
selective attention, working memory, speed of mental processing, and susceptibility to 
interference (Aono et al., 2014; Bronstein et al., 2011; Saint-cyr, Trepanier, Kumar, 
Lozano, & Lang, 2000; Smeding et al., 2006). Although HFS, unlike lesioning, does not 
truly mimic an inactivation of the STN (much of the deficits induced by HFS are 
transient; see: Baunez, Christakou, Chudasama, & Forni, 2007; Hershey et al., 2003), 
current research with Parkinson’s patients has not examined whether this group is 
impaired at attentional set-formation on the ASST, since the impairments in selective 
attention and susceptibility to interference noted in this thesis attest to the importance in 
undertaking this type of research in clinical populations.  
A disruption in attentional selectivity was identified to be likely driving the set-
formation impairment in this thesis, which is different than the set-formation deficits 
induced by disrupting other brain regions, such as the OFC. Unlike in OFC-lesioned rats 
(Chase et al., 2012), additional ID stages did not contribute to evidence of set-formation 
in subthalamic-inhibited rats. Furthermore, OFC-lesioned rats, and not subthalamic-
inhibited rats, are impaired at reversal learning (McAlonan & Brown, 2003; Chase et al., 
2012). Thus, in the absence of a reversal deficit (and no information on set-shifting), we 
must consider that the subthalamic-mediated set-formation impairment arises from 
different mechanisms than the OFC-mediated one.  
It also appears that the subthalamic-mediated deficit does not result from a 
failure to downregulate attention to redundant information, such as after mPFC lesions 
(Sharpe & Killcross, 2014), especially since mPFC-lesioned rats demonstrate robust 
evidence of set-formation, along with significantly impaired ED performance (Birrell & 
Brown, 2000; Tait, Marston, Shahid, & Brown, 2009). Our lab has also recently shown 
that rats with DREADDs-inhibition of the mPFC exhibit a distinctly different pattern of 
behaviour to the DREADDs-inhibited rats in this thesis by demonstrating a shift-cost, 
despite also presenting evidence that they learn about the irrelevant cues during a probe 
stage (Whyte, Tait & Brown, unpublished). This suggests that whilst mPFC-inhibited 
rats fail to downregulate attention to irrelevant information, this doesn’t disrupt 
attentional set-formation. In contrast, CNO-treated rats in this thesis failed to 
demonstrate the ability to parse relevant from irrelevant (implying limited attentional 
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selectivity), and instead solve the compound discriminations by learning the 
correct/incorrect stimulus configurations.   
Seminal research of the STN’s involvement in cognition, spearheaded by 
Christelle Baunez, reported that lesioning the STN results in premature or impulsive 
responding on visuo-spatial attention tasks (Baunez & Robbins, 1997; Baunez, 
Nieoullon, & Amalric, 1995); an effect which has been robustly replicated in similar 
tasks in both lesioned rats (Baunez & Robbins, 1999; Chudasama, Baunez, & Robbins, 
2003; Phillips & Brown, 2000) and following DBS treatment in humans (Aron & 
Poldrack, 2006). Subsequent research by Baunez and colleagues (2001) investigated the 
effect of STN lesions on the response preparatory processes in a modified reaction-time 
task. In one test, rats were presented with information regarding the response location in 
advance, whilst in another test, the information was not presented. Contrasting 
performance between these two tests revealed that STN lesions do not impair the 
‘readiness to respond’ to cues in either task (i.e., ‘motor readiness’), suggesting that the 
signs of impulsive responding seen following STN lesions are likely not due to an 
impairment in the ‘when’ phase of action preparation. Instead, the authors suggested 
that lesions abolish the beneficial effects of information presented in advance (i.e., the 
‘which’ phase of response preparation); implying an impairment in response selection.  
Thus, the function of the STN, namely the ability to ‘hold a response’(see Frank, 
2006), is impaired following lesioning, resulting in ‘impulsive action’ (not being able to 
inhibit the initiation of a response), which actually may reflect a global impairment in 
action selection. This consideration may reconcile the results reported in this thesis, in 
which subthalamic dysregulation here may have introduced a form of ‘cognitive 
disinhibition’; it is speculated that subthalamic-inhibited animals were unable to inhibit 
responding to the irrelevant dimension, such that they never learned that this dimension 
was irrelevant (and by extension, which dimension was relevant). This impairment in 
selecting the correct responses led to an inability to assign relevancy (i.e., switch in 
analysers), and perhaps as a consequence, these rats treated combinations of the cues as 
correct/incorrect. Recent electrophysiology research in monkeys by Espinosa-Parrilla, 
Baunez, & Apicella, (2015) found evidence that STN neurons encode whether or not a 
preferred reward had been received when a choice between response alternatives was 
required. Therefore, by inactivating these neurons within the STN the rats may not have 
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been able perform ‘outcome evaluation’; updating response attachments with stimuli in 
light of reward or punishment. The inability to update response attachments would 
ultimately render a failure to downregulate redundant (irrelevant) information and 
upregulate relevant information, leading to a failure in set-formation.  
This exercising of ‘impulsive action’ can be contrasted from ‘impulsive choice’ 
responding (for review see Eagle & Baunez, 2010; but also Evenden, 1999), in which 
the latter entails the selection of actions without deliberation of other possible outcomes 
or options. ‘Impulsive choice’ behaviour is typically modelled in a delay-discounting 
task, which presents subjects with the option of a small but immediate reward, or a large 
but delayed reward. Interestingly, STN-lesioned rats were able to overcome impulsivity 
to wait for a larger reward (Winstanley, Baunez, Theobald, & Robbins, 2005), and it is 
theorised that this inhibitory control may be modulated by motivation for the outcome 
(Uslaner & Robinson, 2006). This consideration may also entertain why we did not 
observe ‘impulsive digging’ behaviour in this thesis (i.e., no impairment in compound 
discrimination learning), as the option for the ‘other bowl’ was sufficiently motivating 
to subthalamic-inhibited rats that they were able to withhold an impulsive digging 
response. The ability to withhold impulsive/compulsive digging in the incorrect bowl 
also implied that these rats were able to inhibit a prepotent motor response, and perhaps 
the ‘impulsive action’ behaviour previously seen in lesioned animals (Baunez et al., 
1995; Baunez & Robbins, 1997; 1999) manifests differently in the ASST as a failure to 
form attentional set. This also supports the previous observations that tasks which do 
not exert strict time constraints during a given trial (i.e., goal-directed research, 
increased stimulus duration) find fewer deficits associated with impulse control in STN-
lesioned animals (Baunez & Robbins, 1997; El Massioui et al., 2007; Pote et al., 2016).  
Although previous work detailed that lesioning the rat STN may induce 
impairments in working memory, either by impairing the normal operation of a ‘motor 
working memory buffer’ (Baunez et al., 2001), or by inducing an inclination to rapidly 
forget previous response associations between stimuli (El Massioui et al., 2007), there 
was no evidence to suggest that inactivating the STN impairs working memory in this 
thesis. The anthropomorphised ‘motor working memory buffer’ in Baunez et al. (2001) 
is purported to hold a selected response in readiness until its execution is required; this 
ability is rendered dysfunctional in STN lesioned rats, resulting in a conflict in response 
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selection and the observed perseverative behaviour in visuo-spatial attention tasks. 
Conversely, in another study in which working memory deficits are reported in STN-
lesioned rats (El Massioui et al., 2007), the authors did not report increased 
perseverative behaviour. In El Massioui et al. (2007), when a sufficient delay between 
the offset of a cue and presentation of the response levers are introduced, rats apparently 
‘forget’ where to respond, indexing more errors and incomplete trials. By delaying or 
offsetting reversal stages in Chapter 6, we were able to evaluate working memory 
performance by requiring rats to retain pertinent information regarding qualities of the 
stimuli learned during a compound discrimination stage, along with their respective 
response strengths. As reported in Chapter 6, even after three intervening stages, 
subthalamic-inhibited rats clearly retained a memory of the stimulus-response 
attachments by rejecting the previously incorrect bowl as readily as control rats during 
early trials of the delayed reversal stages. Thus, the working memory deficits previously 
observed could again result from the task requirements; the ASST permits up to ten 
minutes per trial to make a response, and therefore the nature of the reported STN-
mediated working memory deficit may depend on task parameters and time constraints.   
STN-lesioned rats in El Massioui et al. (2007) also acquired the reversal in 
fewer sessions than control animals, and the authors postulated that reversal 
performance might be enhanced, stemming from an improvement in attentional 
selectivity following STN lesions. As demonstrated in Chapter 7, facilitation of reversal 
performance owing to improvements in attentional selectivity during two-choice 
discrimination learning typically arises from overtraining (see Sutherland & Mackintosh, 
1971), and is indicative of attentional set-formation. Despite this interpretation, El 
Massioui et al. (2007) did not report any evidence for overtraining in any of the rats in, 
such as comparable performance during discrimination learning and during retraining 
phases, respectively. Furthermore, the interpretation that STN lesions may enhance 
attentional selectivity is inconsistent with the findings reported in this thesis, which 
details an impairment in attentional selectivity following inhibition of the STN. El 
Massioui et al. (2007) postulated that this focussed attention would enhance learning to 
relevant stimuli, but “to the detriment of a general attentional process devoted to all 
components of the experimental situation”. The detriment being referred to here actually 
pertains to the cost associated with shifting set, and therefore this interpretation is 
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problematic in the context of the lever-pressing task used in El Massioui et al. (2007), in 
which there is no task requirement which mimics an ED shift. 
8.3 Why the STN? 
Nearly seventeen years ago in our lab, whilst investigating whether lesions to the 
STN after dopamine depletion would ameliorate the reversal deficits seen in the ASST, 
there was a serendipitous finding: the ‘control’ group of rats that had received only STN 
lesions unexpectedly exhibited a profile of impairment that was not previously observed 
following lesions to any other region of the brain. The experiment was presented as a 
poster at the annual meeting of the Society for Neuroscience but a subsequent 
manuscript was rejected because the authors could not give the reviewers an adequate 
explanation of the findings. The manuscript was not published until 2016 and, in the 
intervening years, a number of studies have been undertaken in an attempt to determine 
both how and why this area was involved in attentional set, culminating to the work 
conducted for this thesis. This work addresses one of these two considerations, yet 
further investigation is needed to determine why this region is involved. Perhaps this 
question can be better fielded by considering how disruption of the STN affects 
downstream neural functioning.  
It has been stressed throughout this thesis that the STN is not the only region of 
the brain that may be implicated in attentional set-formation, with evidence suggesting 
that lesioning the OFC (McAlonan & Brown, 2003; but see Chase et al., 2012) or the 
DMS (Lindgren et al., 2013) also impairs this behaviour. As previously stated, the OFC-
mediated deficit results in a delayed ability to form set: with sufficient experience, after 
multiple ID stages, a set does form. A DMS-mediated deficit, akin to the subthalamic-
mediated deficit, has been reported (Lindgren et al) which was more profound, with no 
evidence of set-formation following at least 4 consecutive ID stages. However, it should 
also be noted that we have not seen such a deficit (Tait et al., 2016) and have failed to 
replicate one (Garcia, unpublished PhD thesis, 2016). Nevertheless, possibility that both 
the STN and DMS are involved in attentional set-formation introduces the possibility 
that dysregulation of input regions of the basal ganglia may cause this lasting set-
formation impairment; however further research – perhaps with the 11-stage task – is 
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needed in this regard to ascertain how similar the DMS-mediated deficit is to the 
subthalamic-mediated one.  
It has been shown that transient inactivation of the dorsal striatum with lidocaine 
before reversal learning, and not before compound discrimination OT, in a lever-
pressing operant task, prevented the ORE (Racht-delatour & El Massioui, 2000), which 
suggested that inactivating the DMS likely disrupts the ability to rapidly change 
responding to novel situations (i.e., learning a new rule), likely resulting in 
perseveration or learned non-reward (see Tait & Brown, 2007). Consequently, lesioning 
the DMS does not likely induce a deficit in attentional selectivity – as evidenced by an 
ORE – whereas inactivating the STN does.  
Although there is clear evidence that the dorsal striatum and the STN exercise 
different roles in cognition, a recent review by Tewari, Jog, & Jog (2016) stresses the 
collaborative nature of these two areas in response selection. They suggest that the 
striatum and the STN work in concert via the ‘indirect’ pathway for selective response 
inhibition, with the striatum promoting action execution via the ‘direct’ pathway, and 
the STN as a rapid response inhibitor via the ‘hyperdirect’ pathway. Tewari et al (2016) 
credit Frank's (2006) neurocomputational model of BG functioning, which illustrates 
that in spite of different inherent functions, the roles exercised by the DMS and STN 
allows for an indirect functional contribution to other brain regions, and possibly 
reciprocal modulation between the STN and striatum themselves. It is therefore possible 
that DMS inactivation may have incurred a downstream effect on STN regulation via 
the GPe, or vice versa; that inactivation of the STN may subsequently dysregulate 
cortico-striatal input, yet further work on this is needed.   
It is also well-documented that both the STN and the striatum receive 
considerable cortical input from regions that have been identified to play a role in 
executive functioning, including the OFC and the mPFC (Joel & Weiner, 1997; Kita et 
al., 2014; for reviews see Haber, 2016; Parent & Hazrati, 1995). The OFC in particular, 
along with the DMS and the STN form a network of regions that may be critical in 
impulsive/compulsive behaviour, and that dysregulating this network results in 
increased impulsive action, premature responding and perseveration (Eagle & Baunez, 
2010; Baunez & Lardeux, 2011). Furthermore, this dysregulation in response selection 
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may differentially disrupt set-formation when the normal functioning of these regions is 
inhibited. 
 Recent fMRI research by Morris, Baek, & Voon (2017) found higher 
connectivity between the STN and the medial OFC (mOFC) in healthy volunteers who 
excelled at tasks of ‘goal directed model-based’ behaviour: slower, deliberative 
behavioural control that required flexible, goal-directed action with an understanding of 
task-structure (see Daw, Gershman, Seymour, Dayan, & Dolan, 2011). This goal 
directed model-based behaviour can be contrasted with a ‘model-free system’, in which 
fast, reactive habitual learning is employed. This finding detailed the importance of the 
‘hyperdirect’ pathway on STN functioning, which aligned with evidence from previous 
studies (Chudasama et al., 2003; Baunez & Lardeux, 2011; Kita, Osten, & Kita, 2014). 
Furthermore this involvement of the OFC-STN connection in modulating deliberative 
response control may suggest that the silencing of these post-synaptic neurons found in 
the (predominantly medial) STN may have contributed to the observed behavioural 
deficits reported in this thesis. It is possible that pertinent information regarding the 
nature of the stimuli was relayed by the OFC to the STN, which was inhibited, and 
therefore the selection of responses that would have led to the formation of set were 
consequently not selected; as stated before, this may have resulted from the inability to 
inhibit responding to the irrelevant dimension. However, how the STN encodes this 
direct cortical (and indirect striatal) information is currently not known, but perhaps it 
plays a crucial role in outcome evaluation (Espinosa-Parilla, Booneze & Apicella, 2013; 
2015). 
Throughout this thesis, attributing behavioural results solely to the STN has not 
been directly possible, since all of the attempts to manipulate medial STN cell 
population have incurred damage/transduction to the ZI and LHA. Despite restricting 
lesion damage or viral transduction to the medial and not the lateral portion of the STN, 
extraneous manipulation of the ZIV (and in some cases the ZID), along with the lateral 
LH area (LHA) was found in some animals. In an effort to better understand how this 
varying level of cellular manipulation might affect the significant behavioural effects 
reported in Chapters 6 & 7, transduction percentages by spatial area were analysed, 
which suggested that increasing levels of bilateral transduction within the ZIV, ZID and 
LHA have a minimal impact on the behavioural deficits found in this thesis, and that 
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furthermore, the behaviour for CNO-treated animals with more overall transduction of 
the ZI/LHA did not differ from those with conservative or no extraneous transduction. 
This conclusion strongly supports that the STN was driving the majority of the effect 
here, but another study in which transduction is limited to the medial STN in all animals 
(or in a larger sample) would bolster this claim. Additionally, future work in this field 
would largely benefit from a more systematic analysis of the transduction percentage by 
counting the colocalised cells. Thickness of the tissue (and therefore a larger z-axis) 
increased the amount of signal such that mCherry and GFP (NeuN) channels imaged 
even individually were too ‘noisy’ in areas with high cell density (e.g., STN), making it 
difficult to distinguish the perimeter of the cell as it was overlapping/unclear along the 
z-axis. This effect remained for imaging at higher magnification, and was exacerbated 
by colocalisation. Whilst the tissue thickness here (50 µm) allowed for detection of 
colocalised transduction within a given region, it did not permit for cell counting, and 
therefore in subsequent research, histological methods should be altered to collect 
thinner sections (5-15µm) to permit accurate counting of colocalised cells.  
Despite this methodological shortcoming, there is no evidence that these 
extraneous regions play a role in executive functions; in previous work investigating the 
cognitive impact of STN-lesioning, some authors have retained rats with ZI-lesions as 
their inclusion does not influence the behaviour of interest, nor statistical outcome 
(Phillips & Brown, 2000; Phillips & Brown, 1999), whilst others have discarded rats 
that present with cell loss in the ZI, but comment that the data obtained from those 
animals had little impact on behaviour, suggesting that the ZI may have a minimal role 
in this type of cognitive behaviour (Baunez et al., 1995; Baunez & Robbins, 1999). 
Despite attempting to restrict DREADDs transduction to the medial STN with a 
CaMKII promoter, the resulting nuclear transduction of the ZI possibly arose from the 
transduction of the glutamatergic cells that are found in the medial ZID, or since 
CaMKII also phosphorylates GABAA, transduction of the GABA-ergic cells of the ZIV 
(Mitrofanis, 2005). Given the overlapping projections found in this area, particularly 
cortical projections from the OFC to the STN and ZI (Kita et al., 2014), it is still 
possible that this region works in concert to modulate output activity, and perhaps 
inhibition of the STN, along with this select region led to the noted behavioural deficits 
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reported here. However, more research regarding the overall role of the ZI and LHA is 
needed, especially to determine if they exclusively hold executive roles.  
The function of the LHA has predominantly been implicated in the modulation 
of attention and sleep/wake cycles, along with food intake/weight management (Sakurai 
et al., 1998), however recent evidence suggests that lesioning these – principally 
orexinergic – neurons impairs the acquisition of a conditioned orienting response, which 
may extend the functional role of this region into associative learning (Wheeler et al., 
2015). Recent research has suggested that the overlapping region between the 
ventrolateral LHA and the medial ZI work together to modulate attention and arousal, 
yet the ZI (with projections from the frontal eye field), and the LHA (with projections 
from the mPFC) also operate independently; the ZI may modulate oculomotor control in 
attention, and the LHA may modulate exploratory behaviour (Chometton et al., 2017). 
Overall however, there is little evidence to suggest that the ZI or the LHA are 
implication in executive functioning, and more research regarding this is needed.  
8.4 Reconciling attention and associability  
This thesis, whilst trying to further elucidate a cognitive role for the STN, was 
also interested in further understanding and exploring how attentional set is formed. 
Two-stage theories of animal discrimination learning (i.e., Mackintosh’s model; see 
Sutherland & Mackintosh, 1971) offer a theoretical reconciliation for processes of 
attentional set and associative learning, which are seen as complimentary, such that 
strengthening an anthropomorphised ‘analyser’ (i.e., a perceptual dimension) will 
increase the salience of a cue and its association with reward. Early ASST work with 
marmoset monkeys revealed evidence for a dissociation of these two processes, and it 
was found that lesioning different parts of the PFC impairs either reversal learning or 
set-shifting ability (Dias, Robbins, & Roberts, 1996). These authors contended that this 
double-dissociation of ‘associative’ and ‘attentional’ shifting processes may be 
hierarchically organised, or conversely may operate independently. In subsequent work, 
this same double-dissociation has also been found in rats (Birrell & Brown, 2000; 
McAlonan & Brown, 2003; Young & Shapiro, 2009). Interestingly, whilst serial 
reversal learning does not reduce the switching deficit following mPFC-muscimol 
infusions (Rich & Shapiro, 2007), Young & Shapiro found that serial strategy-switching 
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in OFC-muscimol animals normalised spatial reversal learning, which led the authors to 
conclude that ‘switching’ behaviour may engage reversal mechanisms, and thus the two 
processes are likely hierarchically organised.    
Despite supporting a double dissociation, along with measuring strategy shifting 
(and not set-shifting), the evidence presented by Young & Shapiro illustrating a 
relationship between reversal learning and attentional processing aligns with our 
findings from this thesis. The results reported in Chapter 7 demonstrated that reversal 
learning and attentional set are not independent processes, and instead, by inhibiting the 
STN it was possible to impair reversal learning in animals that are unable to form an 
attentional set by presenting these rats with OT. This finding illustrated that these two 
processes could be mediated by a single brain region; a conclusion which also 
challenged whether attentional and reversal functions were two, doubly-dissociable 
processes. This finding also provides credence to Chase et al.’s (2012) claim that the 
reversal and set-formation impairments in OFC-lesioned rats may arise from a single 
cognitive deficit.  
The findings in this thesis, including the notion for a hierarchical relationship 
between associative and attentional processes, supports Mackintosh’s model of 
discrimination learning (Sutherland & Mackintosh, 1971). Currently, the two competing 
theories of animal discrimination learning – the Mackintosh model and the Pearce-Hall 
model (Pearce & Hall, 1980) – both acknowledge the important link between learned 
associations and the driving of attention salience (i.e., where attention is directed). 
Pearce’s model asserts that uncertainty, or novelty in cue quality will drive salience, and 
ultimately attention, whereas Mackintosh’s model posits that the cue which is the best 
predictor for reward will drive attention. According to Pearce’s theory, discrimination 
learning is achieved through configural learning, and therefore subjects associate each 
positively reinforced compound separately with reward. Consequently, Pearce’s model 
cannot readily account for attentional set-shifting, nor offer any reconciliation for an 
observation that requires a two-stage theory, such as the ORE.  
Recent computational modelling by Esber & Haselgrove (2011) has introduced a 
‘hybrid model’ of attention, which in an effort to reconcile Pearce and Mackintosh’s 
contradicting models,  utilises both predictiveness and uncertainty to explain how cue 
salience drives attention. Esber and Haselgrove’s model emphasises a single attentional 
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process based on ‘total predictiveness’; during a discrimination learning trial, a 
calculation is made about how well a cue predicts a reward (Mackintosh), and the extent 
to which each cue is followed by an accurately predicted reward (Pearce-Hall), and the 
result of this calculation will determine whether there is an increase or decrease in 
attention.  
In this hybrid model, the ‘Mackintosh mechanism’ would be employed when an 
established predictive cue (i.e., one learned in a pre-training phase) would be presented 
during a discrimination trial alongside other cues varying in attentional salience. This 
comparison of the relative predictiveness (i.e., the extent to which one cue is a better 
predictor than another; see Kattner, 2015) of these competing cues is what drives 
attentional selection in Mackintosh’s model, in which the best predictor will acquire 
salience. For example, the salience of attention toward sudden ripples in water will 
increase for a wetland heron if the ripples predict the catching of a fish, and the salience 
will further increase if it also predictively signals a lurking alligator since adaptively 
learning about different types of ripples may be the difference between eating and being 
eaten.   
The ‘Pearce-Hall mechanism’ would switch in when two cues do not differ in 
their relative predictiveness but do differ in terms of their absolute predictiveness (i.e., 
the overall probability of being followed by a well-predictable outcome). The omission 
of a reinforcer (Σ𝑉) is a motivationally potent event (e.g., relief if the reinforcer is 
aversive, frustration if it is appetitive), and drives the acquisition of salience in the 
Peace-Hall model; the hybrid model suggests that the expectation of ‘no-reinforcement’ 
detracts from the expectation of reinforcement (ΣV) in order to determine the overall 
prediction of reinforcement (ΣV − Σ𝑉).  For example, the fishing heron will not make a 
catch at the detection of every ripple, as occasionally the fish will get away. The hybrid 
model would maintain that the harder it is for the heron to make a catch, the more 
frustrated it would become as the expectation of reinforcement (i.e., making a catch) 
decreases, which will subsequently enhance the salience of the ripples to a level greater 
than the association of the ripple with fish. This will subsequently increases the heron’s 
attention toward qualities of different types of ripples, and will improve the likelihood 
of making a catch.  
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The formalisation of this hybrid model may serve to reconcile existing evidence 
that separate neural circuits or brain regions can be conceptualised as either a 
‘Mackintoshian’ or one that operates in accordance with a ‘Pearce-Hall’ attentional 
system (e.g., Sharpe & Killcross, 2014). The role of the mPFC in downregulating 
attention toward poor predictors of reward, whilst up-regulating attention toward good 
predictors led Sharpe & Killcross to conceptualise this region as one that participates in 
a Mackintosh attentional system. Conversely, recent research by Esber, Torres-tristani, 
& Holland (2015) suggest that the central nucleus of the amygdala (CeA) and the DMS 
are essential for surprise-induced salience enhancements of attention, suggesting that 
these areas may participate in a Pearce-Hall attentional system.  
The findings reported in this thesis would illustrate a condition in which it is 
possible to dissociate the functioning of the hybrid model, in that, dysregulating the 
STN selectively disrupts the Mackintosh mechanism, whilst potentially leaving the 
Pearce-Hall mechanism intact, or perhaps resulting in a state in which the Pearce-Hall 
mechanism is defaulted to. In this state, the hybrid model may illustrate that a heron 
would attempt to associate the configuration of a type of ripple (stimulus) in the water 
with a fish (reward), which may prove costly if the ripple is in fact predictive of an 
alligator. Pending the heron survives, it will learn to configure a particular type of ripple 
as appetitive (i.e., the ripple which led to the catching of a fish), and another ripple-type 
will be configured as aversive (i.e., the ripple that nearly led to being eaten); yet without 
the Mackintosh mechanism, the heron will not learn about the predictiveness of ripples 
in general, which can be retained and utilised when faced with the presentation of newer 
‘ripple types’. In this thesis, this consideration is best supported by an enhanced bi-
conditional acquisition in CNO-treated rats, whilst failing to evidence an attentional set 
consistent with Mackintosh’s model. It is worth noting that the nature of the 
subthalamic-mediated set-formation impairment requires further exploration since we 
still do not know whether learning stimulus configurations results from an inability to 
form set, or whether learning configurations causes the impairment in the first place. 
Essentially, is inactivation of the STN disabling the Mackintosh mechanism? Or is it 
‘locking in’ the Pearce-Hall mechanism?   
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8.5 Limitations: persisting with ibotenic acid lesions  
The chief limitation noted in this thesis pertained to the failure to produce 
consistent and observable cell loss in the STN following infusions of ibotenic acid. 
Without verifiable and replicable lesions, it was not possible to draw any conclusions 
about the contribution of the STN to behaviour in Chapters 3 and 4. Despite this 
shortcoming being an issue in previously unpublished work (Xia, Dhawan, Tait & 
Brown), we persisted with ibotenic acid as a means to lesions the STN in Chapters 3 & 
4 since when visible damage was evidenced, it was detectable in, and restricted to the 
target region. Furthermore, all of the rats which were administered ibotenic acid 
infusions exhibited the expected ‘chewing’ behaviour following surgery (see section 
2.3.3 and Baunez & Robbins, 1997), along with calcium deposits in the MGP, which is 
usually indicative of accurate lesion placement within the STN, and was not observed in 
control rats. However, as Chapters 3 & 4 illustrated, post-operative chewing behaviour, 
and MGP calcium deposits do not always indicate visible lesion damage.  
Throughout this thesis, the targeting of the mSTN has employed the same 
stereotaxic coordinates as those reported in previous studies, with a minor modification 
of the dorsal-ventral (DV) coordinates (Baunez & Robbins, 1997; Chudasama et al., 
2003; Phillips & Brown, 2000; Tait et al., 2016). Previous research took DV coordinates 
from bregma with minor variations (Phillips:  -8.5mm; Baunez: -8.35mm) yet report 
comparable lesion damage, whilst for this thesis, coordinates were taken from dura, 
rather than bregma, as a glass micropipette (for chapters 3 & 4) was used to deliver the 
toxin (which may have broken if contacted with the skull surface). Xia, Dhawan, Tait 
and Brown (unpublished), along with the rats that presented with discernible lesion 
damage in this thesis, have demonstrated that our lesion coordinates are indeed correct 
for generating cell loss localised to the medial portion of the STN (and minimally to 
adjacent areas near the STN), yet this visible damage was only evident in roughly half 
of the total group which received ibotenic acid infusions. In order to restrict the lesion 
size to the medial STN, we reduced the toxin volume from the widely published 0.4-
0.5µl to 0.2µl, whilst maintaining the same concentration of the toxin (0.06M). It is 
possible, however unlikely, that lesioned rats without discernible damage retained a 
perfectly ‘intact’ STN or ZI, or that the toxin was incorrectly injected ventrally into the 
internal capsule, since all rats presented with calcium deposits in the MGP, and chewing 
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behaviour during recovery. In an effort to detect lesions in this group, Xia, Tait & 
Brown (unpublished) utilised a variety of histological staining techniques, including 
tyrosine hydroxylase, parvalbumin, and glial fibrillary acidic protein, yet no observable 
damage in the STN was detected.  
Previous studies that have reported robust STN lesion damage have utilised 
either a barbiturate anaesthetic, such as pentobarbital sodium (Phillips & Brown, 2000; 
Tait et al., 2016), or a combination of xyalzine and ketamine (Baunez et al., 1995). 
Whilst both approaches provide prolonged sedation compared to an inhalant anaesthetic 
(such as isoflurane used in this thesis), they are not currently available for use for 
surgery on animals. Prolonged sedation allows for the excitotoxin to exert its effect 
without having to use diazepam as an adjunct; past observations in our lab suggest that 
administering diazepam before toxin infusion, rather than before surgery may minimise 
subthalamic lesion extent (Xia, Tait & Brown, unpublished). Furthermore, it has also 
been demonstrated that benzodiazepine treatment before administration of glutamatergic 
excitotoxins such as ibotenic acid (Perez-Rico & Gomez-Ramos, 1984) kainic acid 
(Ben-Ari et al., 1978) and quinolinic acid (Lapin, Prakhie, & Kiseleva, 1986) attenuates 
acid damage; it has been argued that benzodiazepines do not act as receptor antagonists 
for kainic, ibotenic and quinolinic acids, but instead may facilitate GABA inhibition 
(Perez-Rico & Gomez-Ramos, 1984). It is possible that given the small volume of 
excitotoxin infused, that the administration of diazepam prior to the injection of ibotenic 
acid may have attenuated the some of the deleterious effects. It is not being suggested 
here that the addition of diazepam is nullifying the effect of ibotenic acid, especially 
since administration of diazepam both before (Chase et al., 2012) and after (Lindgren et 
al., 2013) excitotoxic surgery still induces measurable cell loss, but perhaps it played a 
part in reducing the spread of the lesion, and contributed to preventing lesion detection.  
Following the histology results from Chapter 4, which were consistent with 
Chapter 3 and previous findings, it was determined that the ibotenic acid surgery 
protocol did not satisfy expectations for manipulating the STN, and therefore alternative 
options were sought, which ultimately led to a relatively novel option – DREADDs. 
These designer receptors were transiently controlled by the designer drug CNO, and 
also reconciled the shortcoming of ibotenic acid infusions, namely, the visualisation of 
the surgical manipulation. DREADDs infusions were also made to the same stereotaxic 
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coordinates as the ibotenic acid infusions, validating that these coordinates were indeed 
accurate, whilst concurrently presenting as a refinement which incurred less harm to the 
animal (i.e., no cellular necrosis, and therefore no chewing).    
8.6 Conclusions 
The work presented in this thesis has highlighted the importance of the 
subthalamic area in mediating the processes which lead to the formation of attentional 
set. By inhibiting cells within this region, including the cells of the medial STN, we 
found evidence that this area mediates attentional selectivity, and perhaps arises as a 
failure to inhibit responding to an irrelevant stimulus dimension. Additionally, this 
thesis elucidated that reversal and attentional process are not independent functions, but 
rather exist in a hierarchy and stem from a common manifestation of attention and 
associability. It is possible that the STN is essential in enabling and maintaining a 
‘Mackintosh-ian attentional system’, which consequently permits the formation of an 
attentional set, and in the absence of this system, we may resort to a Pearce-Hall 
attentional system. With this system engaged, it is easier to acquire an ED stage since 
there is no attentional set to shift away from, corroborating the findings that inhibiting 
the STN may facilitate cognitive flexibility (see neurocomputational model by Frank, 
2006). Given that the nature of the set-formation deficit here is profound (i.e., showing 
little improvement in learning after multiple ID stages), future experiments can attempt 
to ameliorate these deficits through the application of cognitive-enhancing drugs, such 
as modafinil.  
The overall findings here ascribe many ‘frontal’ like functions to a subcortical 
region, and that several of the processes examined by the ASST exemplify what is 
known as ‘executive control’. The maintenance of these executive functions has 
classically been the ascribed role of the PFC, yet a newer school of thought has 
postulated that the notion of a ‘central executive’ may be outdated, and that regions 
such as the basal ganglia, hippocampus, and the posterior cortex work in concert with 
the PFC to create an executive network (Hazy, Frank, & Reilly, 2006). Having a central 
executive also raises several problems, such as: how does the PFC ‘know’ which action 
or response profile to select? Essentially, what is controlling the controller? 
Furthermore, how does learning and experience guide the actions taken by the PFC? 
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Without answering these questions, the current concept of the central executive can be 
likened to that of a homunculus (small man) living inside the PFC and dictating action 
in response to stimuli, which, given the important role of subcortical regions – like the 
STN – in this process, may render a central executive outdated (Hazy, Frank, & Reilly, 
2007). It is clear from the work in this thesis that the STN plays a critical role in several 
cognitive processes that would substantially aid us in daily life. The control exerted by 
the STN facilitates a range of tasks we take for granted, from buying a diet Coke at your 
local newsagent, to planning and executing your next challenge in Scotland: whether 
it’s embarking on a holiday to Ballachulish or writing a PhD thesis in St Andrews.  
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